cancer_type qtl_type tag_SNP LD SNP_id gene_id gene_symbol t-stat p-value beta r Traits SNP_position Gene_position COAD cis rs75358501 0.636 rs2241347 MIMAT0014995 hsa-miR-3130-5p -17.1 2.77e-44 -0.91 -0.73 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206783257 chr2:206783276~206783296:- COAD cis rs75358501 0.636 rs2241347 MIMAT0014995_1 hsa-miR-3130-5p -17.1 2.77e-44 -0.91 -0.73 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206783257 chr2:206783246~206783266:+ COAD cis rs75358501 0.636 rs7576591 MIMAT0014995 hsa-miR-3130-5p -16.73 5.32e-43 -0.91 -0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206784502 chr2:206783276~206783296:- COAD cis rs75358501 0.636 rs7576591 MIMAT0014995_1 hsa-miR-3130-5p -16.73 5.32e-43 -0.91 -0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206784502 chr2:206783246~206783266:+ COAD cis rs75358501 0.636 rs2287628 MIMAT0014995 hsa-miR-3130-5p -16.73 5.32e-43 -0.91 -0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206785809 chr2:206783276~206783296:- COAD cis rs75358501 0.636 rs2287628 MIMAT0014995_1 hsa-miR-3130-5p -16.73 5.32e-43 -0.91 -0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206785809 chr2:206783246~206783266:+ COAD cis rs75358501 0.636 rs12471008 MIMAT0014995 hsa-miR-3130-5p -16.73 5.4e-43 -0.9 -0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206775059 chr2:206783276~206783296:- COAD cis rs75358501 0.636 rs12471008 MIMAT0014995_1 hsa-miR-3130-5p -16.73 5.4e-43 -0.9 -0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206775059 chr2:206783246~206783266:+ COAD cis rs75358501 0.636 rs768533 MIMAT0014995 hsa-miR-3130-5p -16.73 5.4e-43 -0.9 -0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206776113 chr2:206783276~206783296:- COAD cis rs75358501 0.636 rs768533 MIMAT0014995_1 hsa-miR-3130-5p -16.73 5.4e-43 -0.9 -0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206776113 chr2:206783246~206783266:+ COAD cis rs75358501 0.636 rs888621 MIMAT0014995 hsa-miR-3130-5p 16.67 8.6e-43 0.9 0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206784626 chr2:206783276~206783296:- COAD cis rs75358501 0.636 rs888621 MIMAT0014995_1 hsa-miR-3130-5p 16.67 8.6e-43 0.9 0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206784626 chr2:206783246~206783266:+ COAD cis rs75358501 0.636 rs10199766 MIMAT0014995 hsa-miR-3130-5p -16.53 2.73e-42 -0.9 -0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206777144 chr2:206783276~206783296:- COAD cis rs75358501 0.636 rs10199766 MIMAT0014995_1 hsa-miR-3130-5p -16.53 2.73e-42 -0.9 -0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206777144 chr2:206783246~206783266:+ COAD cis rs75358501 0.636 rs13427002 MIMAT0014995 hsa-miR-3130-5p -16.53 2.73e-42 -0.9 -0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206778949 chr2:206783276~206783296:- COAD cis rs75358501 0.636 rs13427002 MIMAT0014995_1 hsa-miR-3130-5p -16.53 2.73e-42 -0.9 -0.72 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206778949 chr2:206783246~206783266:+ COAD cis rs75358501 0.636 rs11895370 MIMAT0014995 hsa-miR-3130-5p -16.35 1.08e-41 -0.89 -0.71 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206789990 chr2:206783276~206783296:- COAD cis rs75358501 0.636 rs11895370 MIMAT0014995_1 hsa-miR-3130-5p -16.35 1.08e-41 -0.89 -0.71 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206789990 chr2:206783246~206783266:+ COAD cis rs75358501 0.636 rs725980 MIMAT0014995 hsa-miR-3130-5p -16.34 1.17e-41 -0.9 -0.71 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206773856 chr2:206783276~206783296:- COAD cis rs75358501 0.636 rs725980 MIMAT0014995_1 hsa-miR-3130-5p -16.34 1.17e-41 -0.9 -0.71 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206773856 chr2:206783246~206783266:+ COAD cis rs75358501 0.688 rs2287629 MIMAT0014995 hsa-miR-3130-5p 16.33 1.34e-41 0.88 0.71 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206785690 chr2:206783276~206783296:- COAD cis rs75358501 0.688 rs2287629 MIMAT0014995_1 hsa-miR-3130-5p 16.33 1.34e-41 0.88 0.71 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206785690 chr2:206783246~206783266:+ COAD cis rs75358501 0.636 rs16838834 MIMAT0014995 hsa-miR-3130-5p -16.01 1.68e-40 -0.89 -0.71 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206765071 chr2:206783276~206783296:- COAD cis rs75358501 0.636 rs16838834 MIMAT0014995_1 hsa-miR-3130-5p -16.01 1.68e-40 -0.89 -0.71 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206765071 chr2:206783246~206783266:+ COAD cis rs75358501 0.636 rs3815686 MIMAT0014995 hsa-miR-3130-5p -15.45 1.57e-38 -0.87 -0.69 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206768278 chr2:206783276~206783296:- COAD cis rs75358501 0.636 rs3815686 MIMAT0014995_1 hsa-miR-3130-5p -15.45 1.57e-38 -0.87 -0.69 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206768278 chr2:206783246~206783266:+ COAD cis rs6841433 1 rs13133286 MIMAT0003242 hsa-miR-577 14.78 3.28e-36 0.74 0.68 Hemoglobin concentration; chr4:114701654 chr4:114656774~114656794:+ COAD cis rs6841433 0.948 rs35736852 MIMAT0003242 hsa-miR-577 14.68 7.44e-36 0.72 0.68 Hemoglobin concentration; chr4:114687255 chr4:114656774~114656794:+ COAD cis rs6841433 1 rs34115976 MIMAT0003242 hsa-miR-577 14.64 1.08e-35 0.73 0.67 Hemoglobin concentration; chr4:114656841 chr4:114656774~114656794:+ COAD cis rs6841433 1 rs13133899 MIMAT0003242 hsa-miR-577 14.53 2.47e-35 0.72 0.67 Hemoglobin concentration; chr4:114661153 chr4:114656774~114656794:+ COAD cis rs6841433 1 rs34546485 MIMAT0003242 hsa-miR-577 14.45 4.97e-35 0.73 0.67 Hemoglobin concentration; chr4:114693882 chr4:114656774~114656794:+ COAD cis rs6841433 1 rs7677294 MIMAT0003242 hsa-miR-577 14.35 1.11e-34 0.72 0.67 Hemoglobin concentration; chr4:114633283 chr4:114656774~114656794:+ COAD cis rs6841433 0.948 rs34110012 MIMAT0003242 hsa-miR-577 14.13 6.33e-34 0.72 0.66 Hemoglobin concentration; chr4:114710498 chr4:114656774~114656794:+ COAD cis rs75358501 0.584 rs11894165 MIMAT0014995 hsa-miR-3130-5p -14 1.81e-33 -0.89 -0.66 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206759688 chr2:206783276~206783296:- COAD cis rs75358501 0.584 rs11894165 MIMAT0014995_1 hsa-miR-3130-5p -14 1.81e-33 -0.89 -0.66 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206759688 chr2:206783246~206783266:+ COAD cis rs75358501 0.688 rs1862087 MIMAT0014995 hsa-miR-3130-5p -13.92 3.34e-33 -0.87 -0.66 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206760843 chr2:206783276~206783296:- COAD cis rs75358501 0.688 rs1862087 MIMAT0014995_1 hsa-miR-3130-5p -13.92 3.34e-33 -0.87 -0.66 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206760843 chr2:206783246~206783266:+ COAD cis rs75358501 0.636 rs7580138 MIMAT0014995 hsa-miR-3130-5p -13.37 2.69e-31 -0.87 -0.64 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206750560 chr2:206783276~206783296:- COAD cis rs75358501 0.636 rs7580138 MIMAT0014995_1 hsa-miR-3130-5p -13.37 2.69e-31 -0.87 -0.64 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206750560 chr2:206783246~206783266:+ COAD cis rs6841433 1 rs35217170 MIMAT0003242 hsa-miR-577 13.25 6.87e-31 0.64 0.64 Hemoglobin concentration; chr4:114672701 chr4:114656774~114656794:+ COAD cis rs6841433 0.948 rs13135834 MIMAT0003242 hsa-miR-577 13.25 6.87e-31 0.64 0.64 Hemoglobin concentration; chr4:114678835 chr4:114656774~114656794:+ COAD cis rs6841433 1 rs55875005 MIMAT0003242 hsa-miR-577 13.22 8.91e-31 0.64 0.64 Hemoglobin concentration; chr4:114691920 chr4:114656774~114656794:+ COAD cis rs75358501 0.636 rs1862089 MIMAT0014995 hsa-miR-3130-5p -13.14 1.66e-30 -0.85 -0.63 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206755794 chr2:206783276~206783296:- COAD cis rs75358501 0.636 rs1862089 MIMAT0014995_1 hsa-miR-3130-5p -13.14 1.66e-30 -0.85 -0.63 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206755794 chr2:206783246~206783266:+ COAD cis rs75358501 0.636 rs10932164 MIMAT0014995 hsa-miR-3130-5p -13.13 1.74e-30 -0.84 -0.63 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206751601 chr2:206783276~206783296:- COAD cis rs75358501 0.636 rs10932164 MIMAT0014995_1 hsa-miR-3130-5p -13.13 1.74e-30 -0.84 -0.63 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206751601 chr2:206783246~206783266:+ COAD cis rs6841433 1 rs35271056 MIMAT0003242 hsa-miR-577 13.11 1.99e-30 0.64 0.63 Hemoglobin concentration; chr4:114642195 chr4:114656774~114656794:+ COAD cis rs6841433 1 rs10011293 MIMAT0003242 hsa-miR-577 13.1 2.22e-30 0.64 0.63 Hemoglobin concentration; chr4:114656225 chr4:114656774~114656794:+ COAD cis rs6841433 0.848 rs13328022 MIMAT0003242 hsa-miR-577 13.07 2.8e-30 0.64 0.63 Hemoglobin concentration; chr4:114700701 chr4:114656774~114656794:+ COAD cis rs6841433 0.948 rs7671477 MIMAT0003242 hsa-miR-577 13.04 3.65e-30 0.64 0.63 Hemoglobin concentration; chr4:114632518 chr4:114656774~114656794:+ COAD cis rs6841433 1 rs6533803 MIMAT0003242 hsa-miR-577 13.01 4.73e-30 0.64 0.63 Hemoglobin concentration; chr4:114637085 chr4:114656774~114656794:+ COAD cis rs6841433 1 rs10049660 MIMAT0003242 hsa-miR-577 13.01 4.73e-30 0.64 0.63 Hemoglobin concentration; chr4:114637758 chr4:114656774~114656794:+ COAD cis rs6841433 1 rs10008981 MIMAT0003242 hsa-miR-577 12.82 2.07e-29 0.63 0.62 Hemoglobin concentration; chr4:114650189 chr4:114656774~114656794:+ COAD cis rs6841433 1 rs6828127 MIMAT0003242 hsa-miR-577 12.76 3.14e-29 0.61 0.62 Hemoglobin concentration; chr4:114689927 chr4:114656774~114656794:+ COAD cis rs6841433 0.95 rs28696112 MIMAT0003242 hsa-miR-577 12.74 3.67e-29 0.63 0.62 Hemoglobin concentration; chr4:114601833 chr4:114656774~114656794:+ COAD cis rs6841433 1 rs28390138 MIMAT0003242 hsa-miR-577 12.7 5.42e-29 0.62 0.62 Hemoglobin concentration; chr4:114687320 chr4:114656774~114656794:+ COAD cis rs6841433 1 rs6841433 MIMAT0003242 hsa-miR-577 12.62 9.71e-29 0.62 0.62 Hemoglobin concentration; chr4:114647874 chr4:114656774~114656794:+ COAD cis rs6841433 0.904 rs4130705 MIMAT0003242 hsa-miR-577 12.55 1.66e-28 0.62 0.62 Hemoglobin concentration; chr4:114609479 chr4:114656774~114656794:+ COAD cis rs6841433 1 rs34403669 MIMAT0003242 hsa-miR-577 12.46 3.41e-28 0.62 0.61 Hemoglobin concentration; chr4:114703735 chr4:114656774~114656794:+ COAD cis rs6841433 0.948 rs9884805 MIMAT0003242 hsa-miR-577 12.43 4.21e-28 0.62 0.61 Hemoglobin concentration; chr4:114697040 chr4:114656774~114656794:+ COAD cis rs6841433 0.706 rs13147491 MIMAT0003242 hsa-miR-577 9.7 3.67e-19 0.67 0.52 Hemoglobin concentration; chr4:114696462 chr4:114656774~114656794:+ COAD cis rs6841433 0.706 rs13134858 MIMAT0003242 hsa-miR-577 9.54 1.16e-18 0.67 0.51 Hemoglobin concentration; chr4:114601150 chr4:114656774~114656794:+ COAD cis rs6841433 0.706 rs35571359 MIMAT0003242 hsa-miR-577 9.5 1.54e-18 0.66 0.51 Hemoglobin concentration; chr4:114606130 chr4:114656774~114656794:+ COAD cis rs6841433 0.706 rs35759252 MIMAT0003242 hsa-miR-577 9.5 1.54e-18 0.66 0.51 Hemoglobin concentration; chr4:114608520 chr4:114656774~114656794:+ COAD cis rs6841433 0.904 rs11731984 MIMAT0003242 hsa-miR-577 -8.81 1.95e-16 -0.42 -0.48 Hemoglobin concentration; chr4:114663873 chr4:114656774~114656794:+ COAD cis rs6841433 0.699 rs12643031 MIMAT0003242 hsa-miR-577 8.8 2.03e-16 0.48 0.48 Hemoglobin concentration; chr4:114541449 chr4:114656774~114656794:+ COAD cis rs6841433 0.607 rs34695716 MIMAT0003242 hsa-miR-577 -8.75 2.81e-16 -0.41 -0.48 Hemoglobin concentration; chr4:114658285 chr4:114656774~114656794:+ COAD cis rs6841433 0.75 rs6857337 MIMAT0003242 hsa-miR-577 8.53 1.27e-15 0.39 0.47 Hemoglobin concentration; chr4:114667805 chr4:114656774~114656794:+ COAD cis rs6753739 0.745 rs6436104 MIMAT0014996 hsa-miR-3131 8.42 2.68e-15 0.57 0.46 Height; chr2:219051045 chr2:219058725~219058747:- COAD cis rs6753739 0.745 rs4674356 MIMAT0014996 hsa-miR-3131 8.4 3.02e-15 0.57 0.46 Height; chr2:219049911 chr2:219058725~219058747:- COAD cis rs6841433 0.718 rs7656139 MIMAT0003242 hsa-miR-577 -8.36 3.92e-15 -0.4 -0.46 Hemoglobin concentration; chr4:114672622 chr4:114656774~114656794:+ COAD cis rs6753739 0.871 rs6436113 MIMAT0014996 hsa-miR-3131 8.35 4.32e-15 0.54 0.46 Height; chr2:219120176 chr2:219058725~219058747:- COAD cis rs6841433 0.687 rs12640227 MIMAT0003242 hsa-miR-577 -8.35 4.32e-15 -0.4 -0.46 Hemoglobin concentration; chr4:114700788 chr4:114656774~114656794:+ COAD cis rs6753739 0.745 rs1378640 MIMAT0014996 hsa-miR-3131 8.14 1.74e-14 0.55 0.45 Height; chr2:219052910 chr2:219058725~219058747:- COAD cis rs6841433 0.632 rs7699896 MIMAT0003242 hsa-miR-577 8.1 2.21e-14 0.38 0.45 Hemoglobin concentration; chr4:114617357 chr4:114656774~114656794:+ COAD cis rs6753739 0.784 rs7578383 MIMAT0014996 hsa-miR-3131 8.04 3.39e-14 0.55 0.45 Height; chr2:219066129 chr2:219058725~219058747:- COAD cis rs6753739 0.871 rs6436109 MIMAT0014996 hsa-miR-3131 8 4.35e-14 0.53 0.45 Height; chr2:219115759 chr2:219058725~219058747:- COAD cis rs6753739 0.871 rs1869802 MIMAT0014996 hsa-miR-3131 7.98 4.97e-14 0.52 0.45 Height; chr2:219112311 chr2:219058725~219058747:- COAD cis rs6753739 0.784 rs6730783 MIMAT0014996 hsa-miR-3131 7.92 7.34e-14 0.55 0.44 Height; chr2:219058113 chr2:219058725~219058747:- COAD cis rs6753739 0.826 rs897477 MIMAT0014996 hsa-miR-3131 7.9 8.24e-14 0.53 0.44 Height; chr2:219076341 chr2:219058725~219058747:- COAD cis rs6753739 0.784 rs10168527 MIMAT0014996 hsa-miR-3131 7.88 9.19e-14 0.53 0.44 Height; chr2:219107653 chr2:219058725~219058747:- COAD cis rs6753739 0.871 rs2030450 MIMAT0014996 hsa-miR-3131 7.84 1.21e-13 0.52 0.44 Height; chr2:219132157 chr2:219058725~219058747:- COAD cis rs6753739 0.826 rs10171368 MIMAT0014996 hsa-miR-3131 7.78 1.81e-13 0.53 0.44 Height; chr2:219069055 chr2:219058725~219058747:- COAD cis rs6753739 0.826 rs6732562 MIMAT0014996 hsa-miR-3131 7.77 1.91e-13 0.52 0.44 Height; chr2:219102140 chr2:219058725~219058747:- COAD cis rs6841433 0.632 rs7679995 MIMAT0003242 hsa-miR-577 -7.73 2.45e-13 -0.37 -0.43 Hemoglobin concentration; chr4:114665137 chr4:114656774~114656794:+ COAD cis rs6753739 0.826 rs6711613 MIMAT0014996 hsa-miR-3131 7.69 3.09e-13 0.51 0.43 Height; chr2:219082969 chr2:219058725~219058747:- COAD cis rs6753739 0.784 rs11690649 MIMAT0014996 hsa-miR-3131 7.69 3.09e-13 0.51 0.43 Height; chr2:219083049 chr2:219058725~219058747:- COAD cis rs6753739 0.826 rs7599778 MIMAT0014996 hsa-miR-3131 7.67 3.52e-13 0.52 0.43 Height; chr2:219096938 chr2:219058725~219058747:- COAD cis rs6753739 0.871 rs6436114 MIMAT0014996 hsa-miR-3131 7.66 3.9e-13 0.51 0.43 Height; chr2:219138112 chr2:219058725~219058747:- COAD cis rs6753739 0.826 rs10164493 MIMAT0014996 hsa-miR-3131 7.65 4.13e-13 0.52 0.43 Height; chr2:219083370 chr2:219058725~219058747:- COAD cis rs6753739 0.784 rs1378642 MIMAT0014996 hsa-miR-3131 7.62 4.86e-13 0.51 0.43 Height; chr2:219085388 chr2:219058725~219058747:- COAD cis rs6753739 0.871 rs10932796 MIMAT0014996 hsa-miR-3131 7.55 7.38e-13 0.49 0.43 Height; chr2:219156790 chr2:219058725~219058747:- COAD cis rs6841433 0.615 rs35789595 MIMAT0003242 hsa-miR-577 7.51 9.68e-13 0.48 0.42 Hemoglobin concentration; chr4:114594055 chr4:114656774~114656794:+ COAD cis rs950880 0.71 rs1474309 MIMAT0019926 hsa-miR-4772-5p 7.5 1.03e-12 0.91 0.42 Serum protein levels (sST2); chr2:102474542 chr2:102432300~102432321:+ COAD cis rs6841433 0.615 rs56149980 MIMAT0003242 hsa-miR-577 7.5 1.07e-12 0.48 0.42 Hemoglobin concentration; chr4:114576580 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs12642541 MIMAT0003242 hsa-miR-577 7.5 1.07e-12 0.48 0.42 Hemoglobin concentration; chr4:114579576 chr4:114656774~114656794:+ COAD cis rs6841433 0.571 rs35578985 MIMAT0003242 hsa-miR-577 7.49 1.11e-12 0.48 0.42 Hemoglobin concentration; chr4:114594500 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs34001486 MIMAT0003242 hsa-miR-577 7.49 1.11e-12 0.48 0.42 Hemoglobin concentration; chr4:114594792 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs57930571 MIMAT0003242 hsa-miR-577 7.42 1.66e-12 0.47 0.42 Hemoglobin concentration; chr4:114580433 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs35732213 MIMAT0003242 hsa-miR-577 7.42 1.66e-12 0.47 0.42 Hemoglobin concentration; chr4:114581427 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs35936834 MIMAT0003242 hsa-miR-577 7.42 1.66e-12 0.47 0.42 Hemoglobin concentration; chr4:114581520 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs6813229 MIMAT0003242 hsa-miR-577 7.42 1.66e-12 0.47 0.42 Hemoglobin concentration; chr4:114582721 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs6813283 MIMAT0003242 hsa-miR-577 7.42 1.66e-12 0.47 0.42 Hemoglobin concentration; chr4:114582806 chr4:114656774~114656794:+ COAD cis rs6841433 0.571 rs6839189 MIMAT0003242 hsa-miR-577 7.42 1.66e-12 0.47 0.42 Hemoglobin concentration; chr4:114582848 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs7437576 MIMAT0003242 hsa-miR-577 7.42 1.7e-12 0.48 0.42 Hemoglobin concentration; chr4:114595467 chr4:114656774~114656794:+ COAD cis rs6841433 0.561 rs13148598 MIMAT0003242 hsa-miR-577 -7.36 2.45e-12 -0.36 -0.42 Hemoglobin concentration; chr4:114676939 chr4:114656774~114656794:+ COAD cis rs75358501 0.901 rs16838691 MIMAT0014995 hsa-miR-3130-5p -7.35 2.64e-12 -0.77 -0.42 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206718128 chr2:206783276~206783296:- COAD cis rs75358501 0.901 rs16838691 MIMAT0014995_1 hsa-miR-3130-5p -7.35 2.64e-12 -0.77 -0.42 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206718128 chr2:206783246~206783266:+ COAD cis rs6841433 0.632 rs4585328 MIMAT0003242 hsa-miR-577 -7.35 2.71e-12 -0.35 -0.42 Hemoglobin concentration; chr4:114613660 chr4:114656774~114656794:+ COAD cis rs6841433 0.632 rs7685523 MIMAT0003242 hsa-miR-577 -7.32 3.12e-12 -0.35 -0.42 Hemoglobin concentration; chr4:114621913 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs13144260 MIMAT0003242 hsa-miR-577 7.26 4.66e-12 0.46 0.41 Hemoglobin concentration; chr4:114573271 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs34948407 MIMAT0003242 hsa-miR-577 7.26 4.66e-12 0.46 0.41 Hemoglobin concentration; chr4:114575280 chr4:114656774~114656794:+ COAD cis rs6841433 0.632 rs4834428 MIMAT0003242 hsa-miR-577 -7.24 5.06e-12 -0.35 -0.41 Hemoglobin concentration; chr4:114683908 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs35082726 MIMAT0003242 hsa-miR-577 7.24 5.07e-12 0.47 0.41 Hemoglobin concentration; chr4:114566777 chr4:114656774~114656794:+ COAD cis rs6841433 0.571 rs17047238 MIMAT0003242 hsa-miR-577 7.24 5.07e-12 0.47 0.41 Hemoglobin concentration; chr4:114568870 chr4:114656774~114656794:+ COAD cis rs6753739 0.745 rs7572601 MIMAT0014996 hsa-miR-3131 7.24 5.31e-12 0.48 0.41 Height; chr2:219154762 chr2:219058725~219058747:- COAD cis rs6753739 0.871 rs6724718 MIMAT0014996 hsa-miR-3131 -7.22 5.75e-12 -0.47 -0.41 Height; chr2:219139521 chr2:219058725~219058747:- COAD cis rs6841433 0.571 rs17047244 MIMAT0003242 hsa-miR-577 7.17 7.8e-12 0.46 0.41 Hemoglobin concentration; chr4:114571532 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs17047246 MIMAT0003242 hsa-miR-577 7.17 7.8e-12 0.46 0.41 Hemoglobin concentration; chr4:114571876 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs7434753 MIMAT0003242 hsa-miR-577 7.17 8.01e-12 0.46 0.41 Hemoglobin concentration; chr4:114596387 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs17047239 MIMAT0003242 hsa-miR-577 7.16 8.48e-12 0.46 0.41 Hemoglobin concentration; chr4:114570559 chr4:114656774~114656794:+ COAD cis rs6753739 0.627 rs2293070 MIMAT0014996 hsa-miR-3131 7.14 9.28e-12 0.47 0.41 Height; chr2:219158882 chr2:219058725~219058747:- COAD cis rs6841433 0.615 rs1380932 MIMAT0003242 hsa-miR-577 7.13 1.04e-11 0.46 0.41 Hemoglobin concentration; chr4:114565923 chr4:114656774~114656794:+ COAD cis rs6841433 0.632 rs35717197 MIMAT0003242 hsa-miR-577 -7.1 1.2e-11 -0.34 -0.41 Hemoglobin concentration; chr4:114639584 chr4:114656774~114656794:+ COAD cis rs6841433 0.632 rs13106767 MIMAT0003242 hsa-miR-577 -7.1 1.2e-11 -0.34 -0.41 Hemoglobin concentration; chr4:114635719 chr4:114656774~114656794:+ COAD cis rs6841433 0.632 rs13152031 MIMAT0003242 hsa-miR-577 -7.09 1.33e-11 -0.34 -0.4 Hemoglobin concentration; chr4:114644503 chr4:114656774~114656794:+ COAD cis rs6841433 0.632 rs6533807 MIMAT0003242 hsa-miR-577 -7.04 1.78e-11 -0.34 -0.4 Hemoglobin concentration; chr4:114699454 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs4409025 MIMAT0003242 hsa-miR-577 -7 2.16e-11 -0.31 -0.4 Optic disc area; chr4:114511785 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs4409026 MIMAT0003242 hsa-miR-577 -7 2.16e-11 -0.31 -0.4 Optic disc area; chr4:114511787 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs2054306 MIMAT0003242 hsa-miR-577 -7 2.26e-11 -0.31 -0.4 Optic disc area; chr4:114496204 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs2035059 MIMAT0003242 hsa-miR-577 -7 2.26e-11 -0.31 -0.4 Optic disc area; chr4:114496530 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs993460 MIMAT0003242 hsa-miR-577 -6.97 2.67e-11 -0.31 -0.4 Optic disc area; chr4:114510521 chr4:114656774~114656794:+ COAD cis rs10021731 0.693 rs7686100 MIMAT0003242 hsa-miR-577 -6.97 2.67e-11 -0.31 -0.4 Optic disc area; chr4:114511670 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs7690858 MIMAT0003242 hsa-miR-577 -6.97 2.67e-11 -0.31 -0.4 Optic disc area; chr4:114511804 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs4295329 MIMAT0003242 hsa-miR-577 -6.97 2.67e-11 -0.31 -0.4 Optic disc area; chr4:114511945 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs4409027 MIMAT0003242 hsa-miR-577 -6.97 2.67e-11 -0.31 -0.4 Optic disc area; chr4:114511985 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs4413472 MIMAT0003242 hsa-miR-577 -6.97 2.67e-11 -0.31 -0.4 Optic disc area; chr4:114512090 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs11936113 MIMAT0003242 hsa-miR-577 -6.97 2.67e-11 -0.31 -0.4 Optic disc area; chr4:114512224 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs11936150 MIMAT0003242 hsa-miR-577 -6.97 2.67e-11 -0.31 -0.4 Optic disc area; chr4:114512391 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs28361366 MIMAT0003242 hsa-miR-577 -6.97 2.67e-11 -0.31 -0.4 Optic disc area; chr4:114512809 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs28656197 MIMAT0003242 hsa-miR-577 -6.97 2.67e-11 -0.31 -0.4 Optic disc area; chr4:114512821 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs2199314 MIMAT0003242 hsa-miR-577 -6.97 2.67e-11 -0.31 -0.4 Optic disc area; chr4:114513555 chr4:114656774~114656794:+ COAD cis rs6841433 0.516 rs11098259 MIMAT0003242 hsa-miR-577 -6.96 2.77e-11 -0.44 -0.4 Hemoglobin concentration; chr4:114598669 chr4:114656774~114656794:+ COAD cis rs6841433 0.56 rs11098260 MIMAT0003242 hsa-miR-577 -6.96 2.77e-11 -0.44 -0.4 Hemoglobin concentration; chr4:114598670 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs13102706 MIMAT0003242 hsa-miR-577 -6.95 3.09e-11 -0.31 -0.4 Optic disc area; chr4:114492998 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs13102910 MIMAT0003242 hsa-miR-577 -6.95 3.09e-11 -0.31 -0.4 Optic disc area; chr4:114493049 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs13127839 MIMAT0003242 hsa-miR-577 -6.95 3.09e-11 -0.31 -0.4 Optic disc area; chr4:114493059 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs13103158 MIMAT0003242 hsa-miR-577 -6.95 3.09e-11 -0.31 -0.4 Optic disc area; chr4:114493188 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs13127680 MIMAT0003242 hsa-miR-577 -6.95 3.09e-11 -0.31 -0.4 Optic disc area; chr4:114493217 chr4:114656774~114656794:+ COAD cis rs10021731 0.693 rs4834415 MIMAT0003242 hsa-miR-577 -6.95 3.09e-11 -0.31 -0.4 Optic disc area; chr4:114493245 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs4833458 MIMAT0003242 hsa-miR-577 -6.95 3.09e-11 -0.31 -0.4 Optic disc area; chr4:114493571 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs4833459 MIMAT0003242 hsa-miR-577 -6.95 3.09e-11 -0.31 -0.4 Optic disc area; chr4:114493734 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs12501292 MIMAT0003242 hsa-miR-577 -6.95 3.09e-11 -0.31 -0.4 Optic disc area; chr4:114493876 chr4:114656774~114656794:+ COAD cis rs10021731 0.622 rs12711027 MIMAT0003242 hsa-miR-577 -6.95 3.09e-11 -0.31 -0.4 Optic disc area; chr4:114494204 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs13148430 MIMAT0003242 hsa-miR-577 -6.95 3.09e-11 -0.31 -0.4 Optic disc area; chr4:114494469 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs10028232 MIMAT0003242 hsa-miR-577 -6.93 3.47e-11 -0.31 -0.4 Optic disc area; chr4:114487644 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs7671026 MIMAT0003242 hsa-miR-577 -6.93 3.47e-11 -0.31 -0.4 Optic disc area; chr4:114487736 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs10031142 MIMAT0003242 hsa-miR-577 -6.93 3.47e-11 -0.31 -0.4 Optic disc area; chr4:114488433 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs17678686 MIMAT0003242 hsa-miR-577 -6.93 3.47e-11 -0.31 -0.4 Optic disc area; chr4:114489100 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs28766989 MIMAT0003242 hsa-miR-577 -6.93 3.47e-11 -0.31 -0.4 Optic disc area; chr4:114489752 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs11722125 MIMAT0003242 hsa-miR-577 -6.93 3.47e-11 -0.31 -0.4 Optic disc area; chr4:114490374 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs11722162 MIMAT0003242 hsa-miR-577 -6.93 3.47e-11 -0.31 -0.4 Optic disc area; chr4:114490460 chr4:114656774~114656794:+ COAD cis rs10021731 0.668 rs11722201 MIMAT0003242 hsa-miR-577 -6.93 3.47e-11 -0.31 -0.4 Optic disc area; chr4:114490577 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs1585447 MIMAT0003242 hsa-miR-577 -6.93 3.47e-11 -0.31 -0.4 Optic disc area; chr4:114490912 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs1585448 MIMAT0003242 hsa-miR-577 -6.93 3.47e-11 -0.31 -0.4 Optic disc area; chr4:114491050 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs1870655 MIMAT0003242 hsa-miR-577 -6.93 3.47e-11 -0.31 -0.4 Optic disc area; chr4:114491625 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs2219591 MIMAT0003242 hsa-miR-577 -6.93 3.47e-11 -0.31 -0.4 Optic disc area; chr4:114491902 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs2199310 MIMAT0003242 hsa-miR-577 -6.92 3.54e-11 -0.31 -0.4 Optic disc area; chr4:114492246 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs6839599 MIMAT0003242 hsa-miR-577 -6.92 3.62e-11 -0.31 -0.4 Optic disc area; chr4:114494754 chr4:114656774~114656794:+ COAD cis rs75358501 0.901 rs79499040 MIMAT0014995 hsa-miR-3130-5p -6.91 3.72e-11 -0.76 -0.4 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206776206 chr2:206783276~206783296:- COAD cis rs75358501 0.901 rs79499040 MIMAT0014995_1 hsa-miR-3130-5p -6.91 3.72e-11 -0.76 -0.4 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206776206 chr2:206783246~206783266:+ COAD cis rs10021731 0.692 rs2054303 MIMAT0003242 hsa-miR-577 -6.91 3.84e-11 -0.31 -0.4 Optic disc area; chr4:114495803 chr4:114656774~114656794:+ COAD cis rs10021731 0.645 rs7698524 MIMAT0003242 hsa-miR-577 -6.91 3.92e-11 -0.31 -0.4 Optic disc area; chr4:114492417 chr4:114656774~114656794:+ COAD cis rs10021731 0.668 rs7698363 MIMAT0003242 hsa-miR-577 -6.91 3.92e-11 -0.31 -0.4 Optic disc area; chr4:114492418 chr4:114656774~114656794:+ COAD cis rs6753739 0.871 rs9784128 MIMAT0014996 hsa-miR-3131 -6.9 3.93e-11 -0.48 -0.4 Height; chr2:219113916 chr2:219058725~219058747:- COAD cis rs6841433 0.615 rs6849357 MIMAT0003242 hsa-miR-577 -6.9 3.93e-11 -0.43 -0.4 Hemoglobin concentration; chr4:114598115 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs13112553 MIMAT0003242 hsa-miR-577 -6.9 3.93e-11 -0.43 -0.4 Hemoglobin concentration; chr4:114598194 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs28736894 MIMAT0003242 hsa-miR-577 -6.88 4.52e-11 -0.31 -0.39 Optic disc area; chr4:114514184 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs17622270 MIMAT0003242 hsa-miR-577 -6.88 4.52e-11 -0.31 -0.39 Optic disc area; chr4:114514205 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs958771 MIMAT0003242 hsa-miR-577 -6.88 4.52e-11 -0.31 -0.39 Optic disc area; chr4:114514506 chr4:114656774~114656794:+ COAD cis rs10021731 0.668 rs66482879 MIMAT0003242 hsa-miR-577 -6.88 4.52e-11 -0.31 -0.39 Optic disc area; chr4:114517522 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs28657376 MIMAT0003242 hsa-miR-577 -6.88 4.52e-11 -0.31 -0.39 Optic disc area; chr4:114517650 chr4:114656774~114656794:+ COAD cis rs10021731 0.668 rs7684322 MIMAT0003242 hsa-miR-577 -6.87 4.8e-11 -0.31 -0.39 Optic disc area; chr4:114519788 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs12108520 MIMAT0003242 hsa-miR-577 -6.87 4.8e-11 -0.31 -0.39 Optic disc area; chr4:114522087 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs13117126 MIMAT0003242 hsa-miR-577 -6.87 4.8e-11 -0.31 -0.39 Optic disc area; chr4:114526758 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs10516602 MIMAT0003242 hsa-miR-577 -6.86 4.98e-11 -0.3 -0.39 Optic disc area; chr4:114486174 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs10516604 MIMAT0003242 hsa-miR-577 6.86 5.04e-11 0.44 0.39 Hemoglobin concentration; chr4:114546112 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs13135560 MIMAT0003242 hsa-miR-577 6.86 5.04e-11 0.44 0.39 Hemoglobin concentration; chr4:114547331 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs35777558 MIMAT0003242 hsa-miR-577 6.86 5.04e-11 0.44 0.39 Hemoglobin concentration; chr4:114548111 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs79776742 MIMAT0003242 hsa-miR-577 6.86 5.04e-11 0.44 0.39 Hemoglobin concentration; chr4:114550195 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs57059575 MIMAT0003242 hsa-miR-577 6.86 5.04e-11 0.44 0.39 Hemoglobin concentration; chr4:114551237 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs13147106 MIMAT0003242 hsa-miR-577 6.86 5.04e-11 0.44 0.39 Hemoglobin concentration; chr4:114552206 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs13147485 MIMAT0003242 hsa-miR-577 6.86 5.04e-11 0.44 0.39 Hemoglobin concentration; chr4:114552321 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs35252674 MIMAT0003242 hsa-miR-577 6.86 5.04e-11 0.44 0.39 Hemoglobin concentration; chr4:114556583 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs12641516 MIMAT0003242 hsa-miR-577 6.86 5.04e-11 0.44 0.39 Hemoglobin concentration; chr4:114556972 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs71606719 MIMAT0003242 hsa-miR-577 6.86 5.04e-11 0.44 0.39 Hemoglobin concentration; chr4:114557814 chr4:114656774~114656794:+ COAD cis rs6841433 0.511 rs13125495 MIMAT0003242 hsa-miR-577 6.86 5.04e-11 0.44 0.39 Hemoglobin concentration; chr4:114558326 chr4:114656774~114656794:+ COAD cis rs6841433 0.571 rs13129837 MIMAT0003242 hsa-miR-577 6.82 6.43e-11 0.44 0.39 Hemoglobin concentration; chr4:114563925 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs17047198 MIMAT0003242 hsa-miR-577 6.81 6.91e-11 0.44 0.39 Hemoglobin concentration; chr4:114544338 chr4:114656774~114656794:+ COAD cis rs10021731 0.668 rs12512563 MIMAT0003242 hsa-miR-577 -6.81 7.06e-11 -0.31 -0.39 Optic disc area; chr4:114493973 chr4:114656774~114656794:+ COAD cis rs10021731 0.6 rs12504927 MIMAT0003242 hsa-miR-577 -6.81 7.06e-11 -0.31 -0.39 Optic disc area; chr4:114493975 chr4:114656774~114656794:+ COAD cis rs10021731 0.645 rs13147121 MIMAT0003242 hsa-miR-577 -6.81 7.06e-11 -0.31 -0.39 Optic disc area; chr4:114493994 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs13147488 MIMAT0003242 hsa-miR-577 -6.81 7.06e-11 -0.31 -0.39 Optic disc area; chr4:114494051 chr4:114656774~114656794:+ COAD cis rs10021731 0.693 rs114243292 MIMAT0003242 hsa-miR-577 -6.8 7.2e-11 -0.31 -0.39 Optic disc area; chr4:114516751 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs12511581 MIMAT0003242 hsa-miR-577 -6.8 7.2e-11 -0.42 -0.39 Hemoglobin concentration; chr4:114598400 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs1460772 MIMAT0003242 hsa-miR-577 -6.78 8.07e-11 -0.3 -0.39 Optic disc area; chr4:114487028 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs6840798 MIMAT0003242 hsa-miR-577 -6.78 8.31e-11 -0.31 -0.39 Optic disc area; chr4:114495078 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs6817762 MIMAT0003242 hsa-miR-577 -6.78 8.31e-11 -0.31 -0.39 Optic disc area; chr4:114495098 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs13103833 MIMAT0003242 hsa-miR-577 -6.77 8.65e-11 -0.31 -0.39 Optic disc area; chr4:114495414 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs7662125 MIMAT0003242 hsa-miR-577 -6.77 8.65e-11 -0.31 -0.39 Optic disc area; chr4:114495706 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs2199312 MIMAT0003242 hsa-miR-577 -6.77 8.66e-11 -0.3 -0.39 Optic disc area; chr4:114513322 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs17047201 MIMAT0003242 hsa-miR-577 6.77 8.93e-11 0.44 0.39 Hemoglobin concentration; chr4:114544945 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs10857032 MIMAT0003242 hsa-miR-577 -6.74 1.01e-10 -0.3 -0.39 Optic disc area; chr4:114527831 chr4:114656774~114656794:+ COAD cis rs10021731 0.631 rs11098253 MIMAT0003242 hsa-miR-577 -6.74 1.01e-10 -0.3 -0.39 Optic disc area; chr4:114527990 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs79261962 MIMAT0003242 hsa-miR-577 6.72 1.19e-10 0.44 0.39 Hemoglobin concentration; chr4:114539953 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs77422558 MIMAT0003242 hsa-miR-577 6.72 1.19e-10 0.44 0.39 Hemoglobin concentration; chr4:114540944 chr4:114656774~114656794:+ COAD cis rs6841433 0.571 rs12649041 MIMAT0003242 hsa-miR-577 6.72 1.19e-10 0.44 0.39 Hemoglobin concentration; chr4:114541220 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs12649963 MIMAT0003242 hsa-miR-577 6.72 1.19e-10 0.44 0.39 Hemoglobin concentration; chr4:114542537 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs13105714 MIMAT0003242 hsa-miR-577 -6.71 1.26e-10 -0.3 -0.39 Optic disc area; chr4:114511171 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs12648803 MIMAT0003242 hsa-miR-577 -6.69 1.35e-10 -0.42 -0.39 Hemoglobin concentration; chr4:114546228 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs1460771 MIMAT0003242 hsa-miR-577 6.68 1.43e-10 0.29 0.38 Optic disc area; chr4:114486755 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs7683270 MIMAT0003242 hsa-miR-577 6.68 1.49e-10 0.3 0.38 Optic disc area; chr4:114532438 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs13103719 MIMAT0003242 hsa-miR-577 6.68 1.49e-10 0.3 0.38 Optic disc area; chr4:114532620 chr4:114656774~114656794:+ COAD cis rs10021731 0.681 rs13109008 MIMAT0003242 hsa-miR-577 6.68 1.49e-10 0.3 0.38 Optic disc area; chr4:114532769 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs13109803 MIMAT0003242 hsa-miR-577 6.68 1.49e-10 0.3 0.38 Optic disc area; chr4:114532837 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs7440658 MIMAT0003242 hsa-miR-577 6.68 1.49e-10 0.3 0.38 Optic disc area; chr4:114533303 chr4:114656774~114656794:+ COAD cis rs1712517 0.525 rs2271751 MIMAT0005951 hsa-miR-1307-3p -6.66 1.61e-10 -0.26 -0.38 Migraine; chr10:103415374 chr10:103394301~103394322:- COAD cis rs10021731 0.718 rs2126028 MIMAT0003242 hsa-miR-577 -6.58 2.64e-10 -0.29 -0.38 Optic disc area; chr4:114533453 chr4:114656774~114656794:+ COAD cis rs1163656 0.502 rs7310000 MIMAT0003287 hsa-miR-618 -6.57 2.7e-10 -0.57 -0.38 Dental caries; chr12:80933498 chr12:80935796~80935818:- COAD cis rs10021731 0.718 rs10857031 MIMAT0003242 hsa-miR-577 -6.56 2.89e-10 -0.29 -0.38 Optic disc area; chr4:114527690 chr4:114656774~114656794:+ COAD cis rs6753739 0.784 rs437512 MIMAT0014996 hsa-miR-3131 6.56 2.92e-10 0.5 0.38 Height; chr2:219061446 chr2:219058725~219058747:- COAD cis rs6753739 0.871 rs6436110 MIMAT0014996 hsa-miR-3131 6.56 2.99e-10 0.43 0.38 Height; chr2:219116231 chr2:219058725~219058747:- COAD cis rs1163656 0.502 rs11114658 MIMAT0003287 hsa-miR-618 -6.54 3.35e-10 -0.56 -0.38 Dental caries; chr12:80933378 chr12:80935796~80935818:- COAD cis rs10021731 0.718 rs13104656 MIMAT0003242 hsa-miR-577 -6.53 3.5e-10 -0.3 -0.38 Optic disc area; chr4:114495547 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs13104685 MIMAT0003242 hsa-miR-577 -6.53 3.5e-10 -0.3 -0.38 Optic disc area; chr4:114495590 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs13104693 MIMAT0003242 hsa-miR-577 -6.53 3.5e-10 -0.3 -0.38 Optic disc area; chr4:114495600 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs33914856 MIMAT0003242 hsa-miR-577 6.52 3.6e-10 0.4 0.38 Hemoglobin concentration; chr4:114564668 chr4:114656774~114656794:+ COAD cis rs1163656 0.502 rs17007711 MIMAT0003287 hsa-miR-618 6.51 3.86e-10 0.54 0.38 Dental caries; chr12:80934305 chr12:80935796~80935818:- COAD cis rs10021731 0.809 rs12650546 MIMAT0003242 hsa-miR-577 6.51 3.95e-10 0.3 0.38 Optic disc area; chr4:114578518 chr4:114656774~114656794:+ COAD cis rs7072216 0.763 rs10736129 MIMAT0005878 hsa-miR-1287-5p -6.49 4.41e-10 -0.46 -0.38 Metabolite levels; chr10:98411814 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs12763326 MIMAT0005878 hsa-miR-1287-5p -6.48 4.59e-10 -0.44 -0.37 Metabolite levels; chr10:98407639 chr10:98395271~98395292:- COAD cis rs1163656 0.502 rs10862209 MIMAT0003287 hsa-miR-618 -6.45 5.53e-10 -0.55 -0.37 Dental caries; chr12:80933176 chr12:80935796~80935818:- COAD cis rs10021731 0.718 rs1824490 MIMAT0003242 hsa-miR-577 6.44 5.78e-10 0.29 0.37 Optic disc area; chr4:114529766 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs1824489 MIMAT0003242 hsa-miR-577 6.44 5.78e-10 0.29 0.37 Optic disc area; chr4:114529776 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs7669767 MIMAT0003242 hsa-miR-577 6.44 5.78e-10 0.29 0.37 Optic disc area; chr4:114530264 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs2100782 MIMAT0003242 hsa-miR-577 6.44 5.78e-10 0.29 0.37 Optic disc area; chr4:114530452 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs12508960 MIMAT0003242 hsa-miR-577 6.44 5.78e-10 0.29 0.37 Optic disc area; chr4:114531061 chr4:114656774~114656794:+ COAD cis rs10021731 0.681 rs11098254 MIMAT0003242 hsa-miR-577 6.44 5.78e-10 0.29 0.37 Optic disc area; chr4:114531300 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs11098255 MIMAT0003242 hsa-miR-577 6.44 5.78e-10 0.29 0.37 Optic disc area; chr4:114531393 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs7655989 MIMAT0003242 hsa-miR-577 -6.42 6.36e-10 -0.29 -0.37 Optic disc area; chr4:114528134 chr4:114656774~114656794:+ COAD cis rs7072216 0.69 rs113195335 MIMAT0005878 hsa-miR-1287-5p 6.4 7.19e-10 0.45 0.37 Metabolite levels; chr10:98415775 chr10:98395271~98395292:- COAD cis rs7072216 0.727 rs3750603 MIMAT0005878 hsa-miR-1287-5p 6.4 7.19e-10 0.45 0.37 Metabolite levels; chr10:98415779 chr10:98395271~98395292:- COAD cis rs6841433 0.571 rs1903365 MIMAT0003242 hsa-miR-577 6.4 7.29e-10 0.4 0.37 Hemoglobin concentration; chr4:114561897 chr4:114656774~114656794:+ COAD cis rs7072216 0.763 rs3814142 MIMAT0005878 hsa-miR-1287-5p 6.4 7.51e-10 0.45 0.37 Metabolite levels; chr10:98411347 chr10:98395271~98395292:- COAD cis rs7072216 0.691 rs3829853 MIMAT0005878 hsa-miR-1287-5p 6.4 7.51e-10 0.45 0.37 Metabolite levels; chr10:98411417 chr10:98395271~98395292:- COAD cis rs7072216 0.727 rs10748728 MIMAT0005878 hsa-miR-1287-5p 6.4 7.51e-10 0.45 0.37 Metabolite levels; chr10:98411441 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs10748729 MIMAT0005878 hsa-miR-1287-5p 6.4 7.51e-10 0.45 0.37 Metabolite levels; chr10:98411614 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs10748730 MIMAT0005878 hsa-miR-1287-5p 6.4 7.51e-10 0.45 0.37 Metabolite levels; chr10:98411683 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs7910014 MIMAT0005878 hsa-miR-1287-5p 6.4 7.51e-10 0.45 0.37 Metabolite levels; chr10:98412353 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs7910247 MIMAT0005878 hsa-miR-1287-5p 6.4 7.51e-10 0.45 0.37 Metabolite levels; chr10:98412495 chr10:98395271~98395292:- COAD cis rs7072216 0.727 rs7913541 MIMAT0005878 hsa-miR-1287-5p 6.4 7.51e-10 0.45 0.37 Metabolite levels; chr10:98412722 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs6584204 MIMAT0005878 hsa-miR-1287-5p 6.4 7.51e-10 0.45 0.37 Metabolite levels; chr10:98413823 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs6584205 MIMAT0005878 hsa-miR-1287-5p 6.4 7.51e-10 0.45 0.37 Metabolite levels; chr10:98414049 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs3750601 MIMAT0005878 hsa-miR-1287-5p 6.4 7.51e-10 0.45 0.37 Metabolite levels; chr10:98414804 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs2147900 MIMAT0005878 hsa-miR-1287-5p 6.4 7.51e-10 0.45 0.37 Metabolite levels; chr10:98414964 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs2274246 MIMAT0005878 hsa-miR-1287-5p 6.4 7.51e-10 0.45 0.37 Metabolite levels; chr10:98415303 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs2274245 MIMAT0005878 hsa-miR-1287-5p 6.4 7.51e-10 0.45 0.37 Metabolite levels; chr10:98415325 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs2274244 MIMAT0005878 hsa-miR-1287-5p 6.4 7.51e-10 0.45 0.37 Metabolite levels; chr10:98415461 chr10:98395271~98395292:- COAD cis rs10021731 0.718 rs62309866 MIMAT0003242 hsa-miR-577 -6.39 7.63e-10 -0.29 -0.37 Optic disc area; chr4:114479583 chr4:114656774~114656794:+ COAD cis rs10021731 0.809 rs9884212 MIMAT0003242 hsa-miR-577 6.39 7.95e-10 0.3 0.37 Optic disc area; chr4:114580888 chr4:114656774~114656794:+ COAD cis rs10021731 0.744 rs2388976 MIMAT0003242 hsa-miR-577 6.39 7.95e-10 0.3 0.37 Optic disc area; chr4:114581250 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs2054305 MIMAT0003242 hsa-miR-577 -6.39 7.96e-10 -0.29 -0.37 Optic disc area; chr4:114496175 chr4:114656774~114656794:+ COAD cis rs10021731 0.744 rs6814022 MIMAT0003242 hsa-miR-577 -6.38 8.27e-10 -0.29 -0.37 Optic disc area; chr4:114528667 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs13127912 MIMAT0003242 hsa-miR-577 6.37 8.47e-10 0.4 0.37 Hemoglobin concentration; chr4:114546019 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs10516603 MIMAT0003242 hsa-miR-577 6.37 8.47e-10 0.4 0.37 Hemoglobin concentration; chr4:114546303 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs34685786 MIMAT0003242 hsa-miR-577 6.37 8.47e-10 0.4 0.37 Hemoglobin concentration; chr4:114549280 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs13120552 MIMAT0003242 hsa-miR-577 6.37 8.47e-10 0.4 0.37 Hemoglobin concentration; chr4:114552518 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs13101831 MIMAT0003242 hsa-miR-577 6.37 8.47e-10 0.4 0.37 Hemoglobin concentration; chr4:114552771 chr4:114656774~114656794:+ COAD cis rs6841433 0.66 rs13127941 MIMAT0003242 hsa-miR-577 6.37 8.47e-10 0.4 0.37 Hemoglobin concentration; chr4:114553520 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs13147198 MIMAT0003242 hsa-miR-577 6.37 8.47e-10 0.4 0.37 Hemoglobin concentration; chr4:114553935 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs34403145 MIMAT0003242 hsa-miR-577 6.37 8.47e-10 0.4 0.37 Hemoglobin concentration; chr4:114554629 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs12643074 MIMAT0003242 hsa-miR-577 6.37 8.47e-10 0.4 0.37 Hemoglobin concentration; chr4:114555226 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs2100783 MIMAT0003242 hsa-miR-577 6.37 8.47e-10 0.4 0.37 Hemoglobin concentration; chr4:114555821 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs12650115 MIMAT0003242 hsa-miR-577 6.37 8.47e-10 0.4 0.37 Hemoglobin concentration; chr4:114560232 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs12644238 MIMAT0003242 hsa-miR-577 6.37 8.47e-10 0.4 0.37 Hemoglobin concentration; chr4:114560598 chr4:114656774~114656794:+ COAD cis rs1712517 0.525 rs7911488 MIMAT0005951 hsa-miR-1307-3p -6.36 9.33e-10 -0.25 -0.37 Migraine; chr10:103394332 chr10:103394301~103394322:- COAD cis rs6841433 0.615 rs13110751 MIMAT0003242 hsa-miR-577 6.33 1.08e-09 0.4 0.37 Hemoglobin concentration; chr4:114563572 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs13105144 MIMAT0003242 hsa-miR-577 6.33 1.08e-09 0.4 0.37 Hemoglobin concentration; chr4:114563873 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs7698790 MIMAT0003242 hsa-miR-577 6.33 1.12e-09 0.29 0.37 Optic disc area; chr4:114492647 chr4:114656774~114656794:+ COAD cis rs7072216 0.763 rs942805 MIMAT0005878 hsa-miR-1287-5p 6.31 1.2e-09 0.44 0.37 Metabolite levels; chr10:98408615 chr10:98395271~98395292:- COAD cis rs10021731 0.668 rs1599317 MIMAT0003242 hsa-miR-577 -6.31 1.21e-09 -0.29 -0.37 Optic disc area; chr4:114503010 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs6834235 MIMAT0003242 hsa-miR-577 -6.31 1.23e-09 -0.28 -0.37 Optic disc area; chr4:114531582 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs1599320 MIMAT0003242 hsa-miR-577 -6.31 1.23e-09 -0.28 -0.37 Optic disc area; chr4:114532227 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs7685549 MIMAT0003242 hsa-miR-577 -6.3 1.27e-09 -0.28 -0.37 Optic disc area; chr4:114479772 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs7686774 MIMAT0003242 hsa-miR-577 -6.3 1.27e-09 -0.28 -0.37 Optic disc area; chr4:114480357 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs7687413 MIMAT0003242 hsa-miR-577 -6.3 1.27e-09 -0.28 -0.37 Optic disc area; chr4:114480417 chr4:114656774~114656794:+ COAD cis rs6753739 0.871 rs12694452 MIMAT0014996 hsa-miR-3131 -6.29 1.35e-09 -0.42 -0.37 Height; chr2:219162677 chr2:219058725~219058747:- COAD cis rs6841433 0.615 rs35594431 MIMAT0003242 hsa-miR-577 6.28 1.45e-09 0.39 0.36 Hemoglobin concentration; chr4:114554497 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs1585446 MIMAT0003242 hsa-miR-577 -6.27 1.55e-09 -0.29 -0.36 Optic disc area; chr4:114490871 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs13127822 MIMAT0003242 hsa-miR-577 -6.27 1.55e-09 -0.29 -0.36 Optic disc area; chr4:114493024 chr4:114656774~114656794:+ COAD cis rs10021731 0.668 rs2199311 MIMAT0003242 hsa-miR-577 -6.27 1.56e-09 -0.29 -0.36 Optic disc area; chr4:114492288 chr4:114656774~114656794:+ COAD cis rs7072216 0.763 rs8181292 MIMAT0005878 hsa-miR-1287-5p 6.26 1.59e-09 0.44 0.36 Metabolite levels; chr10:98415720 chr10:98395271~98395292:- COAD cis rs10021731 0.692 rs1599316 MIMAT0003242 hsa-miR-577 -6.26 1.59e-09 -0.29 -0.36 Optic disc area; chr4:114490702 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs7689158 MIMAT0003242 hsa-miR-577 -6.26 1.6e-09 -0.28 -0.36 Optic disc area; chr4:114495770 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs2054304 MIMAT0003242 hsa-miR-577 -6.26 1.6e-09 -0.28 -0.36 Optic disc area; chr4:114495902 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs11724674 MIMAT0003242 hsa-miR-577 -6.26 1.62e-09 -0.28 -0.36 Optic disc area; chr4:114482175 chr4:114656774~114656794:+ COAD cis rs7072216 0.763 rs7909822 MIMAT0005878 hsa-miR-1287-5p 6.26 1.64e-09 0.44 0.36 Metabolite levels; chr10:98412278 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs942803 MIMAT0005878 hsa-miR-1287-5p 6.25 1.66e-09 0.44 0.36 Metabolite levels; chr10:98408874 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs12259939 MIMAT0005878 hsa-miR-1287-5p 6.25 1.66e-09 0.44 0.36 Metabolite levels; chr10:98409264 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs7923729 MIMAT0005878 hsa-miR-1287-5p 6.25 1.66e-09 0.44 0.36 Metabolite levels; chr10:98409708 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs6584198 MIMAT0005878 hsa-miR-1287-5p 6.25 1.66e-09 0.44 0.36 Metabolite levels; chr10:98410149 chr10:98395271~98395292:- COAD cis rs7072216 0.727 rs6584199 MIMAT0005878 hsa-miR-1287-5p 6.25 1.66e-09 0.44 0.36 Metabolite levels; chr10:98410226 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs6584200 MIMAT0005878 hsa-miR-1287-5p 6.25 1.66e-09 0.44 0.36 Metabolite levels; chr10:98410280 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs6584201 MIMAT0005878 hsa-miR-1287-5p 6.25 1.66e-09 0.44 0.36 Metabolite levels; chr10:98410452 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs3814140 MIMAT0005878 hsa-miR-1287-5p 6.25 1.66e-09 0.44 0.36 Metabolite levels; chr10:98411005 chr10:98395271~98395292:- COAD cis rs10021731 0.644 rs7665675 MIMAT0003242 hsa-miR-577 -6.24 1.75e-09 -0.28 -0.36 Optic disc area; chr4:114480704 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs7692571 MIMAT0003242 hsa-miR-577 -6.24 1.75e-09 -0.28 -0.36 Optic disc area; chr4:114480792 chr4:114656774~114656794:+ COAD cis rs10021731 0.809 rs35733223 MIMAT0003242 hsa-miR-577 6.24 1.8e-09 0.29 0.36 Optic disc area; chr4:114566454 chr4:114656774~114656794:+ COAD cis rs7072216 0.763 rs2274243 MIMAT0005878 hsa-miR-1287-5p 6.24 1.83e-09 0.44 0.36 Metabolite levels; chr10:98415510 chr10:98395271~98395292:- COAD cis rs6841433 0.615 rs13136602 MIMAT0003242 hsa-miR-577 6.23 1.85e-09 0.4 0.36 Hemoglobin concentration; chr4:114541864 chr4:114656774~114656794:+ COAD cis rs6841433 0.615 rs12649943 MIMAT0003242 hsa-miR-577 6.23 1.85e-09 0.4 0.36 Hemoglobin concentration; chr4:114542460 chr4:114656774~114656794:+ COAD cis rs10021731 0.521 rs116635794 MIMAT0003242 hsa-miR-577 -6.23 1.85e-09 -0.28 -0.36 Optic disc area; chr4:114520865 chr4:114656774~114656794:+ COAD cis rs7072216 0.806 rs9804285 MIMAT0005878 hsa-miR-1287-5p 6.23 1.85e-09 0.44 0.36 Metabolite levels; chr10:98409715 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs10732782 MIMAT0005878 hsa-miR-1287-5p 6.23 1.91e-09 0.43 0.36 Metabolite levels; chr10:98406749 chr10:98395271~98395292:- COAD cis rs7072216 0.691 rs7910973 MIMAT0005878 hsa-miR-1287-5p 6.23 1.91e-09 0.43 0.36 Metabolite levels; chr10:98406975 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs7911036 MIMAT0005878 hsa-miR-1287-5p 6.23 1.91e-09 0.43 0.36 Metabolite levels; chr10:98407258 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs10883090 MIMAT0005878 hsa-miR-1287-5p 6.23 1.91e-09 0.43 0.36 Metabolite levels; chr10:98407479 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs45523432 MIMAT0005878 hsa-miR-1287-5p 6.23 1.91e-09 0.43 0.36 Metabolite levels; chr10:98407679 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs12763044 MIMAT0005878 hsa-miR-1287-5p 6.23 1.91e-09 0.43 0.36 Metabolite levels; chr10:98407694 chr10:98395271~98395292:- COAD cis rs7072216 0.727 rs942808 MIMAT0005878 hsa-miR-1287-5p 6.23 1.91e-09 0.43 0.36 Metabolite levels; chr10:98408345 chr10:98395271~98395292:- COAD cis rs7072216 0.727 rs942807 MIMAT0005878 hsa-miR-1287-5p 6.23 1.91e-09 0.43 0.36 Metabolite levels; chr10:98408462 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs9787550 MIMAT0005878 hsa-miR-1287-5p 6.23 1.91e-09 0.43 0.36 Metabolite levels; chr10:98409294 chr10:98395271~98395292:- COAD cis rs10021731 0.809 rs12647519 MIMAT0003242 hsa-miR-577 6.23 1.94e-09 0.29 0.36 Optic disc area; chr4:114594742 chr4:114656774~114656794:+ COAD cis rs10021731 0.782 rs12650319 MIMAT0003242 hsa-miR-577 6.21 2.07e-09 0.29 0.36 Optic disc area; chr4:114594734 chr4:114656774~114656794:+ COAD cis rs10021731 0.782 rs7437569 MIMAT0003242 hsa-miR-577 -6.21 2.15e-09 -0.29 -0.36 Optic disc area; chr4:114595431 chr4:114656774~114656794:+ COAD cis rs10021731 0.867 rs12507591 MIMAT0003242 hsa-miR-577 6.2 2.21e-09 0.29 0.36 Optic disc area; chr4:114574339 chr4:114656774~114656794:+ COAD cis rs10021731 0.782 rs2388975 MIMAT0003242 hsa-miR-577 6.2 2.28e-09 0.29 0.36 Optic disc area; chr4:114592899 chr4:114656774~114656794:+ COAD cis rs10021731 0.692 rs12108281 MIMAT0003242 hsa-miR-577 -6.18 2.56e-09 -0.28 -0.36 Optic disc area; chr4:114522147 chr4:114656774~114656794:+ COAD cis rs7072216 0.763 rs942804 MIMAT0005878 hsa-miR-1287-5p 6.16 2.73e-09 0.43 0.36 Metabolite levels; chr10:98408742 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs10883091 MIMAT0005878 hsa-miR-1287-5p 6.13 3.29e-09 0.42 0.36 Metabolite levels; chr10:98407482 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs10883092 MIMAT0005878 hsa-miR-1287-5p 6.13 3.29e-09 0.42 0.36 Metabolite levels; chr10:98407519 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs6584202 MIMAT0005878 hsa-miR-1287-5p 6.12 3.45e-09 0.43 0.36 Metabolite levels; chr10:98410626 chr10:98395271~98395292:- COAD cis rs10021731 0.809 rs7655987 MIMAT0003242 hsa-miR-577 6.12 3.57e-09 0.29 0.36 Optic disc area; chr4:114596146 chr4:114656774~114656794:+ COAD cis rs7255436 0.83 rs4350678 MIMAT0021017 hsa-miR-4999-5p 6.11 3.64e-09 0.47 0.36 HDL cholesterol; chr19:8382482 chr19:8389340~8389360:- COAD cis rs1163656 0.502 rs17007704 MIMAT0003287 hsa-miR-618 -6.1 3.93e-09 -0.54 -0.36 Dental caries; chr12:80932218 chr12:80935796~80935818:- COAD cis rs10021731 0.718 rs11724670 MIMAT0003242 hsa-miR-577 -6.1 3.96e-09 -0.28 -0.36 Optic disc area; chr4:114482122 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs10002657 MIMAT0003242 hsa-miR-577 -6.1 3.96e-09 -0.28 -0.36 Optic disc area; chr4:114483120 chr4:114656774~114656794:+ COAD cis rs7255436 0.931 rs7249520 MIMAT0021017 hsa-miR-4999-5p 6.09 4.2e-09 0.47 0.35 HDL cholesterol; chr19:8381172 chr19:8389340~8389360:- COAD cis rs7255436 0.965 rs7249624 MIMAT0021017 hsa-miR-4999-5p 6.09 4.2e-09 0.47 0.35 HDL cholesterol; chr19:8381251 chr19:8389340~8389360:- COAD cis rs6841433 0.511 rs36078253 MIMAT0003242 hsa-miR-577 6.07 4.66e-09 0.36 0.35 Hemoglobin concentration; chr4:114538112 chr4:114656774~114656794:+ COAD cis rs75358501 0.901 rs76270461 MIMAT0014995 hsa-miR-3130-5p -6.06 4.71e-09 -0.69 -0.35 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206788929 chr2:206783276~206783296:- COAD cis rs75358501 0.901 rs76270461 MIMAT0014995_1 hsa-miR-3130-5p -6.06 4.71e-09 -0.69 -0.35 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206788929 chr2:206783246~206783266:+ COAD cis rs10021731 0.718 rs12505597 MIMAT0003242 hsa-miR-577 -6.06 4.76e-09 -0.28 -0.35 Optic disc area; chr4:114527954 chr4:114656774~114656794:+ COAD cis rs7255436 0.965 rs11668346 MIMAT0021017 hsa-miR-4999-5p 6.06 4.81e-09 0.46 0.35 HDL cholesterol; chr19:8385970 chr19:8389340~8389360:- COAD cis rs7255436 0.965 rs12981318 MIMAT0021017 hsa-miR-4999-5p 6.06 4.81e-09 0.46 0.35 HDL cholesterol; chr19:8386546 chr19:8389340~8389360:- COAD cis rs7255436 0.965 rs7351098 MIMAT0021017 hsa-miR-4999-5p 6.06 4.81e-09 0.46 0.35 HDL cholesterol; chr19:8386787 chr19:8389340~8389360:- COAD cis rs10021731 0.692 rs10021252 MIMAT0003242 hsa-miR-577 -6.06 4.87e-09 -0.28 -0.35 Optic disc area; chr4:114515190 chr4:114656774~114656794:+ COAD cis rs1712517 0.526 rs113528138 MIMAT0005951 hsa-miR-1307-3p -6.05 5.18e-09 -0.24 -0.35 Migraine; chr10:103365694 chr10:103394301~103394322:- COAD cis rs1712517 0.525 rs11191667 MIMAT0005951 hsa-miR-1307-3p -6.05 5.18e-09 -0.24 -0.35 Migraine; chr10:103369141 chr10:103394301~103394322:- COAD cis rs7255436 0.965 rs11666003 MIMAT0021017 hsa-miR-4999-5p 6.04 5.47e-09 0.46 0.35 HDL cholesterol; chr19:8387218 chr19:8389340~8389360:- COAD cis rs1712517 1 rs1712517 MIMAT0005951 hsa-miR-1307-3p -6.03 5.55e-09 -0.22 -0.35 Migraine; chr10:103273258 chr10:103394301~103394322:- COAD cis rs6841433 0.615 rs13114989 MIMAT0003242 hsa-miR-577 6.03 5.67e-09 0.38 0.35 Hemoglobin concentration; chr4:114538869 chr4:114656774~114656794:+ COAD cis rs6753739 0.871 rs10174319 MIMAT0014996 hsa-miR-3131 -6.03 5.76e-09 -0.46 -0.35 Height; chr2:219140586 chr2:219058725~219058747:- COAD cis rs10021731 0.718 rs13104081 MIMAT0003242 hsa-miR-577 -5.99 7.23e-09 -0.28 -0.35 Optic disc area; chr4:114532641 chr4:114656774~114656794:+ COAD cis rs10021731 0.735 rs9995962 MIMAT0003242 hsa-miR-577 5.95 8.66e-09 0.28 0.35 Optic disc area; chr4:114551671 chr4:114656774~114656794:+ COAD cis rs7072216 0.763 rs1061437 MIMAT0005878 hsa-miR-1287-5p 5.94 9.44e-09 0.42 0.35 Metabolite levels; chr10:98416397 chr10:98395271~98395292:- COAD cis rs7255436 0.965 rs11666233 MIMAT0021017 hsa-miR-4999-5p 5.93 9.76e-09 0.46 0.35 HDL cholesterol; chr19:8387161 chr19:8389340~8389360:- COAD cis rs1712517 0.873 rs1891292 MIMAT0005951 hsa-miR-1307-3p 5.91 1.09e-08 0.21 0.35 Migraine; chr10:103241753 chr10:103394301~103394322:- COAD cis rs7255436 0.965 rs62117510 MIMAT0021017 hsa-miR-4999-5p 5.9 1.14e-08 0.46 0.35 HDL cholesterol; chr19:8387729 chr19:8389340~8389360:- COAD cis rs7255436 0.965 rs28729307 MIMAT0021017 hsa-miR-4999-5p 5.9 1.14e-08 0.46 0.35 HDL cholesterol; chr19:8387858 chr19:8389340~8389360:- COAD cis rs7255436 0.894 rs10413136 MIMAT0021017 hsa-miR-4999-5p 5.9 1.14e-08 0.46 0.35 HDL cholesterol; chr19:8387995 chr19:8389340~8389360:- COAD cis rs7255436 1 rs7255436 MIMAT0021017 hsa-miR-4999-5p 5.9 1.17e-08 0.46 0.35 HDL cholesterol; chr19:8368312 chr19:8389340~8389360:- COAD cis rs1712517 1 rs3123794 MIMAT0005951 hsa-miR-1307-3p -5.89 1.2e-08 -0.21 -0.34 Migraine; chr10:103273985 chr10:103394301~103394322:- COAD cis rs7072216 0.763 rs733345 MIMAT0005878 hsa-miR-1287-5p 5.82 1.78e-08 0.4 0.34 Metabolite levels; chr10:98404458 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs733346 MIMAT0005878 hsa-miR-1287-5p 5.82 1.78e-08 0.4 0.34 Metabolite levels; chr10:98404568 chr10:98395271~98395292:- COAD cis rs7255436 0.965 rs7254882 MIMAT0021017 hsa-miR-4999-5p 5.8 1.91e-08 0.45 0.34 HDL cholesterol; chr19:8388938 chr19:8389340~8389360:- COAD cis rs6753739 0.871 rs4674360 MIMAT0014996 hsa-miR-3131 -5.8 1.93e-08 -0.45 -0.34 Height; chr2:219144943 chr2:219058725~219058747:- COAD cis rs12712135 0.709 rs10201184 MIMAT0019927 hsa-miR-4772-3p -5.8 1.98e-08 -0.3 -0.34 Blood protein levels; chr2:102472618 chr2:102432336~102432357:+ COAD cis rs7072216 0.763 rs7914401 MIMAT0005878 hsa-miR-1287-5p 5.79 2.01e-08 0.41 0.34 Metabolite levels; chr10:98404171 chr10:98395271~98395292:- COAD cis rs7255436 0.928 rs7250870 MIMAT0021017 hsa-miR-4999-5p 5.76 2.39e-08 0.44 0.34 HDL cholesterol; chr19:8388798 chr19:8389340~8389360:- COAD cis rs1163656 0.534 rs17007709 MIMAT0003287 hsa-miR-618 -5.74 2.62e-08 -0.43 -0.34 Dental caries; chr12:80934267 chr12:80935796~80935818:- COAD cis rs7072216 0.655 rs3830025 MIMAT0005878 hsa-miR-1287-5p 5.74 2.73e-08 0.41 0.34 Metabolite levels; chr10:98416347 chr10:98395271~98395292:- COAD cis rs7072216 0.655 rs3830024 MIMAT0005878 hsa-miR-1287-5p 5.74 2.73e-08 0.41 0.34 Metabolite levels; chr10:98416349 chr10:98395271~98395292:- COAD cis rs10021731 0.577 rs34941812 MIMAT0003242 hsa-miR-577 -5.73 2.75e-08 -0.29 -0.34 Optic disc area; chr4:114673260 chr4:114656774~114656794:+ COAD cis rs7072216 0.727 rs942809 MIMAT0005878 hsa-miR-1287-5p 5.73 2.78e-08 0.4 0.34 Metabolite levels; chr10:98408244 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs7091709 MIMAT0005878 hsa-miR-1287-5p 5.73 2.87e-08 0.4 0.34 Metabolite levels; chr10:98407848 chr10:98395271~98395292:- COAD cis rs6841433 0.511 rs34534063 MIMAT0003242 hsa-miR-577 5.72 2.97e-08 0.34 0.34 Hemoglobin concentration; chr4:114538077 chr4:114656774~114656794:+ COAD cis rs1712517 0.873 rs1163083 MIMAT0005951 hsa-miR-1307-3p -5.71 3.08e-08 -0.21 -0.34 Migraine; chr10:103278698 chr10:103394301~103394322:- COAD cis rs10021731 0.668 rs28651771 MIMAT0003242 hsa-miR-577 -5.7 3.23e-08 -0.26 -0.34 Optic disc area; chr4:114501291 chr4:114656774~114656794:+ COAD cis rs12712135 0.709 rs55664618 MIMAT0019927 hsa-miR-4772-3p 5.7 3.26e-08 0.29 0.34 Blood protein levels; chr2:102399756 chr2:102432336~102432357:+ COAD cis rs10021731 0.756 rs1460782 MIMAT0003242 hsa-miR-577 -5.7 3.3e-08 -0.28 -0.33 Optic disc area; chr4:114540002 chr4:114656774~114656794:+ COAD cis rs7072216 0.726 rs4474372 MIMAT0005878 hsa-miR-1287-5p 5.69 3.44e-08 0.4 0.33 Metabolite levels; chr10:98404814 chr10:98395271~98395292:- COAD cis rs10021731 0.668 rs62309894 MIMAT0003242 hsa-miR-577 -5.67 3.75e-08 -0.27 -0.33 Optic disc area; chr4:114504575 chr4:114656774~114656794:+ COAD cis rs10021731 0.706 rs1380931 MIMAT0003242 hsa-miR-577 -5.67 3.75e-08 -0.27 -0.33 Optic disc area; chr4:114506853 chr4:114656774~114656794:+ COAD cis rs10021731 0.668 rs2199313 MIMAT0003242 hsa-miR-577 -5.67 3.75e-08 -0.27 -0.33 Optic disc area; chr4:114513488 chr4:114656774~114656794:+ COAD cis rs1712517 0.771 rs11191676 MIMAT0005951 hsa-miR-1307-3p -5.67 3.88e-08 -0.21 -0.33 Migraine; chr10:103395309 chr10:103394301~103394322:- COAD cis rs1712517 1 rs1163084 MIMAT0005951 hsa-miR-1307-3p -5.66 3.98e-08 -0.21 -0.33 Migraine; chr10:103279291 chr10:103394301~103394322:- COAD cis rs7072216 0.763 rs2147901 MIMAT0005878 hsa-miR-1287-5p -5.65 4.18e-08 -0.39 -0.33 Metabolite levels; chr10:98405739 chr10:98395271~98395292:- COAD cis rs12712135 0.709 rs12463588 MIMAT0019927 hsa-miR-4772-3p 5.65 4.26e-08 0.29 0.33 Blood protein levels; chr2:102468797 chr2:102432336~102432357:+ COAD cis rs12712135 0.709 rs2310302 MIMAT0019927 hsa-miR-4772-3p 5.65 4.26e-08 0.29 0.33 Blood protein levels; chr2:102469589 chr2:102432336~102432357:+ COAD cis rs12712135 0.709 rs10195075 MIMAT0019927 hsa-miR-4772-3p 5.65 4.26e-08 0.29 0.33 Blood protein levels; chr2:102471192 chr2:102432336~102432357:+ COAD cis rs12712135 0.709 rs1403553 MIMAT0019927 hsa-miR-4772-3p 5.65 4.26e-08 0.29 0.33 Blood protein levels; chr2:102471202 chr2:102432336~102432357:+ COAD cis rs7072216 0.763 rs4475861 MIMAT0005878 hsa-miR-1287-5p 5.65 4.31e-08 0.39 0.33 Metabolite levels; chr10:98405232 chr10:98395271~98395292:- COAD cis rs6681460 0.625 rs6696812 MIMAT0014979 hsa-miR-3117-3p -5.63 4.65e-08 -0.4 -0.33 Presence of antiphospholipid antibodies; chr1:66634626 chr1:66628485~66628505:+ COAD cis rs1712517 0.503 rs72846198 MIMAT0005951 hsa-miR-1307-3p -5.63 4.81e-08 -0.22 -0.33 Migraine; chr10:103338267 chr10:103394301~103394322:- COAD cis rs10021731 0.692 rs62309904 MIMAT0003242 hsa-miR-577 -5.62 4.92e-08 -0.26 -0.33 Optic disc area; chr4:114514011 chr4:114656774~114656794:+ COAD cis rs12712135 0.709 rs12469887 MIMAT0019927 hsa-miR-4772-3p 5.62 5.07e-08 0.29 0.33 Blood protein levels; chr2:102470298 chr2:102432336~102432357:+ COAD cis rs10021731 0.756 rs28787070 MIMAT0003242 hsa-miR-577 -5.61 5.22e-08 -0.27 -0.33 Optic disc area; chr4:114556918 chr4:114656774~114656794:+ COAD cis rs10021731 0.668 rs7676684 MIMAT0003242 hsa-miR-577 5.6 5.45e-08 0.26 0.33 Optic disc area; chr4:114492371 chr4:114656774~114656794:+ COAD cis rs10021731 0.597 rs12508215 MIMAT0003242 hsa-miR-577 -5.6 5.53e-08 -0.28 -0.33 Optic disc area; chr4:114699103 chr4:114656774~114656794:+ COAD cis rs10021731 0.597 rs11098263 MIMAT0003242 hsa-miR-577 -5.6 5.53e-08 -0.28 -0.33 Optic disc area; chr4:114686481 chr4:114656774~114656794:+ COAD cis rs1867631 1 rs11208928 MIMAT0014979 hsa-miR-3117-3p -5.59 5.79e-08 -0.41 -0.33 Menopause (age at onset); chr1:66623879 chr1:66628485~66628505:+ COAD cis rs12712135 0.709 rs11465730 MIMAT0019927 hsa-miR-4772-3p 5.58 5.94e-08 0.29 0.33 Blood protein levels; chr2:102450398 chr2:102432336~102432357:+ COAD cis rs10021731 0.668 rs13103537 MIMAT0003242 hsa-miR-577 -5.58 6.03e-08 -0.26 -0.33 Optic disc area; chr4:114495092 chr4:114656774~114656794:+ COAD cis rs1712517 0.904 rs4918007 MIMAT0005951 hsa-miR-1307-3p 5.58 6.2e-08 0.21 0.33 Migraine; chr10:103347713 chr10:103394301~103394322:- COAD cis rs10021731 0.668 rs13112732 MIMAT0003242 hsa-miR-577 -5.57 6.26e-08 -0.26 -0.33 Optic disc area; chr4:114483845 chr4:114656774~114656794:+ COAD cis rs10021731 0.668 rs55968476 MIMAT0003242 hsa-miR-577 -5.57 6.57e-08 -0.26 -0.33 Optic disc area; chr4:114532478 chr4:114656774~114656794:+ COAD cis rs1870653 0.516 rs73848142 MIMAT0003242 hsa-miR-577 5.56 6.67e-08 0.41 0.33 Exploratory eye movement dysfunction in schizophrenia (number of eye fixations); chr4:114506178 chr4:114656774~114656794:+ COAD cis rs6681460 0.625 rs12138066 MIMAT0014979 hsa-miR-3117-3p -5.55 7.03e-08 -0.39 -0.33 Presence of antiphospholipid antibodies; chr1:66638133 chr1:66628485~66628505:+ COAD cis rs1712517 0.566 rs1163073 MIMAT0005951 hsa-miR-1307-3p 5.54 7.62e-08 0.22 0.33 Migraine; chr10:103263177 chr10:103394301~103394322:- COAD cis rs6724465 1 rs1052483 MIMAT0014996 hsa-miR-3131 5.53 7.71e-08 0.53 0.33 Height; chr2:219069626 chr2:219058725~219058747:- COAD cis rs10021731 0.718 rs1460779 MIMAT0003242 hsa-miR-577 5.52 8.29e-08 0.25 0.33 Optic disc area; chr4:114528894 chr4:114656774~114656794:+ COAD cis rs6724465 1 rs868945 MIMAT0014996 hsa-miR-3131 -5.5 8.96e-08 -0.63 -0.32 Height; chr2:219059717 chr2:219058725~219058747:- COAD cis rs17027258 0.609 rs4851005 MIMAT0019926 hsa-miR-4772-5p 5.5 9.16e-08 0.38 0.32 White blood cell types; chr2:102395092 chr2:102432300~102432321:+ COAD cis rs10021731 0.756 rs1460783 MIMAT0003242 hsa-miR-577 -5.5 9.18e-08 -0.27 -0.32 Optic disc area; chr4:114540109 chr4:114656774~114656794:+ COAD cis rs1712517 0.844 rs1163081 MIMAT0005951 hsa-miR-1307-3p -5.5 9.24e-08 -0.2 -0.32 Migraine; chr10:103270083 chr10:103394301~103394322:- COAD cis rs12712135 0.677 rs6705385 MIMAT0019927 hsa-miR-4772-3p 5.49 9.55e-08 0.28 0.32 Blood protein levels; chr2:102460109 chr2:102432336~102432357:+ COAD cis rs10021731 0.756 rs35235288 MIMAT0003242 hsa-miR-577 -5.49 9.81e-08 -0.26 -0.32 Optic disc area; chr4:114547620 chr4:114656774~114656794:+ COAD cis rs1870653 0.516 rs80050223 MIMAT0003242 hsa-miR-577 5.48 1.01e-07 0.41 0.32 Exploratory eye movement dysfunction in schizophrenia (number of eye fixations); chr4:114503554 chr4:114656774~114656794:+ COAD cis rs1712517 0.588 rs12220267 MIMAT0005951 hsa-miR-1307-3p -5.48 1.02e-07 -0.22 -0.32 Migraine; chr10:103315955 chr10:103394301~103394322:- COAD cis rs950880 0.56 rs66780767 MIMAT0019927 hsa-miR-4772-3p 5.48 1.02e-07 0.28 0.32 Serum protein levels (sST2); chr2:102323249 chr2:102432336~102432357:+ COAD cis rs12712135 0.709 rs4140786 MIMAT0019927 hsa-miR-4772-3p 5.48 1.02e-07 0.28 0.32 Blood protein levels; chr2:102471716 chr2:102432336~102432357:+ COAD cis rs950880 0.56 rs13020793 MIMAT0019927 hsa-miR-4772-3p 5.47 1.05e-07 0.28 0.32 Serum protein levels (sST2); chr2:102315466 chr2:102432336~102432357:+ COAD cis rs950880 0.517 rs1968170 MIMAT0019927 hsa-miR-4772-3p 5.47 1.05e-07 0.28 0.32 Serum protein levels (sST2); chr2:102317342 chr2:102432336~102432357:+ COAD cis rs950880 0.56 rs11123918 MIMAT0019927 hsa-miR-4772-3p 5.47 1.05e-07 0.28 0.32 Serum protein levels (sST2); chr2:102318777 chr2:102432336~102432357:+ COAD cis rs950880 0.56 rs10182639 MIMAT0019927 hsa-miR-4772-3p 5.47 1.05e-07 0.28 0.32 Serum protein levels (sST2); chr2:102319345 chr2:102432336~102432357:+ COAD cis rs950880 0.56 rs12712136 MIMAT0019927 hsa-miR-4772-3p 5.47 1.05e-07 0.28 0.32 Serum protein levels (sST2); chr2:102319906 chr2:102432336~102432357:+ COAD cis rs1867631 1 rs10889640 MIMAT0014979 hsa-miR-3117-3p -5.47 1.06e-07 -0.4 -0.32 Menopause (age at onset); chr1:66662168 chr1:66628485~66628505:+ COAD cis rs1867631 1 rs10789212 MIMAT0014979 hsa-miR-3117-3p -5.47 1.06e-07 -0.4 -0.32 Menopause (age at onset); chr1:66662472 chr1:66628485~66628505:+ COAD cis rs1867631 1 rs10789213 MIMAT0014979 hsa-miR-3117-3p -5.47 1.06e-07 -0.4 -0.32 Menopause (age at onset); chr1:66662518 chr1:66628485~66628505:+ COAD cis rs1712517 0.771 rs2292807 MIMAT0005951 hsa-miR-1307-3p -5.47 1.06e-07 -0.2 -0.32 Migraine; chr10:103395888 chr10:103394301~103394322:- COAD cis rs12712135 0.709 rs11676236 MIMAT0019927 hsa-miR-4772-3p 5.47 1.08e-07 0.28 0.32 Blood protein levels; chr2:102465235 chr2:102432336~102432357:+ COAD cis rs12712135 0.677 rs11687013 MIMAT0019927 hsa-miR-4772-3p 5.47 1.08e-07 0.28 0.32 Blood protein levels; chr2:102465261 chr2:102432336~102432357:+ COAD cis rs1712517 0.873 rs7894240 MIMAT0005951 hsa-miR-1307-3p 5.47 1.09e-07 0.2 0.32 Migraine; chr10:103240612 chr10:103394301~103394322:- COAD cis rs950880 0.56 rs11690443 MIMAT0019927 hsa-miR-4772-3p 5.46 1.1e-07 0.28 0.32 Serum protein levels (sST2); chr2:102319671 chr2:102432336~102432357:+ COAD cis rs1867631 1 rs11208927 MIMAT0014979 hsa-miR-3117-3p -5.46 1.11e-07 -0.4 -0.32 Menopause (age at onset); chr1:66623878 chr1:66628485~66628505:+ COAD cis rs1712517 0.835 rs2506961 MIMAT0005951 hsa-miR-1307-3p 5.45 1.16e-07 0.2 0.32 Migraine; chr10:103248169 chr10:103394301~103394322:- COAD cis rs1712517 0.873 rs1712510 MIMAT0005951 hsa-miR-1307-3p 5.45 1.16e-07 0.2 0.32 Migraine; chr10:103249329 chr10:103394301~103394322:- COAD cis rs1712517 0.873 rs7903004 MIMAT0005951 hsa-miR-1307-3p 5.45 1.16e-07 0.2 0.32 Migraine; chr10:103244344 chr10:103394301~103394322:- COAD cis rs1712517 0.771 rs10883858 MIMAT0005951 hsa-miR-1307-3p -5.45 1.21e-07 -0.2 -0.32 Migraine; chr10:103367951 chr10:103394301~103394322:- COAD cis rs6724465 1 rs72967954 MIMAT0014996 hsa-miR-3131 -5.43 1.28e-07 -0.62 -0.32 Height; chr2:219057847 chr2:219058725~219058747:- COAD cis rs7072216 0.727 rs7915108 MIMAT0005878 hsa-miR-1287-5p 5.43 1.31e-07 0.39 0.32 Metabolite levels; chr10:98404684 chr10:98395271~98395292:- COAD cis rs7072216 0.727 rs7901577 MIMAT0005878 hsa-miR-1287-5p 5.43 1.31e-07 0.39 0.32 Metabolite levels; chr10:98404685 chr10:98395271~98395292:- COAD cis rs12712135 0.652 rs11465727 MIMAT0019927 hsa-miR-4772-3p 5.43 1.33e-07 0.28 0.32 Blood protein levels; chr2:102448043 chr2:102432336~102432357:+ COAD cis rs1712517 0.566 rs7076274 MIMAT0005951 hsa-miR-1307-3p -5.42 1.35e-07 -0.22 -0.32 Migraine; chr10:103286250 chr10:103394301~103394322:- COAD cis rs1712517 0.545 rs3740381 MIMAT0005951 hsa-miR-1307-3p -5.42 1.35e-07 -0.22 -0.32 Migraine; chr10:103286932 chr10:103394301~103394322:- COAD cis rs1712517 0.566 rs7917388 MIMAT0005951 hsa-miR-1307-3p -5.42 1.35e-07 -0.22 -0.32 Migraine; chr10:103295206 chr10:103394301~103394322:- COAD cis rs1712517 0.525 rs11191642 MIMAT0005951 hsa-miR-1307-3p -5.42 1.35e-07 -0.22 -0.32 Migraine; chr10:103296155 chr10:103394301~103394322:- COAD cis rs6681460 0.604 rs7546825 MIMAT0014979 hsa-miR-3117-3p -5.42 1.36e-07 -0.39 -0.32 Presence of antiphospholipid antibodies; chr1:66636119 chr1:66628485~66628505:+ COAD cis rs6724465 0.929 rs7585868 MIMAT0014996 hsa-miR-3131 -5.41 1.42e-07 -0.61 -0.32 Height; chr2:219117942 chr2:219058725~219058747:- COAD cis rs950880 0.56 rs1997466 MIMAT0019927 hsa-miR-4772-3p 5.4 1.52e-07 0.28 0.32 Serum protein levels (sST2); chr2:102335007 chr2:102432336~102432357:+ COAD cis rs950880 0.56 rs12712140 MIMAT0019927 hsa-miR-4772-3p 5.4 1.52e-07 0.28 0.32 Serum protein levels (sST2); chr2:102334602 chr2:102432336~102432357:+ COAD cis rs950880 0.58 rs1997467 MIMAT0019927 hsa-miR-4772-3p 5.4 1.52e-07 0.28 0.32 Serum protein levels (sST2); chr2:102334613 chr2:102432336~102432357:+ COAD cis rs12712135 0.709 rs11465729 MIMAT0019927 hsa-miR-4772-3p 5.39 1.58e-07 0.28 0.32 Blood protein levels; chr2:102448052 chr2:102432336~102432357:+ COAD cis rs6724465 0.929 rs13410377 MIMAT0014996 hsa-miR-3131 -5.38 1.64e-07 -0.53 -0.32 Height; chr2:219110326 chr2:219058725~219058747:- COAD cis rs10021731 0.668 rs1599322 MIMAT0003242 hsa-miR-577 -5.38 1.71e-07 -0.25 -0.32 Optic disc area; chr4:114531895 chr4:114656774~114656794:+ COAD cis rs950880 0.56 rs12466380 MIMAT0019927 hsa-miR-4772-3p 5.37 1.72e-07 0.28 0.32 Serum protein levels (sST2); chr2:102332479 chr2:102432336~102432357:+ COAD cis rs950880 0.56 rs4142132 MIMAT0019927 hsa-miR-4772-3p 5.37 1.73e-07 0.28 0.32 Serum protein levels (sST2); chr2:102321022 chr2:102432336~102432357:+ COAD cis rs950880 0.517 rs1420088 MIMAT0019927 hsa-miR-4772-3p 5.37 1.73e-07 0.28 0.32 Serum protein levels (sST2); chr2:102322974 chr2:102432336~102432357:+ COAD cis rs950880 0.56 rs11123920 MIMAT0019927 hsa-miR-4772-3p 5.37 1.73e-07 0.28 0.32 Serum protein levels (sST2); chr2:102323373 chr2:102432336~102432357:+ COAD cis rs950880 0.56 rs11676075 MIMAT0019927 hsa-miR-4772-3p 5.37 1.73e-07 0.28 0.32 Serum protein levels (sST2); chr2:102324755 chr2:102432336~102432357:+ COAD cis rs950880 0.518 rs12996772 MIMAT0019927 hsa-miR-4772-3p 5.37 1.73e-07 0.28 0.32 Serum protein levels (sST2); chr2:102330741 chr2:102432336~102432357:+ COAD cis rs10021731 0.546 rs12503437 MIMAT0003242 hsa-miR-577 -5.37 1.75e-07 -0.25 -0.32 Optic disc area; chr4:114534955 chr4:114656774~114656794:+ COAD cis rs10021731 0.546 rs12503481 MIMAT0003242 hsa-miR-577 -5.37 1.75e-07 -0.25 -0.32 Optic disc area; chr4:114535080 chr4:114656774~114656794:+ COAD cis rs10021731 0.546 rs7668023 MIMAT0003242 hsa-miR-577 -5.37 1.75e-07 -0.25 -0.32 Optic disc area; chr4:114535366 chr4:114656774~114656794:+ COAD cis rs6681460 0.625 rs12127199 MIMAT0014979 hsa-miR-3117-3p -5.36 1.86e-07 -0.38 -0.32 Presence of antiphospholipid antibodies; chr1:66638059 chr1:66628485~66628505:+ COAD cis rs1712517 0.771 rs61871160 MIMAT0005951 hsa-miR-1307-3p -5.34 2.04e-07 -0.2 -0.32 Migraine; chr10:103384531 chr10:103394301~103394322:- COAD cis rs1712517 0.771 rs10883857 MIMAT0005951 hsa-miR-1307-3p 5.33 2.14e-07 0.2 0.32 Migraine; chr10:103367830 chr10:103394301~103394322:- COAD cis rs950880 0.56 rs1362349 MIMAT0019927 hsa-miR-4772-3p 5.32 2.24e-07 0.27 0.32 Serum protein levels (sST2); chr2:102335512 chr2:102432336~102432357:+ COAD cis rs1712517 0.836 rs7093039 MIMAT0005951 hsa-miR-1307-3p -5.32 2.25e-07 -0.2 -0.31 Migraine; chr10:103389790 chr10:103394301~103394322:- COAD cis rs12712135 0.677 rs11678721 MIMAT0019927 hsa-miR-4772-3p 5.32 2.3e-07 0.28 0.31 Blood protein levels; chr2:102456778 chr2:102432336~102432357:+ COAD cis rs12712135 0.709 rs11677555 MIMAT0019927 hsa-miR-4772-3p 5.32 2.3e-07 0.28 0.31 Blood protein levels; chr2:102456833 chr2:102432336~102432357:+ COAD cis rs12712135 0.651 rs12712150 MIMAT0019927 hsa-miR-4772-3p 5.32 2.3e-07 0.28 0.31 Blood protein levels; chr2:102458353 chr2:102432336~102432357:+ COAD cis rs12712135 0.709 rs6705498 MIMAT0019927 hsa-miR-4772-3p 5.32 2.3e-07 0.28 0.31 Blood protein levels; chr2:102460210 chr2:102432336~102432357:+ COAD cis rs12712135 0.709 rs6719196 MIMAT0019927 hsa-miR-4772-3p 5.32 2.3e-07 0.28 0.31 Blood protein levels; chr2:102460428 chr2:102432336~102432357:+ COAD cis rs6753739 0.673 rs17608747 MIMAT0014996 hsa-miR-3131 -5.31 2.37e-07 -0.44 -0.31 Height; chr2:219117378 chr2:219058725~219058747:- COAD cis rs1712517 0.844 rs1163075 MIMAT0005951 hsa-miR-1307-3p 5.31 2.4e-07 0.19 0.31 Migraine; chr10:103261506 chr10:103394301~103394322:- COAD cis rs7072216 0.843 rs4400721 MIMAT0005878 hsa-miR-1287-5p 5.3 2.47e-07 0.35 0.31 Metabolite levels; chr10:98387340 chr10:98395271~98395292:- COAD cis rs4917385 1 rs4917385 MIMAT0005951 hsa-miR-1307-3p 5.3 2.53e-07 0.21 0.31 Systemic lupus erythematosus; chr10:103243964 chr10:103394301~103394322:- COAD cis rs6681460 0.625 rs6680364 MIMAT0014979 hsa-miR-3117-3p -5.29 2.59e-07 -0.38 -0.31 Presence of antiphospholipid antibodies; chr1:66639151 chr1:66628485~66628505:+ COAD cis rs1712517 0.844 rs1163074 MIMAT0005951 hsa-miR-1307-3p -5.29 2.61e-07 -0.19 -0.31 Migraine; chr10:103262005 chr10:103394301~103394322:- COAD cis rs1712517 0.838 rs6584543 MIMAT0005951 hsa-miR-1307-3p 5.28 2.7e-07 0.19 0.31 Migraine; chr10:103237257 chr10:103394301~103394322:- COAD cis rs1870653 0.516 rs115941533 MIMAT0003242 hsa-miR-577 5.27 2.82e-07 0.39 0.31 Exploratory eye movement dysfunction in schizophrenia (number of eye fixations); chr4:114521099 chr4:114656774~114656794:+ COAD cis rs1712517 0.771 rs11191672 MIMAT0005951 hsa-miR-1307-3p -5.27 2.85e-07 -0.19 -0.31 Migraine; chr10:103379204 chr10:103394301~103394322:- COAD cis rs950880 0.56 rs1362350 MIMAT0019927 hsa-miR-4772-3p 5.27 2.85e-07 0.27 0.31 Serum protein levels (sST2); chr2:102335338 chr2:102432336~102432357:+ COAD cis rs950880 0.56 rs59247511 MIMAT0019927 hsa-miR-4772-3p 5.27 2.9e-07 0.27 0.31 Serum protein levels (sST2); chr2:102337730 chr2:102432336~102432357:+ COAD cis rs1712517 0.873 rs1712516 MIMAT0005951 hsa-miR-1307-3p -5.27 2.94e-07 -0.19 -0.31 Migraine; chr10:103273871 chr10:103394301~103394322:- COAD cis rs1712517 0.771 rs11191666 MIMAT0005951 hsa-miR-1307-3p -5.25 3.13e-07 -0.19 -0.31 Migraine; chr10:103367521 chr10:103394301~103394322:- COAD cis rs1712517 0.524 rs1712509 MIMAT0005951 hsa-miR-1307-3p -5.25 3.18e-07 -0.21 -0.31 Migraine; chr10:103254113 chr10:103394301~103394322:- COAD cis rs1867631 0.876 rs10889637 MIMAT0014979 hsa-miR-3117-3p -5.25 3.24e-07 -0.38 -0.31 Menopause (age at onset); chr1:66631782 chr1:66628485~66628505:+ COAD cis rs1870653 0.516 rs7671567 MIMAT0003242 hsa-miR-577 5.24 3.38e-07 0.38 0.31 Exploratory eye movement dysfunction in schizophrenia (number of eye fixations); chr4:114517952 chr4:114656774~114656794:+ COAD cis rs950880 0.56 rs10183388 MIMAT0019927 hsa-miR-4772-3p 5.23 3.47e-07 0.27 0.31 Serum protein levels (sST2); chr2:102315787 chr2:102432336~102432357:+ COAD cis rs7072216 0.65 rs10883089 MIMAT0005878 hsa-miR-1287-5p 5.23 3.51e-07 0.37 0.31 Metabolite levels; chr10:98403363 chr10:98395271~98395292:- COAD cis rs1870653 0.516 rs73848130 MIMAT0003242 hsa-miR-577 5.23 3.56e-07 0.38 0.31 Exploratory eye movement dysfunction in schizophrenia (number of eye fixations); chr4:114489234 chr4:114656774~114656794:+ COAD cis rs6724465 1 rs56033548 MIMAT0014996 hsa-miR-3131 -5.22 3.66e-07 -0.61 -0.31 Height; chr2:219071772 chr2:219058725~219058747:- COAD cis rs1712517 0.771 rs61869827 MIMAT0005951 hsa-miR-1307-3p -5.22 3.66e-07 -0.19 -0.31 Migraine; chr10:103319682 chr10:103394301~103394322:- COAD cis rs950880 0.56 rs1420102 MIMAT0019927 hsa-miR-4772-3p 5.22 3.72e-07 0.26 0.31 Serum protein levels (sST2); chr2:102332359 chr2:102432336~102432357:+ COAD cis rs1712517 0.904 rs7905968 MIMAT0005951 hsa-miR-1307-3p -5.21 3.8e-07 -0.19 -0.31 Migraine; chr10:103375562 chr10:103394301~103394322:- COAD cis rs950880 0.56 rs1558622 MIMAT0019927 hsa-miR-4772-3p 5.21 3.93e-07 0.26 0.31 Serum protein levels (sST2); chr2:102313687 chr2:102432336~102432357:+ COAD cis rs950880 0.56 rs10189202 MIMAT0019927 hsa-miR-4772-3p 5.21 3.93e-07 0.26 0.31 Serum protein levels (sST2); chr2:102313920 chr2:102432336~102432357:+ COAD cis rs950880 0.56 rs10191914 MIMAT0019927 hsa-miR-4772-3p 5.21 3.93e-07 0.26 0.31 Serum protein levels (sST2); chr2:102314197 chr2:102432336~102432357:+ COAD cis rs950880 0.56 rs1558620 MIMAT0019927 hsa-miR-4772-3p 5.21 3.93e-07 0.26 0.31 Serum protein levels (sST2); chr2:102314935 chr2:102432336~102432357:+ COAD cis rs950880 0.56 rs11685480 MIMAT0019927 hsa-miR-4772-3p 5.21 3.94e-07 0.26 0.31 Serum protein levels (sST2); chr2:102310626 chr2:102432336~102432357:+ COAD cis rs1712517 0.771 rs59744322 MIMAT0005951 hsa-miR-1307-3p -5.2 4.09e-07 -0.19 -0.31 Migraine; chr10:103386935 chr10:103394301~103394322:- COAD cis rs7894407 0.892 rs10883859 MIMAT0005951 hsa-miR-1307-3p 5.2 4.16e-07 0.2 0.31 White matter hyperintensity burden; chr10:103368377 chr10:103394301~103394322:- COAD cis rs6724465 1 rs10177466 MIMAT0014996 hsa-miR-3131 -5.19 4.29e-07 -0.5 -0.31 Height; chr2:219046266 chr2:219058725~219058747:- COAD cis rs75358501 0.636 rs7576591 MIMAT0014994 hsa-miR-3130-3p 5.19 4.34e-07 0.43 0.31 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206784502 chr2:206783245~206783265:- COAD cis rs75358501 0.636 rs7576591 MIMAT0014994_1 hsa-miR-3130-3p 5.19 4.34e-07 0.43 0.31 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206784502 chr2:206783277~206783297:+ COAD cis rs75358501 0.636 rs2287628 MIMAT0014994 hsa-miR-3130-3p 5.19 4.34e-07 0.43 0.31 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206785809 chr2:206783245~206783265:- COAD cis rs75358501 0.636 rs2287628 MIMAT0014994_1 hsa-miR-3130-3p 5.19 4.34e-07 0.43 0.31 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206785809 chr2:206783277~206783297:+ COAD cis rs6724465 1 rs72967942 MIMAT0014996 hsa-miR-3131 -5.19 4.36e-07 -0.5 -0.31 Height; chr2:219052800 chr2:219058725~219058747:- COAD cis rs76886731 1 rs76886731 MIMAT0019927 hsa-miR-4772-3p 5.18 4.43e-07 0.27 0.31 Leprosy; chr2:102328956 chr2:102432336~102432357:+ COAD cis rs1712517 0.844 rs4918003 MIMAT0005951 hsa-miR-1307-3p -5.18 4.49e-07 -0.19 -0.31 Migraine; chr10:103284400 chr10:103394301~103394322:- COAD cis rs75358501 0.636 rs11895370 MIMAT0014994 hsa-miR-3130-3p 5.17 4.8e-07 0.42 0.31 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206789990 chr2:206783245~206783265:- COAD cis rs75358501 0.636 rs11895370 MIMAT0014994_1 hsa-miR-3130-3p 5.17 4.8e-07 0.42 0.31 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206789990 chr2:206783277~206783297:+ COAD cis rs12712135 0.709 rs11465728 MIMAT0019927 hsa-miR-4772-3p 5.16 4.97e-07 0.27 0.31 Blood protein levels; chr2:102448051 chr2:102432336~102432357:+ COAD cis rs1867631 1 rs10889636 MIMAT0014979 hsa-miR-3117-3p 5.16 5e-07 0.37 0.31 Menopause (age at onset); chr1:66624241 chr1:66628485~66628505:+ COAD cis rs6753739 0.625 rs359974 MIMAT0014996 hsa-miR-3131 5.16 5.05e-07 0.43 0.31 Height; chr2:219065469 chr2:219058725~219058747:- COAD cis rs75358501 0.636 rs16838834 MIMAT0014994 hsa-miR-3130-3p 5.15 5.23e-07 0.42 0.31 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206765071 chr2:206783245~206783265:- COAD cis rs75358501 0.636 rs16838834 MIMAT0014994_1 hsa-miR-3130-3p 5.15 5.23e-07 0.42 0.31 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206765071 chr2:206783277~206783297:+ COAD cis rs6841433 0.615 rs17047236 MIMAT0003242 hsa-miR-577 5.15 5.26e-07 0.32 0.31 Hemoglobin concentration; chr4:114564575 chr4:114656774~114656794:+ COAD cis rs10021731 0.718 rs7698391 MIMAT0003242 hsa-miR-577 -5.14 5.37e-07 -0.23 -0.31 Optic disc area; chr4:114492457 chr4:114656774~114656794:+ COAD cis rs1712517 0.524 rs4917384 MIMAT0005951 hsa-miR-1307-3p 5.12 6.04e-07 0.21 0.3 Migraine; chr10:103236031 chr10:103394301~103394322:- COAD cis rs75358501 0.636 rs10199766 MIMAT0014994 hsa-miR-3130-3p 5.11 6.16e-07 0.42 0.3 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206777144 chr2:206783245~206783265:- COAD cis rs75358501 0.636 rs10199766 MIMAT0014994_1 hsa-miR-3130-3p 5.11 6.16e-07 0.42 0.3 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206777144 chr2:206783277~206783297:+ COAD cis rs75358501 0.636 rs13427002 MIMAT0014994 hsa-miR-3130-3p 5.11 6.16e-07 0.42 0.3 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206778949 chr2:206783245~206783265:- COAD cis rs75358501 0.636 rs13427002 MIMAT0014994_1 hsa-miR-3130-3p 5.11 6.16e-07 0.42 0.3 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206778949 chr2:206783277~206783297:+ COAD cis rs7072216 0.621 rs3750605 MIMAT0005878 hsa-miR-1287-5p 5.11 6.36e-07 0.39 0.3 Metabolite levels; chr10:98415897 chr10:98395271~98395292:- COAD cis rs1712517 0.873 rs1163086 MIMAT0005951 hsa-miR-1307-3p -5.11 6.42e-07 -0.19 -0.3 Migraine; chr10:103279822 chr10:103394301~103394322:- COAD cis rs75358501 0.636 rs888621 MIMAT0014994 hsa-miR-3130-3p -5.1 6.45e-07 -0.42 -0.3 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206784626 chr2:206783245~206783265:- COAD cis rs75358501 0.636 rs888621 MIMAT0014994_1 hsa-miR-3130-3p -5.1 6.45e-07 -0.42 -0.3 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206784626 chr2:206783277~206783297:+ COAD cis rs6755560 0.963 rs1862090 MIMAT0014995 hsa-miR-3130-5p 5.1 6.52e-07 0.35 0.3 QT interval (drug interaction); chr2:206828016 chr2:206783276~206783296:- COAD cis rs6755560 0.963 rs1862090 MIMAT0014995_1 hsa-miR-3130-5p 5.1 6.52e-07 0.35 0.3 QT interval (drug interaction); chr2:206828016 chr2:206783246~206783266:+ COAD cis rs6543140 0.601 rs7558013 MIMAT0019927 hsa-miR-4772-3p -5.1 6.65e-07 -0.33 -0.3 Blood protein levels; chr2:102376346 chr2:102432336~102432357:+ COAD cis rs1712517 0.904 rs6584547 MIMAT0005951 hsa-miR-1307-3p -5.09 6.8e-07 -0.19 -0.3 Migraine; chr10:103305652 chr10:103394301~103394322:- COAD cis rs1712517 0.787 rs1163089 MIMAT0005951 hsa-miR-1307-3p -5.09 6.96e-07 -0.19 -0.3 Migraine; chr10:103284207 chr10:103394301~103394322:- COAD cis rs6724465 1 rs7598980 MIMAT0014996 hsa-miR-3131 -5.09 7.07e-07 -0.54 -0.3 Height; chr2:219103700 chr2:219058725~219058747:- COAD cis rs6724465 1 rs56388436 MIMAT0014996 hsa-miR-3131 -5.09 7.08e-07 -0.6 -0.3 Height; chr2:219094181 chr2:219058725~219058747:- COAD cis rs75358501 0.636 rs12471008 MIMAT0014994 hsa-miR-3130-3p 5.08 7.13e-07 0.41 0.3 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206775059 chr2:206783245~206783265:- COAD cis rs75358501 0.636 rs12471008 MIMAT0014994_1 hsa-miR-3130-3p 5.08 7.13e-07 0.41 0.3 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206775059 chr2:206783277~206783297:+ COAD cis rs75358501 0.636 rs768533 MIMAT0014994 hsa-miR-3130-3p 5.08 7.13e-07 0.41 0.3 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206776113 chr2:206783245~206783265:- COAD cis rs75358501 0.636 rs768533 MIMAT0014994_1 hsa-miR-3130-3p 5.08 7.13e-07 0.41 0.3 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206776113 chr2:206783277~206783297:+ COAD cis rs6724465 1 rs72951738 MIMAT0014996 hsa-miR-3131 -5.08 7.22e-07 -0.59 -0.3 Height; chr2:219102079 chr2:219058725~219058747:- COAD cis rs1712517 0.836 rs11191649 MIMAT0005951 hsa-miR-1307-3p -5.06 8.11e-07 -0.19 -0.3 Migraine; chr10:103307280 chr10:103394301~103394322:- COAD cis rs950880 0.56 rs12712141 MIMAT0019927 hsa-miR-4772-3p 5.06 8.16e-07 0.26 0.3 Serum protein levels (sST2); chr2:102336607 chr2:102432336~102432357:+ COAD cis rs6724465 1 rs10197172 MIMAT0014996 hsa-miR-3131 -5.06 8.16e-07 -0.59 -0.3 Height; chr2:219091214 chr2:219058725~219058747:- COAD cis rs1712517 0.771 rs11191654 MIMAT0005951 hsa-miR-1307-3p -5.05 8.24e-07 -0.18 -0.3 Migraine; chr10:103317367 chr10:103394301~103394322:- COAD cis rs1712517 0.771 rs7074749 MIMAT0005951 hsa-miR-1307-3p -5.05 8.32e-07 -0.19 -0.3 Migraine; chr10:103356299 chr10:103394301~103394322:- COAD cis rs1712517 0.74 rs11191663 MIMAT0005951 hsa-miR-1307-3p -5.05 8.32e-07 -0.19 -0.3 Migraine; chr10:103358705 chr10:103394301~103394322:- COAD cis rs7072216 0.587 rs3814141 MIMAT0005878 hsa-miR-1287-5p 5.05 8.36e-07 0.38 0.3 Metabolite levels; chr10:98411271 chr10:98395271~98395292:- COAD cis rs75358501 0.636 rs725980 MIMAT0014994 hsa-miR-3130-3p 5.04 8.67e-07 0.42 0.3 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206773856 chr2:206783245~206783265:- COAD cis rs75358501 0.636 rs725980 MIMAT0014994_1 hsa-miR-3130-3p 5.04 8.67e-07 0.42 0.3 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206773856 chr2:206783277~206783297:+ COAD cis rs950880 0.542 rs953934 MIMAT0019927 hsa-miR-4772-3p 5.04 8.77e-07 0.25 0.3 Serum protein levels (sST2); chr2:102315833 chr2:102432336~102432357:+ COAD cis rs6543140 0.601 rs78178597 MIMAT0019927 hsa-miR-4772-3p -5.04 8.92e-07 -0.33 -0.3 Blood protein levels; chr2:102407136 chr2:102432336~102432357:+ COAD cis rs950880 0.542 rs12996505 MIMAT0019927 hsa-miR-4772-3p 5.03 9.13e-07 0.26 0.3 Serum protein levels (sST2); chr2:102315342 chr2:102432336~102432357:+ COAD cis rs6753739 0.673 rs62191797 MIMAT0014996 hsa-miR-3131 -5.02 9.52e-07 -0.42 -0.3 Height; chr2:219129221 chr2:219058725~219058747:- COAD cis rs6724465 1 rs79986235 MIMAT0014996 hsa-miR-3131 -5.02 9.57e-07 -0.59 -0.3 Height; chr2:219079413 chr2:219058725~219058747:- COAD cis rs75358501 0.636 rs2241347 MIMAT0014994 hsa-miR-3130-3p 5.02 9.63e-07 0.41 0.3 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206783257 chr2:206783245~206783265:- COAD cis rs75358501 0.636 rs2241347 MIMAT0014994_1 hsa-miR-3130-3p 5.02 9.63e-07 0.41 0.3 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206783257 chr2:206783277~206783297:+ COAD cis rs6724465 0.925 rs13408333 MIMAT0014996 hsa-miR-3131 -5.02 9.7e-07 -0.54 -0.3 Height; chr2:219106795 chr2:219058725~219058747:- COAD cis rs6724465 0.925 rs13408334 MIMAT0014996 hsa-miR-3131 -5.02 9.7e-07 -0.54 -0.3 Height; chr2:219106796 chr2:219058725~219058747:- COAD cis rs6724465 1 rs13408337 MIMAT0014996 hsa-miR-3131 -5.02 9.7e-07 -0.54 -0.3 Height; chr2:219106804 chr2:219058725~219058747:- COAD cis rs1870653 0.516 rs9995562 MIMAT0003242 hsa-miR-577 5.02 9.81e-07 0.36 0.3 Exploratory eye movement dysfunction in schizophrenia (number of eye fixations); chr4:114491077 chr4:114656774~114656794:+ COAD cis rs6724465 1 rs72951729 MIMAT0014996 hsa-miR-3131 -5.02 9.86e-07 -0.59 -0.3 Height; chr2:219095821 chr2:219058725~219058747:- COAD cis rs950880 0.56 rs971764 MIMAT0019927 hsa-miR-4772-3p 5.01 1.01e-06 0.25 0.3 Serum protein levels (sST2); chr2:102321875 chr2:102432336~102432357:+ COAD cis rs950880 0.56 rs6706844 MIMAT0019927 hsa-miR-4772-3p 5.01 1.01e-06 0.25 0.3 Serum protein levels (sST2); chr2:102323952 chr2:102432336~102432357:+ COAD cis rs7072216 0.555 rs2296433 MIMAT0005878 hsa-miR-1287-5p 5.01 1.03e-06 0.39 0.3 Metabolite levels; chr10:98424305 chr10:98395271~98395292:- COAD cis rs7072216 0.555 rs2296432 MIMAT0005878 hsa-miR-1287-5p 5.01 1.03e-06 0.39 0.3 Metabolite levels; chr10:98424306 chr10:98395271~98395292:- COAD cis rs1867631 1 rs7546090 MIMAT0014979 hsa-miR-3117-3p -5 1.06e-06 -0.36 -0.3 Menopause (age at onset); chr1:66618298 chr1:66628485~66628505:+ COAD cis rs6681460 0.625 rs2872079 MIMAT0014979 hsa-miR-3117-3p -5 1.08e-06 -0.35 -0.3 Presence of antiphospholipid antibodies; chr1:66664388 chr1:66628485~66628505:+ COAD cis rs6543140 0.601 rs6543135 MIMAT0019927 hsa-miR-4772-3p -4.99 1.13e-06 -0.33 -0.3 Blood protein levels; chr2:102445946 chr2:102432336~102432357:+ COAD cis rs1712517 0.844 rs1163087 MIMAT0005951 hsa-miR-1307-3p -4.97 1.21e-06 -0.19 -0.3 Migraine; chr10:103283532 chr10:103394301~103394322:- COAD cis rs6724465 0.929 rs13410177 MIMAT0014996 hsa-miR-3131 -4.97 1.21e-06 -0.53 -0.3 Height; chr2:219110130 chr2:219058725~219058747:- COAD cis rs6724465 1 rs56345933 MIMAT0014996 hsa-miR-3131 -4.94 1.42e-06 -0.48 -0.29 Height; chr2:219049013 chr2:219058725~219058747:- COAD cis rs6724465 1 rs56006038 MIMAT0014996 hsa-miR-3131 -4.94 1.42e-06 -0.48 -0.29 Height; chr2:219049115 chr2:219058725~219058747:- COAD cis rs7072216 1 rs7072216 MIMAT0005878 hsa-miR-1287-5p 4.92 1.53e-06 0.33 0.29 Metabolite levels; chr10:98397096 chr10:98395271~98395292:- COAD cis rs1712517 0.771 rs7921655 MIMAT0005951 hsa-miR-1307-3p -4.92 1.54e-06 -0.18 -0.29 Migraine; chr10:103353944 chr10:103394301~103394322:- COAD cis rs1867631 0.958 rs7536188 MIMAT0014979 hsa-miR-3117-3p 4.92 1.56e-06 0.36 0.29 Menopause (age at onset); chr1:66622243 chr1:66628485~66628505:+ COAD cis rs6681460 0.625 rs4488004 MIMAT0014979 hsa-miR-3117-3p -4.92 1.57e-06 -0.36 -0.29 Presence of antiphospholipid antibodies; chr1:66607631 chr1:66628485~66628505:+ COAD cis rs6681460 0.584 rs7528182 MIMAT0014979 hsa-miR-3117-3p -4.92 1.57e-06 -0.35 -0.29 Presence of antiphospholipid antibodies; chr1:66601686 chr1:66628485~66628505:+ COAD cis rs6753739 0.54 rs394452 MIMAT0014996 hsa-miR-3131 4.92 1.58e-06 0.42 0.29 Height; chr2:219055315 chr2:219058725~219058747:- COAD cis rs1712517 0.771 rs11191645 MIMAT0005951 hsa-miR-1307-3p -4.91 1.62e-06 -0.18 -0.29 Migraine; chr10:103299551 chr10:103394301~103394322:- COAD cis rs6755560 0.889 rs7597011 MIMAT0014995 hsa-miR-3130-5p 4.91 1.65e-06 0.35 0.29 QT interval (drug interaction); chr2:206855115 chr2:206783276~206783296:- COAD cis rs6755560 0.889 rs7597011 MIMAT0014995_1 hsa-miR-3130-5p 4.91 1.65e-06 0.35 0.29 QT interval (drug interaction); chr2:206855115 chr2:206783246~206783266:+ COAD cis rs1867631 0.958 rs7520226 MIMAT0014979 hsa-miR-3117-3p -4.9 1.72e-06 -0.36 -0.29 Menopause (age at onset); chr1:66615312 chr1:66628485~66628505:+ COAD cis rs1712517 0.771 rs61350103 MIMAT0005951 hsa-miR-1307-3p -4.89 1.75e-06 -0.18 -0.29 Migraine; chr10:103309363 chr10:103394301~103394322:- COAD cis rs1870653 0.516 rs28555162 MIMAT0003242 hsa-miR-577 4.88 1.87e-06 0.35 0.29 Exploratory eye movement dysfunction in schizophrenia (number of eye fixations); chr4:114517408 chr4:114656774~114656794:+ COAD cis rs6543140 0.572 rs17027173 MIMAT0019927 hsa-miR-4772-3p -4.87 1.97e-06 -0.32 -0.29 Blood protein levels; chr2:102440583 chr2:102432336~102432357:+ COAD cis rs1712517 0.771 rs11191664 MIMAT0005951 hsa-miR-1307-3p -4.87 1.99e-06 -0.18 -0.29 Migraine; chr10:103358719 chr10:103394301~103394322:- COAD cis rs7894407 0.76 rs1163085 MIMAT0005951 hsa-miR-1307-3p -4.86 2.04e-06 -0.19 -0.29 White matter hyperintensity burden; chr10:103279484 chr10:103394301~103394322:- COAD cis rs75358501 0.688 rs2287629 MIMAT0014994 hsa-miR-3130-3p -4.86 2.08e-06 -0.39 -0.29 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206785690 chr2:206783245~206783265:- COAD cis rs75358501 0.688 rs2287629 MIMAT0014994_1 hsa-miR-3130-3p -4.86 2.08e-06 -0.39 -0.29 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206785690 chr2:206783277~206783297:+ COAD cis rs6724465 1 rs7586856 MIMAT0014996 hsa-miR-3131 -4.86 2.08e-06 -0.49 -0.29 Height; chr2:219103854 chr2:219058725~219058747:- COAD cis rs7072216 0.621 rs3750604 MIMAT0005878 hsa-miR-1287-5p 4.84 2.27e-06 0.38 0.29 Metabolite levels; chr10:98415824 chr10:98395271~98395292:- COAD cis rs7894407 0.76 rs4917386 MIMAT0005951 hsa-miR-1307-3p 4.83 2.32e-06 0.19 0.29 White matter hyperintensity burden; chr10:103247771 chr10:103394301~103394322:- COAD cis rs1867631 1 rs6665859 MIMAT0014979 hsa-miR-3117-3p -4.81 2.52e-06 -0.35 -0.29 Menopause (age at onset); chr1:66611872 chr1:66628485~66628505:+ COAD cis rs1712517 0.873 rs7913461 MIMAT0005951 hsa-miR-1307-3p -4.81 2.54e-06 -0.18 -0.29 Migraine; chr10:103241568 chr10:103394301~103394322:- COAD cis rs1712517 0.838 rs1891293 MIMAT0005951 hsa-miR-1307-3p 4.79 2.79e-06 0.18 0.29 Migraine; chr10:103242040 chr10:103394301~103394322:- COAD cis rs1712517 0.873 rs7916056 MIMAT0005951 hsa-miR-1307-3p 4.78 2.92e-06 0.18 0.29 Migraine; chr10:103238157 chr10:103394301~103394322:- COAD cis rs6724465 1 rs72967918 MIMAT0014996 hsa-miR-3131 -4.78 2.95e-06 -0.5 -0.29 Height; chr2:219047122 chr2:219058725~219058747:- COAD cis rs6724465 1 rs10172118 MIMAT0014996 hsa-miR-3131 -4.78 2.95e-06 -0.5 -0.29 Height; chr2:219048790 chr2:219058725~219058747:- COAD cis rs1712517 0.771 rs2008530 MIMAT0005951 hsa-miR-1307-3p -4.78 2.95e-06 -0.18 -0.29 Migraine; chr10:103299082 chr10:103394301~103394322:- COAD cis rs75358501 0.636 rs3815686 MIMAT0014994 hsa-miR-3130-3p 4.77 3.06e-06 0.39 0.29 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206768278 chr2:206783245~206783265:- COAD cis rs75358501 0.636 rs3815686 MIMAT0014994_1 hsa-miR-3130-3p 4.77 3.06e-06 0.39 0.29 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206768278 chr2:206783277~206783297:+ COAD cis rs7588654 0.793 rs422702 MIMAT0014996 hsa-miR-3131 -4.75 3.43e-06 -0.55 -0.28 Height; chr2:219037931 chr2:219058725~219058747:- COAD cis rs1712517 0.74 rs4917387 MIMAT0005951 hsa-miR-1307-3p -4.74 3.6e-06 -0.18 -0.28 Migraine; chr10:103348698 chr10:103394301~103394322:- COAD cis rs6724465 1 rs6724465 MIMAT0014996 hsa-miR-3131 -4.73 3.71e-06 -0.51 -0.28 Height; chr2:219079124 chr2:219058725~219058747:- COAD cis rs950880 0.56 rs974389 MIMAT0019927 hsa-miR-4772-3p -4.73 3.71e-06 -0.24 -0.28 Serum protein levels (sST2); chr2:102320521 chr2:102432336~102432357:+ COAD cis rs6755560 1 rs4283403 MIMAT0014995 hsa-miR-3130-5p 4.72 3.83e-06 0.32 0.28 QT interval (drug interaction); chr2:206829091 chr2:206783276~206783296:- COAD cis rs6755560 1 rs4283403 MIMAT0014995_1 hsa-miR-3130-5p 4.72 3.83e-06 0.32 0.28 QT interval (drug interaction); chr2:206829091 chr2:206783246~206783266:+ COAD cis rs6724465 1 rs13386793 MIMAT0014996 hsa-miR-3131 -4.72 3.94e-06 -0.47 -0.28 Height; chr2:219107852 chr2:219058725~219058747:- COAD cis rs6724465 0.929 rs12104660 MIMAT0014996 hsa-miR-3131 -4.72 3.94e-06 -0.47 -0.28 Height; chr2:219108262 chr2:219058725~219058747:- COAD cis rs75358501 0.584 rs11894165 MIMAT0014994 hsa-miR-3130-3p 4.71 4.14e-06 0.42 0.28 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206759688 chr2:206783245~206783265:- COAD cis rs75358501 0.584 rs11894165 MIMAT0014994_1 hsa-miR-3130-3p 4.71 4.14e-06 0.42 0.28 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206759688 chr2:206783277~206783297:+ COAD cis rs950880 0.71 rs1474309 MIMAT0019927 hsa-miR-4772-3p -4.7 4.26e-06 -0.5 -0.28 Serum protein levels (sST2); chr2:102474542 chr2:102432336~102432357:+ COAD cis rs6724465 1 rs6752757 MIMAT0014996 hsa-miR-3131 -4.7 4.27e-06 -0.51 -0.28 Height; chr2:219079079 chr2:219058725~219058747:- COAD cis rs6724465 1 rs13396442 MIMAT0014996 hsa-miR-3131 -4.7 4.27e-06 -0.51 -0.28 Height; chr2:219106808 chr2:219058725~219058747:- COAD cis rs75358501 0.688 rs1862087 MIMAT0014994 hsa-miR-3130-3p 4.69 4.36e-06 0.41 0.28 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206760843 chr2:206783245~206783265:- COAD cis rs75358501 0.688 rs1862087 MIMAT0014994_1 hsa-miR-3130-3p 4.69 4.36e-06 0.41 0.28 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206760843 chr2:206783277~206783297:+ COAD cis rs6724465 0.866 rs12185751 MIMAT0014996 hsa-miR-3131 -4.69 4.46e-06 -0.52 -0.28 Height; chr2:219040186 chr2:219058725~219058747:- COAD cis rs6681460 0.565 rs2147776 MIMAT0014979 hsa-miR-3117-3p -4.67 4.78e-06 -0.34 -0.28 Presence of antiphospholipid antibodies; chr1:66641720 chr1:66628485~66628505:+ COAD cis rs6724465 1 rs13394499 MIMAT0014996 hsa-miR-3131 -4.67 4.79e-06 -0.56 -0.28 Height; chr2:219104363 chr2:219058725~219058747:- COAD cis rs7072216 0.77 rs1061115 MIMAT0005878 hsa-miR-1287-5p 4.67 4.82e-06 0.33 0.28 Metabolite levels; chr10:98417292 chr10:98395271~98395292:- COAD cis rs6724465 0.929 rs77945941 MIMAT0014996 hsa-miR-3131 -4.67 4.88e-06 -0.56 -0.28 Height; chr2:219109023 chr2:219058725~219058747:- COAD cis rs6724465 1 rs55836193 MIMAT0014996 hsa-miR-3131 -4.66 5.03e-06 -0.53 -0.28 Height; chr2:219042371 chr2:219058725~219058747:- COAD cis rs7072216 0.621 rs11189595 MIMAT0005878 hsa-miR-1287-5p 4.64 5.54e-06 0.36 0.28 Metabolite levels; chr10:98407565 chr10:98395271~98395292:- COAD cis rs1870653 0.516 rs6852269 MIMAT0003242 hsa-miR-577 4.63 5.72e-06 0.35 0.28 Exploratory eye movement dysfunction in schizophrenia (number of eye fixations); chr4:114481622 chr4:114656774~114656794:+ COAD cis rs6724465 1 rs72967917 MIMAT0014996 hsa-miR-3131 -4.63 5.73e-06 -0.56 -0.28 Height; chr2:219046300 chr2:219058725~219058747:- COAD cis rs6681460 0.966 rs10789214 MIMAT0014979 hsa-miR-3117-3p -4.63 5.82e-06 -0.35 -0.28 Presence of antiphospholipid antibodies; chr1:66681134 chr1:66628485~66628505:+ COAD cis rs1870653 0.516 rs7682565 MIMAT0003242 hsa-miR-577 4.62 6e-06 0.35 0.28 Exploratory eye movement dysfunction in schizophrenia (number of eye fixations); chr4:114532315 chr4:114656774~114656794:+ COAD cis rs1870653 0.516 rs56228000 MIMAT0003242 hsa-miR-577 4.62 6e-06 0.35 0.28 Exploratory eye movement dysfunction in schizophrenia (number of eye fixations); chr4:114533268 chr4:114656774~114656794:+ COAD cis rs6724465 1 rs13393738 MIMAT0014996 hsa-miR-3131 -4.62 6.11e-06 -0.5 -0.28 Height; chr2:219049422 chr2:219058725~219058747:- COAD cis rs10021731 1 rs11098258 MIMAT0003242 hsa-miR-577 4.61 6.26e-06 0.23 0.28 Optic disc area; chr4:114564528 chr4:114656774~114656794:+ COAD cis rs7894407 0.856 rs7093667 MIMAT0005951 hsa-miR-1307-3p -4.59 6.91e-06 -0.17 -0.28 White matter hyperintensity burden; chr10:103320818 chr10:103394301~103394322:- COAD cis rs10021731 1 rs10021731 MIMAT0003242 hsa-miR-577 4.59 6.97e-06 0.22 0.28 Optic disc area; chr4:114560759 chr4:114656774~114656794:+ COAD cis rs7072216 0.922 rs4488133 MIMAT0005878 hsa-miR-1287-5p -4.59 6.99e-06 -0.31 -0.28 Metabolite levels; chr10:98399379 chr10:98395271~98395292:- COAD cis rs6681460 0.565 rs6689755 MIMAT0014979 hsa-miR-3117-3p -4.59 7.04e-06 -0.33 -0.28 Presence of antiphospholipid antibodies; chr1:66647367 chr1:66628485~66628505:+ COAD cis rs6724465 1 rs17608677 MIMAT0014996 hsa-miR-3131 4.59 7.08e-06 0.42 0.28 Height; chr2:219072149 chr2:219058725~219058747:- COAD cis rs7072216 0.652 rs11189600 MIMAT0005878 hsa-miR-1287-5p -4.58 7.16e-06 -0.32 -0.27 Metabolite levels; chr10:98419517 chr10:98395271~98395292:- COAD cis rs1712517 0.773 rs1063461 MIMAT0005951 hsa-miR-1307-3p -4.58 7.23e-06 -0.17 -0.27 Migraine; chr10:103289348 chr10:103394301~103394322:- COAD cis rs1712517 0.74 rs4293062 MIMAT0005951 hsa-miR-1307-3p -4.58 7.23e-06 -0.17 -0.27 Migraine; chr10:103292867 chr10:103394301~103394322:- COAD cis rs1712517 0.744 rs11191641 MIMAT0005951 hsa-miR-1307-3p -4.58 7.23e-06 -0.17 -0.27 Migraine; chr10:103293183 chr10:103394301~103394322:- COAD cis rs1712517 0.744 rs4293063 MIMAT0005951 hsa-miR-1307-3p -4.58 7.23e-06 -0.17 -0.27 Migraine; chr10:103293219 chr10:103394301~103394322:- COAD cis rs6724465 0.866 rs3736403 MIMAT0014996 hsa-miR-3131 -4.58 7.28e-06 -0.55 -0.27 Height; chr2:219040525 chr2:219058725~219058747:- COAD cis rs1870653 0.85 rs7687339 MIMAT0003242 hsa-miR-577 4.58 7.32e-06 0.32 0.27 Exploratory eye movement dysfunction in schizophrenia (number of eye fixations); chr4:114450571 chr4:114656774~114656794:+ COAD cis rs6724465 0.714 rs72951802 MIMAT0014996 hsa-miR-3131 -4.58 7.38e-06 -0.42 -0.27 Height; chr2:219141408 chr2:219058725~219058747:- COAD cis rs7072216 0.77 rs1061123 MIMAT0005878 hsa-miR-1287-5p 4.57 7.6e-06 0.33 0.27 Metabolite levels; chr10:98417240 chr10:98395271~98395292:- COAD cis rs6681460 0.966 rs6588215 MIMAT0014979 hsa-miR-3117-3p -4.56 7.83e-06 -0.34 -0.27 Presence of antiphospholipid antibodies; chr1:66676266 chr1:66628485~66628505:+ COAD cis rs7072216 0.77 rs1739 MIMAT0005878 hsa-miR-1287-5p 4.55 8.25e-06 0.33 0.27 Metabolite levels; chr10:98416582 chr10:98395271~98395292:- COAD cis rs1014286 0.706 rs10202404 MIMAT0019926 hsa-miR-4772-5p -4.55 8.31e-06 -0.29 -0.27 Serum protein levels (sST2); chr2:102560955 chr2:102432300~102432321:+ COAD cis rs7072216 0.763 rs942804 MIMAT0026738 hsa-miR-1287-3p 4.55 8.45e-06 0.24 0.27 Metabolite levels; chr10:98408742 chr10:98395232~98395253:- COAD cis rs7072216 0.77 rs1737 MIMAT0005878 hsa-miR-1287-5p 4.54 8.65e-06 0.32 0.27 Metabolite levels; chr10:98416609 chr10:98395271~98395292:- COAD cis rs6755560 1 rs35311487 MIMAT0014995 hsa-miR-3130-5p 4.53 8.85e-06 0.31 0.27 QT interval (drug interaction); chr2:206848647 chr2:206783276~206783296:- COAD cis rs6755560 1 rs35311487 MIMAT0014995_1 hsa-miR-3130-5p 4.53 8.85e-06 0.31 0.27 QT interval (drug interaction); chr2:206848647 chr2:206783246~206783266:+ COAD cis rs6724465 1 rs10201445 MIMAT0014996 hsa-miR-3131 -4.52 9.25e-06 -0.48 -0.27 Height; chr2:219049995 chr2:219058725~219058747:- COAD cis rs6724465 1 rs6719931 MIMAT0014996 hsa-miR-3131 -4.52 9.25e-06 -0.48 -0.27 Height; chr2:219050217 chr2:219058725~219058747:- COAD cis rs1014286 0.706 rs4851019 MIMAT0019926 hsa-miR-4772-5p 4.52 9.57e-06 0.28 0.27 Serum protein levels (sST2); chr2:102561106 chr2:102432300~102432321:+ COAD cis rs950880 0.56 rs1558619 MIMAT0019927 hsa-miR-4772-3p 4.5 1.01e-05 0.23 0.27 Serum protein levels (sST2); chr2:102315090 chr2:102432336~102432357:+ COAD cis rs7072216 0.727 rs7915108 MIMAT0026738 hsa-miR-1287-3p 4.5 1.01e-05 0.25 0.27 Metabolite levels; chr10:98404684 chr10:98395232~98395253:- COAD cis rs7072216 0.727 rs7901577 MIMAT0026738 hsa-miR-1287-3p 4.5 1.01e-05 0.25 0.27 Metabolite levels; chr10:98404685 chr10:98395232~98395253:- COAD cis rs1014286 0.706 rs6761291 MIMAT0019926 hsa-miR-4772-5p 4.5 1.02e-05 0.28 0.27 Serum protein levels (sST2); chr2:102538610 chr2:102432300~102432321:+ COAD cis rs6755560 1 rs6755560 MIMAT0014995 hsa-miR-3130-5p 4.49 1.06e-05 0.31 0.27 QT interval (drug interaction); chr2:206853059 chr2:206783276~206783296:- COAD cis rs6755560 1 rs6755560 MIMAT0014995_1 hsa-miR-3130-5p 4.49 1.06e-05 0.31 0.27 QT interval (drug interaction); chr2:206853059 chr2:206783246~206783266:+ COAD cis rs6724465 1 rs13404123 MIMAT0014996 hsa-miR-3131 4.49 1.06e-05 0.44 0.27 Height; chr2:219052075 chr2:219058725~219058747:- COAD cis rs7072216 0.843 rs2296441 MIMAT0005878 hsa-miR-1287-5p 4.49 1.07e-05 0.31 0.27 Metabolite levels; chr10:98385025 chr10:98395271~98395292:- COAD cis rs950880 0.56 rs4090473 MIMAT0019927 hsa-miR-4772-3p 4.49 1.1e-05 0.23 0.27 Serum protein levels (sST2); chr2:102306527 chr2:102432336~102432357:+ COAD cis rs6681460 0.966 rs4655650 MIMAT0014979 hsa-miR-3117-3p -4.48 1.1e-05 -0.34 -0.27 Presence of antiphospholipid antibodies; chr1:66676603 chr1:66628485~66628505:+ COAD cis rs10021731 1 rs13104222 MIMAT0003242 hsa-miR-577 4.48 1.13e-05 0.23 0.27 Optic disc area; chr4:114549757 chr4:114656774~114656794:+ COAD cis rs6681460 0.966 rs11208932 MIMAT0014979 hsa-miR-3117-3p -4.47 1.15e-05 -0.35 -0.27 Presence of antiphospholipid antibodies; chr1:66632170 chr1:66628485~66628505:+ COAD cis rs6681460 1 rs10889641 MIMAT0014979 hsa-miR-3117-3p -4.47 1.19e-05 -0.34 -0.27 Presence of antiphospholipid antibodies; chr1:66672684 chr1:66628485~66628505:+ COAD cis rs10021731 1 rs4834419 MIMAT0003242 hsa-miR-577 4.47 1.19e-05 0.22 0.27 Optic disc area; chr4:114548870 chr4:114656774~114656794:+ COAD cis rs10021731 1 rs1599323 MIMAT0003242 hsa-miR-577 4.47 1.19e-05 0.22 0.27 Optic disc area; chr4:114549176 chr4:114656774~114656794:+ COAD cis rs10021731 1 rs6533801 MIMAT0003242 hsa-miR-577 4.47 1.19e-05 0.22 0.27 Optic disc area; chr4:114553199 chr4:114656774~114656794:+ COAD cis rs6724465 0.852 rs7561119 MIMAT0014996 hsa-miR-3131 -4.46 1.22e-05 -0.51 -0.27 Height; chr2:219121531 chr2:219058725~219058747:- COAD cis rs6724465 1 rs13419740 MIMAT0014996 hsa-miR-3131 -4.46 1.22e-05 -0.48 -0.27 Height; chr2:219104375 chr2:219058725~219058747:- COAD cis rs7072216 0.763 rs942805 MIMAT0026738 hsa-miR-1287-3p 4.46 1.22e-05 0.24 0.27 Metabolite levels; chr10:98408615 chr10:98395232~98395253:- COAD cis rs7588654 1 rs3100776 MIMAT0014996 hsa-miR-3131 -4.46 1.24e-05 -0.53 -0.27 Height; chr2:219056478 chr2:219058725~219058747:- COAD cis rs4072705 0.967 rs10120039 MIMAT0004558 hsa-miR-181a-2-3p -4.45 1.25e-05 -0.29 -0.27 Menarche (age at onset); chr9:124644682 chr9:124692518~124692539:+ COAD cis rs1014286 0.641 rs10172553 MIMAT0019926 hsa-miR-4772-5p 4.45 1.26e-05 0.28 0.27 Serum protein levels (sST2); chr2:102536516 chr2:102432300~102432321:+ COAD cis rs6724465 1 rs13398898 MIMAT0014996 hsa-miR-3131 -4.45 1.3e-05 -0.56 -0.27 Height; chr2:219063025 chr2:219058725~219058747:- COAD cis rs12290811 0.572 rs12577328 MIMAT0004927 hsa-miR-708-3p -4.44 1.31e-05 -0.3 -0.27 Bipolar disorder; chr11:79382430 chr11:79402032~79402053:- COAD cis rs6724465 0.673 rs2293081 MIMAT0014996 hsa-miR-3131 -4.44 1.32e-05 -0.4 -0.27 Height; chr2:219146370 chr2:219058725~219058747:- COAD cis rs1870653 0.516 rs76290069 MIMAT0003242 hsa-miR-577 4.44 1.35e-05 0.36 0.27 Exploratory eye movement dysfunction in schizophrenia (number of eye fixations); chr4:114582168 chr4:114656774~114656794:+ COAD cis rs6724465 1 rs7600987 MIMAT0014996 hsa-miR-3131 -4.42 1.48e-05 -0.45 -0.27 Height; chr2:219051149 chr2:219058725~219058747:- COAD cis rs1163656 0.559 rs7136415 MIMAT0003287 hsa-miR-618 -4.41 1.5e-05 -0.55 -0.27 Dental caries; chr12:80915511 chr12:80935796~80935818:- COAD cis rs7072216 0.763 rs10732782 MIMAT0026738 hsa-miR-1287-3p 4.4 1.59e-05 0.24 0.26 Metabolite levels; chr10:98406749 chr10:98395232~98395253:- COAD cis rs7072216 0.691 rs7910973 MIMAT0026738 hsa-miR-1287-3p 4.4 1.59e-05 0.24 0.26 Metabolite levels; chr10:98406975 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs7911036 MIMAT0026738 hsa-miR-1287-3p 4.4 1.59e-05 0.24 0.26 Metabolite levels; chr10:98407258 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs10883090 MIMAT0026738 hsa-miR-1287-3p 4.4 1.59e-05 0.24 0.26 Metabolite levels; chr10:98407479 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs45523432 MIMAT0026738 hsa-miR-1287-3p 4.4 1.59e-05 0.24 0.26 Metabolite levels; chr10:98407679 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs12763044 MIMAT0026738 hsa-miR-1287-3p 4.4 1.59e-05 0.24 0.26 Metabolite levels; chr10:98407694 chr10:98395232~98395253:- COAD cis rs7072216 0.727 rs942808 MIMAT0026738 hsa-miR-1287-3p 4.4 1.59e-05 0.24 0.26 Metabolite levels; chr10:98408345 chr10:98395232~98395253:- COAD cis rs7072216 0.727 rs942807 MIMAT0026738 hsa-miR-1287-3p 4.4 1.59e-05 0.24 0.26 Metabolite levels; chr10:98408462 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs9787550 MIMAT0026738 hsa-miR-1287-3p 4.4 1.59e-05 0.24 0.26 Metabolite levels; chr10:98409294 chr10:98395232~98395253:- COAD cis rs6681460 1 rs4655647 MIMAT0014979 hsa-miR-3117-3p -4.4 1.6e-05 -0.34 -0.26 Presence of antiphospholipid antibodies; chr1:66640394 chr1:66628485~66628505:+ COAD cis rs7072216 0.77 rs3830020 MIMAT0005878 hsa-miR-1287-5p -4.39 1.68e-05 -0.32 -0.26 Metabolite levels; chr10:98416858 chr10:98395271~98395292:- COAD cis rs7829975 0.54 rs2976909 MIMAT0019728 hsa-miR-4660 -4.39 1.69e-05 -0.3 -0.26 Mood instability; chr8:8489180 chr8:9048453~9048475:+ COAD cis rs75358501 0.636 rs12473690 MIMAT0014995 hsa-miR-3130-5p 4.38 1.72e-05 0.4 0.26 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206734939 chr2:206783276~206783296:- COAD cis rs75358501 0.636 rs12473690 MIMAT0014995_1 hsa-miR-3130-5p 4.38 1.72e-05 0.4 0.26 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206734939 chr2:206783246~206783266:+ COAD cis rs730566 1 rs4858819 MIMAT0001618 hsa-miR-191-3p 4.38 1.73e-05 0.23 0.26 Prion diseases; chr3:48436678 chr3:49020631~49020652:- COAD cis rs10021731 0.729 rs17047190 MIMAT0003242 hsa-miR-577 4.38 1.75e-05 0.21 0.26 Optic disc area; chr4:114536699 chr4:114656774~114656794:+ COAD cis rs7072216 0.922 rs59667296 MIMAT0005878 hsa-miR-1287-5p 4.38 1.76e-05 0.3 0.26 Metabolite levels; chr10:98386556 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs10883091 MIMAT0026738 hsa-miR-1287-3p 4.37 1.77e-05 0.23 0.26 Metabolite levels; chr10:98407482 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs10883092 MIMAT0026738 hsa-miR-1287-3p 4.37 1.77e-05 0.23 0.26 Metabolite levels; chr10:98407519 chr10:98395232~98395253:- COAD cis rs6724465 1 rs55973978 MIMAT0014996 hsa-miR-3131 -4.34 2.04e-05 -0.53 -0.26 Height; chr2:219049092 chr2:219058725~219058747:- COAD cis rs6681460 0.966 rs1325261 MIMAT0014979 hsa-miR-3117-3p -4.33 2.13e-05 -0.33 -0.26 Presence of antiphospholipid antibodies; chr1:66644833 chr1:66628485~66628505:+ COAD cis rs4851551 1 rs4851552 MIMAT0019927 hsa-miR-4772-3p -4.33 2.17e-05 -0.47 -0.26 Blood protein levels; chr2:102185873 chr2:102432336~102432357:+ COAD cis rs7072216 0.763 rs10736129 MIMAT0026738 hsa-miR-1287-3p -4.32 2.2e-05 -0.24 -0.26 Metabolite levels; chr10:98411814 chr10:98395232~98395253:- COAD cis rs6681460 0.966 rs10889642 MIMAT0014979 hsa-miR-3117-3p -4.32 2.22e-05 -0.33 -0.26 Presence of antiphospholipid antibodies; chr1:66677651 chr1:66628485~66628505:+ COAD cis rs12290811 0.572 rs11237816 MIMAT0004927 hsa-miR-708-3p 4.32 2.25e-05 0.29 0.26 Bipolar disorder; chr11:79380852 chr11:79402032~79402053:- COAD cis rs8064299 0.967 rs3744208 MIMAT0017994 hsa-miR-3615 -4.32 2.25e-05 -0.25 -0.26 Monocyte count; chr17:74771426 chr17:74748663~74748683:+ COAD cis rs7588654 0.826 rs10932795 MIMAT0014996 hsa-miR-3131 4.3 2.38e-05 0.5 0.26 Height; chr2:219093740 chr2:219058725~219058747:- COAD cis rs1712517 0.566 rs7076274 MIMAT0022727 hsa-miR-1307-5p -4.3 2.38e-05 -0.19 -0.26 Migraine; chr10:103286250 chr10:103394341~103394361:- COAD cis rs1712517 0.545 rs3740381 MIMAT0022727 hsa-miR-1307-5p -4.3 2.38e-05 -0.19 -0.26 Migraine; chr10:103286932 chr10:103394341~103394361:- COAD cis rs1712517 0.566 rs7917388 MIMAT0022727 hsa-miR-1307-5p -4.3 2.38e-05 -0.19 -0.26 Migraine; chr10:103295206 chr10:103394341~103394361:- COAD cis rs1712517 0.525 rs11191642 MIMAT0022727 hsa-miR-1307-5p -4.3 2.38e-05 -0.19 -0.26 Migraine; chr10:103296155 chr10:103394341~103394361:- COAD cis rs6681460 0.966 rs7519747 MIMAT0014979 hsa-miR-3117-3p -4.3 2.38e-05 -0.33 -0.26 Presence of antiphospholipid antibodies; chr1:66675040 chr1:66628485~66628505:+ COAD cis rs7072216 0.763 rs7914401 MIMAT0026738 hsa-miR-1287-3p 4.3 2.39e-05 0.23 0.26 Metabolite levels; chr10:98404171 chr10:98395232~98395253:- COAD cis rs1014286 0.706 rs10171438 MIMAT0019926 hsa-miR-4772-5p -4.3 2.43e-05 -0.27 -0.26 Serum protein levels (sST2); chr2:102558917 chr2:102432300~102432321:+ COAD cis rs1712517 0.588 rs12220267 MIMAT0022727 hsa-miR-1307-5p -4.3 2.46e-05 -0.19 -0.26 Migraine; chr10:103315955 chr10:103394341~103394361:- COAD cis rs12290811 0.572 rs111460293 MIMAT0004927 hsa-miR-708-3p 4.3 2.46e-05 0.29 0.26 Bipolar disorder; chr11:79386392 chr11:79402032~79402053:- COAD cis rs12290811 0.508 rs79822078 MIMAT0004927 hsa-miR-708-3p 4.3 2.46e-05 0.29 0.26 Bipolar disorder; chr11:79386980 chr11:79402032~79402053:- COAD cis rs7072216 0.922 rs4539242 MIMAT0005878 hsa-miR-1287-5p 4.29 2.48e-05 0.29 0.26 Metabolite levels; chr10:98388301 chr10:98395271~98395292:- COAD cis rs7072216 0.881 rs2147896 MIMAT0005878 hsa-miR-1287-5p 4.29 2.48e-05 0.29 0.26 Metabolite levels; chr10:98388419 chr10:98395271~98395292:- COAD cis rs6681460 0.565 rs1536112 MIMAT0014979 hsa-miR-3117-3p 4.29 2.5e-05 0.32 0.26 Presence of antiphospholipid antibodies; chr1:66641542 chr1:66628485~66628505:+ COAD cis rs1014286 0.706 rs4851615 MIMAT0019926 hsa-miR-4772-5p -4.29 2.54e-05 -0.27 -0.26 Serum protein levels (sST2); chr2:102530540 chr2:102432300~102432321:+ COAD cis rs7072216 0.691 rs10786419 MIMAT0005878 hsa-miR-1287-5p 4.28 2.61e-05 0.31 0.26 Metabolite levels; chr10:98421183 chr10:98395271~98395292:- COAD cis rs11792861 0.53 rs1772047 MIMAT0000090 hsa-miR-32-5p -4.28 2.66e-05 -0.21 -0.26 Menarche (age at onset); chr9:108916732 chr9:109046272~109046293:- COAD cis rs7829975 0.564 rs2976855 MIMAT0019728 hsa-miR-4660 4.28 2.7e-05 0.27 0.26 Mood instability; chr8:8444284 chr8:9048453~9048475:+ COAD cis rs7072216 0.763 rs733345 MIMAT0026738 hsa-miR-1287-3p 4.27 2.71e-05 0.23 0.26 Metabolite levels; chr10:98404458 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs733346 MIMAT0026738 hsa-miR-1287-3p 4.27 2.71e-05 0.23 0.26 Metabolite levels; chr10:98404568 chr10:98395232~98395253:- COAD cis rs8064299 0.967 rs880827 MIMAT0017994 hsa-miR-3615 4.27 2.73e-05 0.25 0.26 Monocyte count; chr17:74771296 chr17:74748663~74748683:+ COAD cis rs7072216 0.922 rs10786415 MIMAT0005878 hsa-miR-1287-5p 4.27 2.78e-05 0.29 0.26 Metabolite levels; chr10:98391509 chr10:98395271~98395292:- COAD cis rs7072216 0.922 rs942814 MIMAT0005878 hsa-miR-1287-5p 4.27 2.78e-05 0.29 0.26 Metabolite levels; chr10:98391548 chr10:98395271~98395292:- COAD cis rs7072216 0.922 rs6584191 MIMAT0005878 hsa-miR-1287-5p 4.27 2.78e-05 0.29 0.26 Metabolite levels; chr10:98392298 chr10:98395271~98395292:- COAD cis rs7072216 0.69 rs113195335 MIMAT0026738 hsa-miR-1287-3p 4.27 2.8e-05 0.23 0.26 Metabolite levels; chr10:98415775 chr10:98395232~98395253:- COAD cis rs7072216 0.727 rs3750603 MIMAT0026738 hsa-miR-1287-3p 4.27 2.8e-05 0.23 0.26 Metabolite levels; chr10:98415779 chr10:98395232~98395253:- COAD cis rs8064299 0.967 rs878905 MIMAT0017994 hsa-miR-3615 -4.27 2.81e-05 -0.25 -0.26 Monocyte count; chr17:74773272 chr17:74748663~74748683:+ COAD cis rs6681460 0.625 rs6679568 MIMAT0014979 hsa-miR-3117-3p -4.26 2.82e-05 -0.31 -0.26 Presence of antiphospholipid antibodies; chr1:66608494 chr1:66628485~66628505:+ COAD cis rs1014286 0.706 rs10194822 MIMAT0019926 hsa-miR-4772-5p -4.26 2.83e-05 -0.26 -0.26 Serum protein levels (sST2); chr2:102549045 chr2:102432300~102432321:+ COAD cis rs6681460 0.901 rs1570815 MIMAT0014979 hsa-miR-3117-3p -4.26 2.85e-05 -0.33 -0.26 Presence of antiphospholipid antibodies; chr1:66673984 chr1:66628485~66628505:+ COAD cis rs6681460 1 rs7524818 MIMAT0014979 hsa-miR-3117-3p -4.26 2.92e-05 -0.32 -0.26 Presence of antiphospholipid antibodies; chr1:66606348 chr1:66628485~66628505:+ COAD cis rs7588654 1 rs7588654 MIMAT0014996 hsa-miR-3131 4.25 2.99e-05 0.46 0.26 Height; chr2:219118308 chr2:219058725~219058747:- COAD cis rs7072216 0.763 rs2147901 MIMAT0026738 hsa-miR-1287-3p -4.25 2.99e-05 -0.23 -0.26 Metabolite levels; chr10:98405739 chr10:98395232~98395253:- COAD cis rs1712517 0.526 rs113528138 MIMAT0022727 hsa-miR-1307-5p -4.25 3.02e-05 -0.19 -0.26 Migraine; chr10:103365694 chr10:103394341~103394361:- COAD cis rs1712517 0.525 rs11191667 MIMAT0022727 hsa-miR-1307-5p -4.25 3.02e-05 -0.19 -0.26 Migraine; chr10:103369141 chr10:103394341~103394361:- COAD cis rs7072216 0.763 rs3814142 MIMAT0026738 hsa-miR-1287-3p 4.25 3.04e-05 0.23 0.26 Metabolite levels; chr10:98411347 chr10:98395232~98395253:- COAD cis rs7072216 0.691 rs3829853 MIMAT0026738 hsa-miR-1287-3p 4.25 3.04e-05 0.23 0.26 Metabolite levels; chr10:98411417 chr10:98395232~98395253:- COAD cis rs7072216 0.727 rs10748728 MIMAT0026738 hsa-miR-1287-3p 4.25 3.04e-05 0.23 0.26 Metabolite levels; chr10:98411441 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs10748729 MIMAT0026738 hsa-miR-1287-3p 4.25 3.04e-05 0.23 0.26 Metabolite levels; chr10:98411614 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs10748730 MIMAT0026738 hsa-miR-1287-3p 4.25 3.04e-05 0.23 0.26 Metabolite levels; chr10:98411683 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs7910014 MIMAT0026738 hsa-miR-1287-3p 4.25 3.04e-05 0.23 0.26 Metabolite levels; chr10:98412353 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs7910247 MIMAT0026738 hsa-miR-1287-3p 4.25 3.04e-05 0.23 0.26 Metabolite levels; chr10:98412495 chr10:98395232~98395253:- COAD cis rs7072216 0.727 rs7913541 MIMAT0026738 hsa-miR-1287-3p 4.25 3.04e-05 0.23 0.26 Metabolite levels; chr10:98412722 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs6584204 MIMAT0026738 hsa-miR-1287-3p 4.25 3.04e-05 0.23 0.26 Metabolite levels; chr10:98413823 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs6584205 MIMAT0026738 hsa-miR-1287-3p 4.25 3.04e-05 0.23 0.26 Metabolite levels; chr10:98414049 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs3750601 MIMAT0026738 hsa-miR-1287-3p 4.25 3.04e-05 0.23 0.26 Metabolite levels; chr10:98414804 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs2147900 MIMAT0026738 hsa-miR-1287-3p 4.25 3.04e-05 0.23 0.26 Metabolite levels; chr10:98414964 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs2274246 MIMAT0026738 hsa-miR-1287-3p 4.25 3.04e-05 0.23 0.26 Metabolite levels; chr10:98415303 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs2274245 MIMAT0026738 hsa-miR-1287-3p 4.25 3.04e-05 0.23 0.26 Metabolite levels; chr10:98415325 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs2274244 MIMAT0026738 hsa-miR-1287-3p 4.25 3.04e-05 0.23 0.26 Metabolite levels; chr10:98415461 chr10:98395232~98395253:- COAD cis rs6681460 1 rs4655648 MIMAT0014979 hsa-miR-3117-3p -4.24 3.1e-05 -0.32 -0.26 Presence of antiphospholipid antibodies; chr1:66648626 chr1:66628485~66628505:+ COAD cis rs1712517 0.503 rs72846198 MIMAT0022727 hsa-miR-1307-5p -4.24 3.1e-05 -0.19 -0.26 Migraine; chr10:103338267 chr10:103394341~103394361:- COAD cis rs7894407 0.856 rs10883855 MIMAT0005951 hsa-miR-1307-3p -4.24 3.16e-05 -0.16 -0.26 White matter hyperintensity burden; chr10:103332690 chr10:103394301~103394322:- COAD cis rs7072216 0.763 rs4475861 MIMAT0026738 hsa-miR-1287-3p 4.23 3.2e-05 0.23 0.26 Metabolite levels; chr10:98405232 chr10:98395232~98395253:- COAD cis rs74233809 1 rs11191499 MIMAT0005951 hsa-miR-1307-3p -4.23 3.22e-05 -0.25 -0.26 Birth weight; chr10:103004514 chr10:103394301~103394322:- COAD cis rs6681460 1 rs1325263 MIMAT0014979 hsa-miR-3117-3p -4.23 3.23e-05 -0.33 -0.26 Presence of antiphospholipid antibodies; chr1:66664108 chr1:66628485~66628505:+ COAD cis rs7072216 0.763 rs12763326 MIMAT0026738 hsa-miR-1287-3p -4.23 3.26e-05 -0.23 -0.26 Metabolite levels; chr10:98407639 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs942803 MIMAT0026738 hsa-miR-1287-3p 4.23 3.29e-05 0.23 0.25 Metabolite levels; chr10:98408874 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs12259939 MIMAT0026738 hsa-miR-1287-3p 4.23 3.29e-05 0.23 0.25 Metabolite levels; chr10:98409264 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs7923729 MIMAT0026738 hsa-miR-1287-3p 4.23 3.29e-05 0.23 0.25 Metabolite levels; chr10:98409708 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs6584198 MIMAT0026738 hsa-miR-1287-3p 4.23 3.29e-05 0.23 0.25 Metabolite levels; chr10:98410149 chr10:98395232~98395253:- COAD cis rs7072216 0.727 rs6584199 MIMAT0026738 hsa-miR-1287-3p 4.23 3.29e-05 0.23 0.25 Metabolite levels; chr10:98410226 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs6584200 MIMAT0026738 hsa-miR-1287-3p 4.23 3.29e-05 0.23 0.25 Metabolite levels; chr10:98410280 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs6584201 MIMAT0026738 hsa-miR-1287-3p 4.23 3.29e-05 0.23 0.25 Metabolite levels; chr10:98410452 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs3814140 MIMAT0026738 hsa-miR-1287-3p 4.23 3.29e-05 0.23 0.25 Metabolite levels; chr10:98411005 chr10:98395232~98395253:- COAD cis rs6681460 1 rs6670378 MIMAT0014979 hsa-miR-3117-3p -4.23 3.3e-05 -0.32 -0.25 Presence of antiphospholipid antibodies; chr1:66660902 chr1:66628485~66628505:+ COAD cis rs6681460 1 rs2147777 MIMAT0014979 hsa-miR-3117-3p -4.23 3.3e-05 -0.32 -0.25 Presence of antiphospholipid antibodies; chr1:66663571 chr1:66628485~66628505:+ COAD cis rs6681460 1 rs6680876 MIMAT0014979 hsa-miR-3117-3p -4.23 3.3e-05 -0.32 -0.25 Presence of antiphospholipid antibodies; chr1:66663799 chr1:66628485~66628505:+ COAD cis rs7072216 0.726 rs4474372 MIMAT0026738 hsa-miR-1287-3p 4.23 3.31e-05 0.23 0.25 Metabolite levels; chr10:98404814 chr10:98395232~98395253:- COAD cis rs1014286 0.73 rs2215998 MIMAT0019926 hsa-miR-4772-5p 4.22 3.33e-05 0.26 0.25 Serum protein levels (sST2); chr2:102549584 chr2:102432300~102432321:+ COAD cis rs1014286 0.706 rs10196579 MIMAT0019926 hsa-miR-4772-5p 4.22 3.46e-05 0.27 0.25 Serum protein levels (sST2); chr2:102553722 chr2:102432300~102432321:+ COAD cis rs1014286 0.706 rs2310295 MIMAT0019926 hsa-miR-4772-5p 4.22 3.46e-05 0.27 0.25 Serum protein levels (sST2); chr2:102554607 chr2:102432300~102432321:+ COAD cis rs7072216 0.763 rs8181292 MIMAT0026738 hsa-miR-1287-3p 4.21 3.47e-05 0.23 0.25 Metabolite levels; chr10:98415720 chr10:98395232~98395253:- COAD cis rs950880 0.56 rs10189711 MIMAT0019927 hsa-miR-4772-3p 4.21 3.48e-05 0.21 0.25 Serum protein levels (sST2); chr2:102314421 chr2:102432336~102432357:+ COAD cis rs12290811 0.63 rs12277834 MIMAT0004927 hsa-miR-708-3p 4.21 3.5e-05 0.29 0.25 Bipolar disorder; chr11:79389112 chr11:79402032~79402053:- COAD cis rs12290811 0.63 rs79406027 MIMAT0004927 hsa-miR-708-3p 4.21 3.5e-05 0.29 0.25 Bipolar disorder; chr11:79390059 chr11:79402032~79402053:- COAD cis rs7072216 0.806 rs9804285 MIMAT0026738 hsa-miR-1287-3p 4.21 3.59e-05 0.23 0.25 Metabolite levels; chr10:98409715 chr10:98395232~98395253:- COAD cis rs7072216 0.555 rs2296433 MIMAT0026738 hsa-miR-1287-3p 4.21 3.6e-05 0.25 0.25 Metabolite levels; chr10:98424305 chr10:98395232~98395253:- COAD cis rs7072216 0.555 rs2296432 MIMAT0026738 hsa-miR-1287-3p 4.21 3.6e-05 0.25 0.25 Metabolite levels; chr10:98424306 chr10:98395232~98395253:- COAD cis rs7894407 0.76 rs1163072 MIMAT0005951 hsa-miR-1307-3p 4.2 3.61e-05 0.16 0.25 White matter hyperintensity burden; chr10:103264621 chr10:103394301~103394322:- COAD cis rs11792861 0.541 rs838824 MIMAT0000090 hsa-miR-32-5p -4.2 3.62e-05 -0.21 -0.25 Menarche (age at onset); chr9:108908427 chr9:109046272~109046293:- COAD cis rs6724465 1 rs72967946 MIMAT0014996 hsa-miR-3131 -4.2 3.62e-05 -0.52 -0.25 Height; chr2:219053257 chr2:219058725~219058747:- COAD cis rs6681460 1 rs1562217 MIMAT0014979 hsa-miR-3117-3p 4.2 3.68e-05 0.32 0.25 Presence of antiphospholipid antibodies; chr1:66607883 chr1:66628485~66628505:+ COAD cis rs75358501 0.636 rs1862089 MIMAT0014994 hsa-miR-3130-3p 4.2 3.71e-05 0.37 0.25 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206755794 chr2:206783245~206783265:- COAD cis rs75358501 0.636 rs1862089 MIMAT0014994_1 hsa-miR-3130-3p 4.2 3.71e-05 0.37 0.25 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206755794 chr2:206783277~206783297:+ COAD cis rs7072216 0.727 rs942809 MIMAT0026738 hsa-miR-1287-3p 4.2 3.71e-05 0.23 0.25 Metabolite levels; chr10:98408244 chr10:98395232~98395253:- COAD cis rs7072216 0.763 rs7909822 MIMAT0026738 hsa-miR-1287-3p 4.2 3.73e-05 0.23 0.25 Metabolite levels; chr10:98412278 chr10:98395232~98395253:- COAD cis rs330203 0.574 rs7730715 MIMAT0022500 hsa-miR-5706 -4.18 3.94e-05 -0.31 -0.25 Iris color (a* coordinate);Iris color (b* coordinate); chr5:119671259 chr5:119154646~119154667:+ COAD cis rs7072216 0.763 rs6584202 MIMAT0026738 hsa-miR-1287-3p 4.18 4e-05 0.23 0.25 Metabolite levels; chr10:98410626 chr10:98395232~98395253:- COAD cis rs6681460 0.966 rs4655646 MIMAT0014979 hsa-miR-3117-3p -4.18 4.02e-05 -0.34 -0.25 Presence of antiphospholipid antibodies; chr1:66628653 chr1:66628485~66628505:+ COAD cis rs1867631 0.585 rs11208940 MIMAT0014979 hsa-miR-3117-3p 4.18 4.06e-05 0.3 0.25 Menopause (age at onset); chr1:66661559 chr1:66628485~66628505:+ COAD cis rs1712517 0.525 rs7911488 MIMAT0022727 hsa-miR-1307-5p -4.17 4.13e-05 -0.19 -0.25 Migraine; chr10:103394332 chr10:103394341~103394361:- COAD cis rs75358501 0.636 rs7580138 MIMAT0014994 hsa-miR-3130-3p 4.17 4.14e-05 0.38 0.25 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206750560 chr2:206783245~206783265:- COAD cis rs75358501 0.636 rs7580138 MIMAT0014994_1 hsa-miR-3130-3p 4.17 4.14e-05 0.38 0.25 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206750560 chr2:206783277~206783297:+ COAD cis rs7072216 0.922 rs942813 MIMAT0005878 hsa-miR-1287-5p 4.17 4.22e-05 0.29 0.25 Metabolite levels; chr10:98393851 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs1061437 MIMAT0026738 hsa-miR-1287-3p 4.17 4.24e-05 0.23 0.25 Metabolite levels; chr10:98416397 chr10:98395232~98395253:- COAD cis rs7072216 0.881 rs11189591 MIMAT0005878 hsa-miR-1287-5p 4.16 4.37e-05 0.28 0.25 Metabolite levels; chr10:98395539 chr10:98395271~98395292:- COAD cis rs6681460 1 rs6659968 MIMAT0014979 hsa-miR-3117-3p -4.15 4.5e-05 -0.31 -0.25 Presence of antiphospholipid antibodies; chr1:66657776 chr1:66628485~66628505:+ COAD cis rs6681460 1 rs2031478 MIMAT0014979 hsa-miR-3117-3p -4.15 4.5e-05 -0.31 -0.25 Presence of antiphospholipid antibodies; chr1:66658059 chr1:66628485~66628505:+ COAD cis rs7072216 0.763 rs2274243 MIMAT0026738 hsa-miR-1287-3p 4.15 4.56e-05 0.23 0.25 Metabolite levels; chr10:98415510 chr10:98395232~98395253:- COAD cis rs6681460 0.604 rs11208920 MIMAT0014979 hsa-miR-3117-3p -4.15 4.57e-05 -0.3 -0.25 Presence of antiphospholipid antibodies; chr1:66609629 chr1:66628485~66628505:+ COAD cis rs7072216 0.881 rs2274247 MIMAT0005878 hsa-miR-1287-5p 4.15 4.6e-05 0.28 0.25 Metabolite levels; chr10:98390391 chr10:98395271~98395292:- COAD cis rs6681460 0.932 rs2044399 MIMAT0014979 hsa-miR-3117-3p -4.14 4.62e-05 -0.33 -0.25 Presence of antiphospholipid antibodies; chr1:66588397 chr1:66628485~66628505:+ COAD cis rs6681460 0.932 rs2044400 MIMAT0014979 hsa-miR-3117-3p -4.14 4.62e-05 -0.33 -0.25 Presence of antiphospholipid antibodies; chr1:66588398 chr1:66628485~66628505:+ COAD cis rs8064299 0.967 rs878906 MIMAT0017994 hsa-miR-3615 -4.14 4.67e-05 -0.24 -0.25 Monocyte count; chr17:74773195 chr17:74748663~74748683:+ COAD cis rs8064299 0.967 rs878907 MIMAT0017994 hsa-miR-3615 -4.14 4.67e-05 -0.24 -0.25 Monocyte count; chr17:74773555 chr17:74748663~74748683:+ COAD cis rs1867631 0.585 rs6694782 MIMAT0014979 hsa-miR-3117-3p 4.14 4.68e-05 0.3 0.25 Menopause (age at onset); chr1:66661079 chr1:66628485~66628505:+ COAD cis rs950880 0.56 rs11685424 MIMAT0019927 hsa-miR-4772-3p 4.14 4.79e-05 0.21 0.25 Serum protein levels (sST2); chr2:102310521 chr2:102432336~102432357:+ COAD cis rs6681460 1 rs1329978 MIMAT0014979 hsa-miR-3117-3p -4.13 4.85e-05 -0.32 -0.25 Presence of antiphospholipid antibodies; chr1:66650548 chr1:66628485~66628505:+ COAD cis rs12290811 0.63 rs77749926 MIMAT0004927 hsa-miR-708-3p 4.13 4.88e-05 0.28 0.25 Bipolar disorder; chr11:79391873 chr11:79402032~79402053:- COAD cis rs12290811 0.63 rs11237820 MIMAT0004927 hsa-miR-708-3p 4.13 4.88e-05 0.28 0.25 Bipolar disorder; chr11:79393621 chr11:79402032~79402053:- COAD cis rs12290811 0.63 rs4433593 MIMAT0004927 hsa-miR-708-3p 4.13 4.88e-05 0.28 0.25 Bipolar disorder; chr11:79395571 chr11:79402032~79402053:- COAD cis rs6584202 0.589 rs10883094 MIMAT0005878 hsa-miR-1287-5p 4.13 4.99e-05 0.31 0.25 Obesity-related traits; chr10:98428349 chr10:98395271~98395292:- COAD cis rs1867631 0.585 rs12094526 MIMAT0014979 hsa-miR-3117-3p -4.13 5.01e-05 -0.3 -0.25 Menopause (age at onset); chr1:66660431 chr1:66628485~66628505:+ COAD cis rs1867631 0.585 rs6670827 MIMAT0014979 hsa-miR-3117-3p -4.13 5.01e-05 -0.3 -0.25 Menopause (age at onset); chr1:66661323 chr1:66628485~66628505:+ COAD cis rs950880 0.542 rs1558621 MIMAT0019927 hsa-miR-4772-3p 4.12 5.07e-05 0.21 0.25 Serum protein levels (sST2); chr2:102313847 chr2:102432336~102432357:+ COAD cis rs7072216 0.881 rs2147895 MIMAT0005878 hsa-miR-1287-5p 4.12 5.1e-05 0.28 0.25 Metabolite levels; chr10:98388551 chr10:98395271~98395292:- COAD cis rs6681460 1 rs2872078 MIMAT0014979 hsa-miR-3117-3p -4.12 5.14e-05 -0.32 -0.25 Presence of antiphospholipid antibodies; chr1:66661684 chr1:66628485~66628505:+ COAD cis rs1014286 0.706 rs4851612 MIMAT0019926 hsa-miR-4772-5p 4.12 5.2e-05 0.26 0.25 Serum protein levels (sST2); chr2:102521421 chr2:102432300~102432321:+ COAD cis rs1014286 0.706 rs2058656 MIMAT0019926 hsa-miR-4772-5p 4.12 5.21e-05 0.26 0.25 Serum protein levels (sST2); chr2:102520567 chr2:102432300~102432321:+ COAD cis rs950880 0.56 rs6733174 MIMAT0019927 hsa-miR-4772-3p 4.11 5.35e-05 0.21 0.25 Serum protein levels (sST2); chr2:102312552 chr2:102432336~102432357:+ COAD cis rs6724465 1 rs6436106 MIMAT0014996 hsa-miR-3131 -4.11 5.39e-05 -0.47 -0.25 Height; chr2:219062191 chr2:219058725~219058747:- COAD cis rs6724465 1 rs7595949 MIMAT0014996 hsa-miR-3131 -4.11 5.39e-05 -0.47 -0.25 Height; chr2:219062496 chr2:219058725~219058747:- COAD cis rs6681460 1 rs6656550 MIMAT0014979 hsa-miR-3117-3p -4.11 5.41e-05 -0.32 -0.25 Presence of antiphospholipid antibodies; chr1:66656869 chr1:66628485~66628505:+ COAD cis rs1014286 0.706 rs4851608 MIMAT0019926 hsa-miR-4772-5p 4.1 5.63e-05 0.25 0.25 Serum protein levels (sST2); chr2:102509525 chr2:102432300~102432321:+ COAD cis rs1014286 0.66 rs1476999 MIMAT0019926 hsa-miR-4772-5p 4.1 5.63e-05 0.25 0.25 Serum protein levels (sST2); chr2:102515220 chr2:102432300~102432321:+ COAD cis rs1014286 0.665 rs1523204 MIMAT0019926 hsa-miR-4772-5p 4.09 5.67e-05 0.25 0.25 Serum protein levels (sST2); chr2:102519178 chr2:102432300~102432321:+ COAD cis rs1014286 0.706 rs2216000 MIMAT0019926 hsa-miR-4772-5p 4.09 5.68e-05 0.25 0.25 Serum protein levels (sST2); chr2:102516181 chr2:102432300~102432321:+ COAD cis rs7894407 0.634 rs755577 MIMAT0005951 hsa-miR-1307-3p 4.09 5.81e-05 0.19 0.25 White matter hyperintensity burden; chr10:103464309 chr10:103394301~103394322:- COAD cis rs6724465 1 rs17655003 MIMAT0014996 hsa-miR-3131 -4.09 5.83e-05 -0.47 -0.25 Height; chr2:219065759 chr2:219058725~219058747:- COAD cis rs6724465 1 rs10208728 MIMAT0014996 hsa-miR-3131 -4.09 5.84e-05 -0.38 -0.25 Height; chr2:219052581 chr2:219058725~219058747:- COAD cis rs12290811 0.63 rs7108878 MIMAT0004927 hsa-miR-708-3p 4.07 6.31e-05 0.28 0.25 Bipolar disorder; chr11:79396763 chr11:79402032~79402053:- COAD cis rs953387 0.666 rs10180515 MIMAT0026477 hsa-miR-128-1-5p -4.06 6.45e-05 -0.22 -0.25 Arthritis (juvenile idiopathic); chr2:136164133 chr2:135665411~135665433:+ COAD cis rs6681460 0.966 rs7524851 MIMAT0014979 hsa-miR-3117-3p -4.06 6.62e-05 -0.33 -0.25 Presence of antiphospholipid antibodies; chr1:66627335 chr1:66628485~66628505:+ COAD cis rs7072216 0.666 rs11598689 MIMAT0005878 hsa-miR-1287-5p 4.06 6.65e-05 0.3 0.25 Metabolite levels; chr10:98396270 chr10:98395271~98395292:- COAD cis rs6724465 0.673 rs6751232 MIMAT0014996 hsa-miR-3131 -4.05 6.71e-05 -0.38 -0.25 Height; chr2:219151208 chr2:219058725~219058747:- COAD cis rs6724465 0.636 rs6436119 MIMAT0014996 hsa-miR-3131 -4.05 6.71e-05 -0.38 -0.25 Height; chr2:219154306 chr2:219058725~219058747:- COAD cis rs6681460 0.546 rs1998716 MIMAT0014979 hsa-miR-3117-3p -4.05 6.76e-05 -0.3 -0.24 Presence of antiphospholipid antibodies; chr1:66651423 chr1:66628485~66628505:+ COAD cis rs6681460 1 rs9662962 MIMAT0014979 hsa-miR-3117-3p -4.05 6.83e-05 -0.31 -0.24 Presence of antiphospholipid antibodies; chr1:66655681 chr1:66628485~66628505:+ COAD cis rs6681460 0.966 rs9659879 MIMAT0014979 hsa-miR-3117-3p -4.05 6.83e-05 -0.31 -0.24 Presence of antiphospholipid antibodies; chr1:66655751 chr1:66628485~66628505:+ COAD cis rs6681460 1 rs7521111 MIMAT0014979 hsa-miR-3117-3p -4.05 6.83e-05 -0.31 -0.24 Presence of antiphospholipid antibodies; chr1:66655951 chr1:66628485~66628505:+ COAD cis rs6681460 1 rs7521123 MIMAT0014979 hsa-miR-3117-3p -4.05 6.83e-05 -0.31 -0.24 Presence of antiphospholipid antibodies; chr1:66655980 chr1:66628485~66628505:+ COAD cis rs6681460 1 rs6680944 MIMAT0014979 hsa-miR-3117-3p -4.05 6.83e-05 -0.31 -0.24 Presence of antiphospholipid antibodies; chr1:66656882 chr1:66628485~66628505:+ COAD cis rs6681460 1 rs4655636 MIMAT0014979 hsa-miR-3117-3p -4.04 7.13e-05 -0.3 -0.24 Presence of antiphospholipid antibodies; chr1:66602854 chr1:66628485~66628505:+ COAD cis rs10021731 0.798 rs34581144 MIMAT0003242 hsa-miR-577 4.03 7.22e-05 0.22 0.24 Optic disc area; chr4:114583571 chr4:114656774~114656794:+ COAD cis rs6681460 1 rs964574 MIMAT0014979 hsa-miR-3117-3p -4.03 7.22e-05 -0.31 -0.24 Presence of antiphospholipid antibodies; chr1:66597202 chr1:66628485~66628505:+ COAD cis rs6681460 0.966 rs10889643 MIMAT0014979 hsa-miR-3117-3p -4.03 7.24e-05 -0.31 -0.24 Presence of antiphospholipid antibodies; chr1:66677685 chr1:66628485~66628505:+ COAD cis rs6724465 1 rs3731878 MIMAT0014996 hsa-miR-3131 -4.03 7.41e-05 -0.46 -0.24 Height; chr2:219055843 chr2:219058725~219058747:- COAD cis rs3915499 0.63 rs216160 MIMAT0002174 hsa-miR-484 4.03 7.45e-05 0.17 0.24 Resting heart rate; chr16:15825103 chr16:15643301~15643322:+ COAD cis rs6724465 1 rs55838820 MIMAT0014996 hsa-miR-3131 -4.02 7.52e-05 -0.52 -0.24 Height; chr2:219082963 chr2:219058725~219058747:- COAD cis rs6724465 1 rs72951747 MIMAT0014996 hsa-miR-3131 -4.02 7.52e-05 -0.52 -0.24 Height; chr2:219107321 chr2:219058725~219058747:- COAD cis rs12290811 0.572 rs12289486 MIMAT0004927 hsa-miR-708-3p 4.02 7.55e-05 0.27 0.24 Bipolar disorder; chr11:79381483 chr11:79402032~79402053:- COAD cis rs6681460 1 rs1445575 MIMAT0014979 hsa-miR-3117-3p -4.02 7.7e-05 -0.31 -0.24 Presence of antiphospholipid antibodies; chr1:66586481 chr1:66628485~66628505:+ COAD cis rs6681460 0.934 rs4655628 MIMAT0014979 hsa-miR-3117-3p -4.02 7.7e-05 -0.31 -0.24 Presence of antiphospholipid antibodies; chr1:66586926 chr1:66628485~66628505:+ COAD cis rs216303 0.642 rs216315 MIMAT0000432 hsa-miR-141-3p -4.01 7.82e-05 -0.2 -0.24 Low vWF levels; chr12:6027748 chr12:6964155~6964176:+ COAD cis rs75358501 0.636 rs10932164 MIMAT0014994 hsa-miR-3130-3p 4.01 7.82e-05 0.35 0.24 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206751601 chr2:206783245~206783265:- COAD cis rs75358501 0.636 rs10932164 MIMAT0014994_1 hsa-miR-3130-3p 4.01 7.82e-05 0.35 0.24 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206751601 chr2:206783277~206783297:+ COAD cis rs7072216 0.881 rs6584192 MIMAT0005878 hsa-miR-1287-5p 4.01 7.93e-05 0.28 0.24 Metabolite levels; chr10:98392616 chr10:98395271~98395292:- COAD cis rs7072216 0.881 rs10883084 MIMAT0005878 hsa-miR-1287-5p 4.01 7.99e-05 0.28 0.24 Metabolite levels; chr10:98391432 chr10:98395271~98395292:- COAD cis rs7072216 0.922 rs7097824 MIMAT0005878 hsa-miR-1287-5p 4.01 7.99e-05 0.28 0.24 Metabolite levels; chr10:98392042 chr10:98395271~98395292:- COAD cis rs7072216 0.763 rs7091709 MIMAT0026738 hsa-miR-1287-3p 4.01 8.04e-05 0.22 0.24 Metabolite levels; chr10:98407848 chr10:98395232~98395253:- COAD cis rs7072216 0.881 rs2182169 MIMAT0005878 hsa-miR-1287-5p 4.01 8.04e-05 0.27 0.24 Metabolite levels; chr10:98388247 chr10:98395271~98395292:- COAD cis rs7072216 0.881 rs1079179 MIMAT0005878 hsa-miR-1287-5p 4.01 8.04e-05 0.27 0.24 Metabolite levels; chr10:98389589 chr10:98395271~98395292:- COAD cis rs6681460 1 rs6681460 MIMAT0014979 hsa-miR-3117-3p 4.01 8.05e-05 0.3 0.24 Presence of antiphospholipid antibodies; chr1:66657374 chr1:66628485~66628505:+ COAD cis rs1712517 0.873 rs1712516 MIMAT0022727 hsa-miR-1307-5p -4 8.29e-05 -0.16 -0.24 Migraine; chr10:103273871 chr10:103394341~103394361:- COAD cis rs10231759 0.617 rs11982695 MIMAT0004819 hsa-miR-671-3p -4 8.42e-05 -0.35 -0.24 Height; chr7:150815012 chr7:151238488~151238508:+ COAD cis rs7072216 0.881 rs2182168 MIMAT0005878 hsa-miR-1287-5p 4 8.43e-05 0.27 0.24 Metabolite levels; chr10:98388596 chr10:98395271~98395292:- COAD cis rs7072216 0.881 rs7916469 MIMAT0005878 hsa-miR-1287-5p 4 8.43e-05 0.27 0.24 Metabolite levels; chr10:98388896 chr10:98395271~98395292:- COAD cis rs7072216 0.881 rs755126 MIMAT0005878 hsa-miR-1287-5p 4 8.43e-05 0.27 0.24 Metabolite levels; chr10:98389194 chr10:98395271~98395292:- COAD cis rs2303282 0.933 rs4784670 MIMAT0000430 hsa-miR-138-5p -3.99 8.46e-05 -0.28 -0.24 Breast cancer; chr16:56464599 chr16:56858527~56858549:+ COAD cis rs2303282 0.933 rs4784670 MIMAT0000430_1 hsa-miR-138-5p -3.99 8.46e-05 -0.28 -0.24 Breast cancer; chr16:56464599 chr3:44114234~44114256:+ COAD cis rs6681460 0.966 rs10749763 MIMAT0014979 hsa-miR-3117-3p -3.98 8.84e-05 -0.32 -0.24 Presence of antiphospholipid antibodies; chr1:66596443 chr1:66628485~66628505:+ COAD cis rs6681460 0.932 rs4655640 MIMAT0014979 hsa-miR-3117-3p -3.98 9.12e-05 -0.32 -0.24 Presence of antiphospholipid antibodies; chr1:66623537 chr1:66628485~66628505:+ COAD cis rs6543140 0.964 rs2080288 MIMAT0019927 hsa-miR-4772-3p -3.98 9.14e-05 -0.23 -0.24 Blood protein levels; chr2:102405706 chr2:102432336~102432357:+ COAD cis rs16960773 0.609 rs16960833 MIMAT0018358 hsa-miR-3942-5p -3.97 9.25e-05 -0.36 -0.24 Optic nerve measurement (cup-to-disc ratio); chr15:35374528 chr15:35372321~35372342:- COAD cis rs2456930 0.676 rs2471038 MIMAT0000458 hsa-miR-190a-5p 3.97 9.27e-05 0.27 0.24 Brain structure (temporal lobe volume); chr15:62382642 chr15:62823971~62823992:+ COAD cis rs4851551 0.867 rs3917299 MIMAT0019927 hsa-miR-4772-3p -3.97 9.36e-05 -0.42 -0.24 Blood protein levels; chr2:102169626 chr2:102432336~102432357:+ COAD cis rs7072216 0.77 rs7909131 MIMAT0005878 hsa-miR-1287-5p 3.96 9.56e-05 0.28 0.24 Metabolite levels; chr10:98411714 chr10:98395271~98395292:- COAD cis rs10231759 0.617 rs11982701 MIMAT0004819 hsa-miR-671-3p -3.96 9.65e-05 -0.35 -0.24 Height; chr7:150815068 chr7:151238488~151238508:+ COAD cis rs10021731 0.628 rs6533791 MIMAT0003242 hsa-miR-577 -3.96 9.77e-05 -0.2 -0.24 Optic disc area; chr4:114491869 chr4:114656774~114656794:+ COAD cis rs950880 0.542 rs6543118 MIMAT0019927 hsa-miR-4772-3p 3.95 1e-04 0.2 0.24 Serum protein levels (sST2); chr2:102313009 chr2:102432336~102432357:+ COAD cis rs6681460 0.934 rs4655631 MIMAT0014979 hsa-miR-3117-3p -3.95 1e-04 -0.3 -0.24 Presence of antiphospholipid antibodies; chr1:66589224 chr1:66628485~66628505:+ COAD cis rs6681460 1 rs6689864 MIMAT0014979 hsa-miR-3117-3p -3.95 0.000101 -0.31 -0.24 Presence of antiphospholipid antibodies; chr1:66602429 chr1:66628485~66628505:+ COAD cis rs6681460 0.901 rs1373911 MIMAT0014979 hsa-miR-3117-3p -3.95 0.000102 -0.32 -0.24 Presence of antiphospholipid antibodies; chr1:66575382 chr1:66628485~66628505:+ COAD cis rs6681460 0.966 rs10889644 MIMAT0014979 hsa-miR-3117-3p -3.95 0.000102 -0.29 -0.24 Presence of antiphospholipid antibodies; chr1:66679639 chr1:66628485~66628505:+ COAD cis rs950880 0.542 rs12712135 MIMAT0019927 hsa-miR-4772-3p 3.95 0.000103 0.2 0.24 Serum protein levels (sST2); chr2:102314488 chr2:102432336~102432357:+ COAD cis rs7072216 0.77 rs1061115 MIMAT0026738 hsa-miR-1287-3p 3.94 0.000104 0.21 0.24 Metabolite levels; chr10:98417292 chr10:98395232~98395253:- COAD cis rs6681460 1 rs1536115 MIMAT0014979 hsa-miR-3117-3p -3.94 0.000105 -0.3 -0.24 Presence of antiphospholipid antibodies; chr1:66655318 chr1:66628485~66628505:+ COAD cis rs6981523 0.553 rs11989369 MIMAT0003266 hsa-miR-598-3p 3.94 0.000106 0.3 0.24 Neuroticism; chr8:11197876 chr8:11035221~11035242:- COAD cis rs6543140 0.89 rs61122764 MIMAT0019927 hsa-miR-4772-3p -3.94 0.000107 -0.23 -0.24 Blood protein levels; chr2:102383060 chr2:102432336~102432357:+ COAD cis rs10021731 0.793 rs12650568 MIMAT0003242 hsa-miR-577 3.93 0.000109 0.21 0.24 Optic disc area; chr4:114578461 chr4:114656774~114656794:+ COAD cis rs4851551 1 rs4851551 MIMAT0019927 hsa-miR-4772-3p -3.93 0.000109 -0.42 -0.24 Blood protein levels; chr2:102183770 chr2:102432336~102432357:+ COAD cis rs6681460 1 rs10789210 MIMAT0014979 hsa-miR-3117-3p -3.93 0.00011 -0.3 -0.24 Presence of antiphospholipid antibodies; chr1:66600347 chr1:66628485~66628505:+ COAD cis rs7072216 0.691 rs10786419 MIMAT0026738 hsa-miR-1287-3p 3.93 0.00011 0.21 0.24 Metabolite levels; chr10:98421183 chr10:98395232~98395253:- COAD cis rs6543140 0.964 rs1035126 MIMAT0019927 hsa-miR-4772-3p -3.92 0.000112 -0.23 -0.24 Blood protein levels; chr2:102403521 chr2:102432336~102432357:+ COAD cis rs6724465 0.673 rs77397607 MIMAT0014996 hsa-miR-3131 -3.92 0.000112 -0.38 -0.24 Height; chr2:219157074 chr2:219058725~219058747:- COAD cis rs113401313 0.541 rs79480054 MIMAT0000090 hsa-miR-32-5p 3.92 0.000112 0.23 0.24 CTACK levels; chr9:109362271 chr9:109046272~109046293:- COAD cis rs3915499 0.591 rs2733854 MIMAT0002174 hsa-miR-484 3.92 0.000113 0.17 0.24 Resting heart rate; chr16:15824841 chr16:15643301~15643322:+ COAD cis rs4713675 0.584 rs9368776 MIMAT0022975 hsa-miR-3934-3p -3.92 0.000114 -0.25 -0.24 Plateletcrit; chr6:33728628 chr6:33698191~33698212:+ COAD cis rs4711336 0.527 rs28651968 MIMAT0022975 hsa-miR-3934-3p -3.92 0.000115 -0.25 -0.24 Height; chr6:33749647 chr6:33698191~33698212:+ COAD cis rs6724465 0.673 rs7596389 MIMAT0014996 hsa-miR-3131 3.91 0.000117 0.37 0.24 Height; chr2:219150495 chr2:219058725~219058747:- COAD cis rs4865762 0.686 rs6867917 MIMAT0003246 hsa-miR-581 -3.91 0.000118 -0.25 -0.24 Intraocular pressure; chr5:53130776 chr5:53951564~53951584:- COAD cis rs12290811 0.572 rs77165503 MIMAT0004927 hsa-miR-708-3p 3.91 0.000118 0.27 0.24 Bipolar disorder; chr11:79419350 chr11:79402032~79402053:- COAD cis rs12612435 0.869 rs67150460 MIMAT0000424 hsa-miR-128-3p 3.91 0.000119 0.21 0.24 Takotsubo syndrome; chr2:136370631 chr2:135665446~135665466:+ COAD cis rs12612435 0.869 rs67150460 MIMAT0000424_1 hsa-miR-128-3p 3.91 0.000119 0.21 0.24 Takotsubo syndrome; chr2:136370631 chr3:35744527~35744547:+ COAD cis rs12612435 0.793 rs59951306 MIMAT0000424 hsa-miR-128-3p 3.91 0.000119 0.21 0.24 Takotsubo syndrome; chr2:136374497 chr2:135665446~135665466:+ COAD cis rs12612435 0.793 rs59951306 MIMAT0000424_1 hsa-miR-128-3p 3.91 0.000119 0.21 0.24 Takotsubo syndrome; chr2:136374497 chr3:35744527~35744547:+ COAD cis rs950880 0.553 rs2241116 MIMAT0019927 hsa-miR-4772-3p 3.91 0.00012 0.26 0.24 Serum protein levels (sST2); chr2:102386805 chr2:102432336~102432357:+ COAD cis rs6543140 0.964 rs4851578 MIMAT0019927 hsa-miR-4772-3p -3.91 0.00012 -0.23 -0.24 Blood protein levels; chr2:102412491 chr2:102432336~102432357:+ COAD cis rs6681460 0.625 rs2312154 MIMAT0014979 hsa-miR-3117-3p 3.91 0.00012 0.28 0.24 Presence of antiphospholipid antibodies; chr1:66607293 chr1:66628485~66628505:+ COAD cis rs950880 0.767 rs6710885 MIMAT0019927 hsa-miR-4772-3p -3.9 0.000122 -0.21 -0.24 Serum protein levels (sST2); chr2:102361077 chr2:102432336~102432357:+ COAD cis rs330203 0.519 rs17145639 MIMAT0022500 hsa-miR-5706 -3.9 0.000123 -0.31 -0.24 Iris color (a* coordinate);Iris color (b* coordinate); chr5:119661069 chr5:119154646~119154667:+ COAD cis rs12290811 0.506 rs968369 MIMAT0004927 hsa-miR-708-3p 3.9 0.000124 0.25 0.24 Bipolar disorder; chr11:79442036 chr11:79402032~79402053:- COAD cis rs7527798 0.577 rs34883952 MIMAT0004515 hsa-miR-29b-2-5p 3.9 0.000124 0.23 0.24 Erythrocyte sedimentation rate; chr1:207567523 chr1:207802492~207802513:- COAD cis rs1712517 0.873 rs7913461 MIMAT0022727 hsa-miR-1307-5p -3.9 0.000124 -0.16 -0.24 Migraine; chr10:103241568 chr10:103394341~103394361:- COAD cis rs6681460 0.932 rs523188 MIMAT0014979 hsa-miR-3117-3p -3.9 0.000125 -0.28 -0.24 Presence of antiphospholipid antibodies; chr1:66708739 chr1:66628485~66628505:+ COAD cis rs330203 0.574 rs330215 MIMAT0022500 hsa-miR-5706 -3.9 0.000125 -0.3 -0.24 Iris color (a* coordinate);Iris color (b* coordinate); chr5:119671335 chr5:119154646~119154667:+ COAD cis rs3771180 0.505 rs2160203 MIMAT0019926 hsa-miR-4772-5p 3.9 0.000125 0.29 0.24 Asthma; chr2:102344364 chr2:102432300~102432321:+ COAD cis rs11792861 0.962 rs72607161 MIMAT0000090 hsa-miR-32-5p 3.89 0.000126 0.2 0.24 Menarche (age at onset); chr9:109030360 chr9:109046272~109046293:- COAD cis rs114034759 0.655 rs73726303 MIMAT0000086 hsa-miR-29a-3p -3.89 0.000129 -0.34 -0.24 Bipolar disorder (early onset); chr7:131124556 chr7:130876748~130876769:- COAD cis rs11792861 0.926 rs7470160 MIMAT0000090 hsa-miR-32-5p 3.89 0.00013 0.2 0.24 Menarche (age at onset); chr9:109081966 chr9:109046272~109046293:- COAD cis rs11792861 0.926 rs1051474 MIMAT0000090 hsa-miR-32-5p 3.88 0.00013 0.2 0.24 Menarche (age at onset); chr9:109119576 chr9:109046272~109046293:- COAD cis rs35847492 1 rs35847492 MIMAT0019728 hsa-miR-4660 3.88 0.000131 0.28 0.24 Neuroticism; chr8:9418515 chr8:9048453~9048475:+ COAD cis rs1712517 0.873 rs1163086 MIMAT0022727 hsa-miR-1307-5p -3.88 0.000133 -0.16 -0.24 Migraine; chr10:103279822 chr10:103394341~103394361:- COAD cis rs7072216 0.587 rs2296435 MIMAT0026738 hsa-miR-1287-3p -3.88 0.000133 -0.22 -0.24 Metabolite levels; chr10:98422528 chr10:98395232~98395253:- COAD cis rs6681460 1 rs10889634 MIMAT0014979 hsa-miR-3117-3p 3.88 0.000134 0.3 0.24 Presence of antiphospholipid antibodies; chr1:66600228 chr1:66628485~66628505:+ COAD cis rs7735249 0.53 rs9686938 MIMAT0003246 hsa-miR-581 3.88 0.000134 0.5 0.24 Glomerular filtration rate (creatinine); chr5:54083472 chr5:53951564~53951584:- COAD cis rs7894407 0.629 rs11598702 MIMAT0005951 hsa-miR-1307-3p 3.88 0.000135 0.16 0.24 White matter hyperintensity burden; chr10:103138228 chr10:103394301~103394322:- COAD cis rs6543140 0.929 rs11465700 MIMAT0019927 hsa-miR-4772-3p -3.87 0.000135 -0.23 -0.23 Blood protein levels; chr2:102441208 chr2:102432336~102432357:+ COAD cis rs7072216 0.77 rs1061123 MIMAT0026738 hsa-miR-1287-3p 3.87 0.000136 0.21 0.23 Metabolite levels; chr10:98417240 chr10:98395232~98395253:- COAD cis rs7072216 0.587 rs2296435 MIMAT0005878 hsa-miR-1287-5p -3.87 0.000137 -0.29 -0.23 Metabolite levels; chr10:98422528 chr10:98395271~98395292:- COAD cis rs2456930 0.648 rs2261443 MIMAT0000458 hsa-miR-190a-5p 3.87 0.000138 0.26 0.23 Brain structure (temporal lobe volume); chr15:62387973 chr15:62823971~62823992:+ COAD cis rs17783634 0.509 rs11775489 MIMAT0003266 hsa-miR-598-3p -3.87 0.000138 -0.29 -0.23 Subjective well-being; chr8:11179334 chr8:11035221~11035242:- COAD cis rs4865762 0.514 rs2547526 MIMAT0003246 hsa-miR-581 -3.87 0.000138 -0.25 -0.23 Intraocular pressure; chr5:53141038 chr5:53951564~53951584:- COAD cis rs953387 0.628 rs2176716 MIMAT0026477 hsa-miR-128-1-5p 3.87 0.00014 0.21 0.23 Arthritis (juvenile idiopathic); chr2:136166123 chr2:135665411~135665433:+ COAD cis rs953387 0.666 rs11684458 MIMAT0026477 hsa-miR-128-1-5p 3.87 0.00014 0.21 0.23 Arthritis (juvenile idiopathic); chr2:136166586 chr2:135665411~135665433:+ COAD cis rs8064299 0.967 rs7420 MIMAT0017994 hsa-miR-3615 3.87 0.000141 0.23 0.23 Monocyte count; chr17:74769076 chr17:74748663~74748683:+ COAD cis rs6681460 1 rs6588207 MIMAT0014979 hsa-miR-3117-3p -3.86 0.000142 -0.29 -0.23 Presence of antiphospholipid antibodies; chr1:66600872 chr1:66628485~66628505:+ COAD cis rs950880 0.553 rs3755272 MIMAT0019927 hsa-miR-4772-3p 3.86 0.000142 0.25 0.23 Serum protein levels (sST2); chr2:102417365 chr2:102432336~102432357:+ COAD cis rs330203 0.574 rs1597713 MIMAT0022500 hsa-miR-5706 -3.86 0.000143 -0.29 -0.23 Iris color (a* coordinate);Iris color (b* coordinate); chr5:119666652 chr5:119154646~119154667:+ COAD cis rs7894407 0.623 rs10883846 MIMAT0005951 hsa-miR-1307-3p 3.86 0.000143 0.16 0.23 White matter hyperintensity burden; chr10:103198487 chr10:103394301~103394322:- COAD cis rs950880 0.56 rs11679191 MIMAT0019927 hsa-miR-4772-3p 3.86 0.000143 0.2 0.23 Serum protein levels (sST2); chr2:102310340 chr2:102432336~102432357:+ COAD cis rs79387448 0.638 rs74731686 MIMAT0019926 hsa-miR-4772-5p -3.86 0.000145 -0.36 -0.23 Gut microbiota (bacterial taxa); chr2:102427521 chr2:102432300~102432321:+ COAD cis rs7735249 0.618 rs7709659 MIMAT0003246 hsa-miR-581 3.86 0.000145 0.52 0.23 Glomerular filtration rate (creatinine); chr5:54086609 chr5:53951564~53951584:- COAD cis rs6681460 0.933 rs7554101 MIMAT0014979 hsa-miR-3117-3p 3.86 0.000145 0.28 0.23 Presence of antiphospholipid antibodies; chr1:66690789 chr1:66628485~66628505:+ COAD cis rs1712517 0.773 rs1063461 MIMAT0022727 hsa-miR-1307-5p -3.86 0.000145 -0.16 -0.23 Migraine; chr10:103289348 chr10:103394341~103394361:- COAD cis rs1712517 0.74 rs4293062 MIMAT0022727 hsa-miR-1307-5p -3.86 0.000145 -0.16 -0.23 Migraine; chr10:103292867 chr10:103394341~103394361:- COAD cis rs1712517 0.744 rs11191641 MIMAT0022727 hsa-miR-1307-5p -3.86 0.000145 -0.16 -0.23 Migraine; chr10:103293183 chr10:103394341~103394361:- COAD cis rs1712517 0.744 rs4293063 MIMAT0022727 hsa-miR-1307-5p -3.86 0.000145 -0.16 -0.23 Migraine; chr10:103293219 chr10:103394341~103394361:- COAD cis rs1712517 0.525 rs2271751 MIMAT0022727 hsa-miR-1307-5p -3.86 0.000146 -0.17 -0.23 Migraine; chr10:103415374 chr10:103394341~103394361:- COAD cis rs6681460 0.966 rs4655506 MIMAT0014979 hsa-miR-3117-3p -3.86 0.000146 -0.29 -0.23 Presence of antiphospholipid antibodies; chr1:66685128 chr1:66628485~66628505:+ COAD cis rs4917385 1 rs4917385 MIMAT0022727 hsa-miR-1307-5p 3.85 0.000147 0.17 0.23 Systemic lupus erythematosus; chr10:103243964 chr10:103394341~103394361:- COAD cis rs6981523 0.553 rs2409730 MIMAT0003266 hsa-miR-598-3p -3.85 0.000148 -0.3 -0.23 Neuroticism; chr8:11203129 chr8:11035221~11035242:- COAD cis rs6681460 0.837 rs6669023 MIMAT0014979 hsa-miR-3117-3p -3.85 0.00015 -0.28 -0.23 Presence of antiphospholipid antibodies; chr1:66706185 chr1:66628485~66628505:+ COAD cis rs6681460 0.932 rs492109 MIMAT0014979 hsa-miR-3117-3p 3.85 0.000151 0.29 0.23 Presence of antiphospholipid antibodies; chr1:66721450 chr1:66628485~66628505:+ COAD cis rs4713675 0.546 rs10947435 MIMAT0022975 hsa-miR-3934-3p -3.84 0.000154 -0.24 -0.23 Plateletcrit; chr6:33750298 chr6:33698191~33698212:+ COAD cis rs950880 0.767 rs12999364 MIMAT0019927 hsa-miR-4772-3p 3.84 0.000155 0.21 0.23 Serum protein levels (sST2); chr2:102357669 chr2:102432336~102432357:+ COAD cis rs950880 0.767 rs12998521 MIMAT0019927 hsa-miR-4772-3p 3.84 0.000155 0.21 0.23 Serum protein levels (sST2); chr2:102357957 chr2:102432336~102432357:+ COAD cis rs950880 0.796 rs12987977 MIMAT0019927 hsa-miR-4772-3p 3.84 0.000155 0.21 0.23 Serum protein levels (sST2); chr2:102358876 chr2:102432336~102432357:+ COAD cis rs4072705 0.967 rs4144630 MIMAT0004558 hsa-miR-181a-2-3p -3.84 0.000156 -0.26 -0.23 Menarche (age at onset); chr9:124676921 chr9:124692518~124692539:+ COAD cis rs7588654 1 rs2293072 MIMAT0014996 hsa-miR-3131 3.84 0.000158 0.54 0.23 Height; chr2:219180732 chr2:219058725~219058747:- COAD cis rs330203 0.574 rs55714737 MIMAT0022500 hsa-miR-5706 -3.83 0.000162 -0.3 -0.23 Iris color (a* coordinate);Iris color (b* coordinate); chr5:119662587 chr5:119154646~119154667:+ COAD cis rs330203 0.574 rs55977325 MIMAT0022500 hsa-miR-5706 -3.83 0.000162 -0.3 -0.23 Iris color (a* coordinate);Iris color (b* coordinate); chr5:119662723 chr5:119154646~119154667:+ COAD cis rs330203 0.574 rs56329994 MIMAT0022500 hsa-miR-5706 -3.83 0.000162 -0.3 -0.23 Iris color (a* coordinate);Iris color (b* coordinate); chr5:119663741 chr5:119154646~119154667:+ COAD cis rs330203 0.547 rs1823665 MIMAT0022500 hsa-miR-5706 -3.83 0.000162 -0.3 -0.23 Iris color (a* coordinate);Iris color (b* coordinate); chr5:119664058 chr5:119154646~119154667:+ COAD cis rs6681460 0.932 rs523956 MIMAT0014979 hsa-miR-3117-3p 3.83 0.000162 0.29 0.23 Presence of antiphospholipid antibodies; chr1:66722593 chr1:66628485~66628505:+ COAD cis rs216303 0.642 rs216314 MIMAT0000432 hsa-miR-141-3p -3.82 0.000165 -0.2 -0.23 Low vWF levels; chr12:6027414 chr12:6964155~6964176:+ COAD cis rs6543140 0.964 rs6761350 MIMAT0019927 hsa-miR-4772-3p -3.82 0.000165 -0.23 -0.23 Blood protein levels; chr2:102414316 chr2:102432336~102432357:+ COAD cis rs6543140 0.929 rs7602207 MIMAT0019927 hsa-miR-4772-3p -3.82 0.000165 -0.23 -0.23 Blood protein levels; chr2:102415906 chr2:102432336~102432357:+ COAD cis rs6543140 0.964 rs2160200 MIMAT0019927 hsa-miR-4772-3p -3.82 0.000165 -0.23 -0.23 Blood protein levels; chr2:102417503 chr2:102432336~102432357:+ COAD cis rs113401313 0.541 rs12551180 MIMAT0000090 hsa-miR-32-5p 3.82 0.000166 0.23 0.23 CTACK levels; chr9:109371131 chr9:109046272~109046293:- COAD cis rs12034383 0.783 rs11576522 MIMAT0004515 hsa-miR-29b-2-5p -3.82 0.000166 -0.2 -0.23 Erythrocyte sedimentation rate; chr1:207615924 chr1:207802492~207802513:- COAD cis rs4865762 0.692 rs1374058 MIMAT0003246 hsa-miR-581 3.82 0.000169 0.25 0.23 Intraocular pressure; chr5:53131816 chr5:53951564~53951584:- COAD cis rs6681460 0.899 rs502690 MIMAT0014979 hsa-miR-3117-3p -3.82 0.000169 -0.28 -0.23 Presence of antiphospholipid antibodies; chr1:66716720 chr1:66628485~66628505:+ COAD cis rs1163656 0.527 rs1402347 MIMAT0003287 hsa-miR-618 3.82 0.000169 0.46 0.23 Dental caries; chr12:80913217 chr12:80935796~80935818:- COAD cis rs6543140 0.964 rs6543136 MIMAT0019927 hsa-miR-4772-3p -3.82 0.00017 -0.22 -0.23 Blood protein levels; chr2:102449087 chr2:102432336~102432357:+ COAD cis rs1712517 0.873 rs7916056 MIMAT0022727 hsa-miR-1307-5p 3.82 0.00017 0.16 0.23 Migraine; chr10:103238157 chr10:103394341~103394361:- COAD cis rs12290811 0.515 rs12286448 MIMAT0004927 hsa-miR-708-3p 3.81 0.000172 0.26 0.23 Bipolar disorder; chr11:79410298 chr11:79402032~79402053:- COAD cis rs2871473 0.951 rs1030025 MIMAT0019926 hsa-miR-4772-5p -3.81 0.000174 -0.27 -0.23 Blood protein levels; chr2:102489152 chr2:102432300~102432321:+ COAD cis rs6681460 0.934 rs10889635 MIMAT0014979 hsa-miR-3117-3p -3.81 0.000174 -0.3 -0.23 Presence of antiphospholipid antibodies; chr1:66609892 chr1:66628485~66628505:+ COAD cis rs6543140 0.964 rs62154972 MIMAT0019927 hsa-miR-4772-3p -3.8 0.000177 -0.22 -0.23 Blood protein levels; chr2:102432278 chr2:102432336~102432357:+ COAD cis rs6681460 0.932 rs523132 MIMAT0014979 hsa-miR-3117-3p 3.8 0.000178 0.28 0.23 Presence of antiphospholipid antibodies; chr1:66708757 chr1:66628485~66628505:+ COAD cis rs7072216 0.65 rs10883089 MIMAT0026738 hsa-miR-1287-3p 3.8 0.000179 0.2 0.23 Metabolite levels; chr10:98403363 chr10:98395232~98395253:- COAD cis rs4713675 0.546 rs9348925 MIMAT0022975 hsa-miR-3934-3p -3.8 0.000179 -0.24 -0.23 Plateletcrit; chr6:33742919 chr6:33698191~33698212:+ COAD cis rs2456930 0.714 rs2261472 MIMAT0000458 hsa-miR-190a-5p -3.8 0.00018 -0.25 -0.23 Brain structure (temporal lobe volume); chr15:62388751 chr15:62823971~62823992:+ COAD cis rs1712517 0.524 rs4917384 MIMAT0022727 hsa-miR-1307-5p 3.8 0.00018 0.17 0.23 Migraine; chr10:103236031 chr10:103394341~103394361:- COAD cis rs7527798 0.577 rs10127904 MIMAT0004515 hsa-miR-29b-2-5p 3.8 0.00018 0.23 0.23 Erythrocyte sedimentation rate; chr1:207574762 chr1:207802492~207802513:- COAD cis rs1867631 0.585 rs5008753 MIMAT0014979 hsa-miR-3117-3p -3.8 0.00018 -0.27 -0.23 Menopause (age at onset); chr1:66626565 chr1:66628485~66628505:+ COAD cis rs4713675 0.565 rs60704560 MIMAT0022975 hsa-miR-3934-3p -3.8 0.00018 -0.24 -0.23 Plateletcrit; chr6:33745523 chr6:33698191~33698212:+ COAD cis rs12368653 0.641 rs11172300 MIMAT0004681 hsa-miR-26a-2-3p 3.8 0.000182 0.22 0.23 Multiple sclerosis; chr12:57682732 chr12:57824620~57824641:- COAD cis rs453301 0.653 rs11784393 MIMAT0019728 hsa-miR-4660 3.8 0.000184 0.25 0.23 Joint mobility (Beighton score); chr8:9045624 chr8:9048453~9048475:+ COAD cis rs75358501 0.901 rs79499040 MIMAT0014994 hsa-miR-3130-3p 3.79 0.000186 0.48 0.23 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206776206 chr2:206783245~206783265:- COAD cis rs75358501 0.901 rs79499040 MIMAT0014994_1 hsa-miR-3130-3p 3.79 0.000186 0.48 0.23 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206776206 chr2:206783277~206783297:+ COAD cis rs7072216 0.621 rs3750604 MIMAT0026738 hsa-miR-1287-3p 3.79 0.000187 0.23 0.23 Metabolite levels; chr10:98415824 chr10:98395232~98395253:- COAD cis rs6543140 0.964 rs6736135 MIMAT0019927 hsa-miR-4772-3p -3.79 0.000188 -0.22 -0.23 Blood protein levels; chr2:102448464 chr2:102432336~102432357:+ COAD cis rs6681460 0.932 rs2146904 MIMAT0014979 hsa-miR-3117-3p 3.79 0.000189 0.28 0.23 Presence of antiphospholipid antibodies; chr1:66694653 chr1:66628485~66628505:+ COAD cis rs113401313 0.573 rs74519113 MIMAT0000090 hsa-miR-32-5p 3.79 0.000189 0.22 0.23 CTACK levels; chr9:109383920 chr9:109046272~109046293:- COAD cis rs11792861 0.962 rs72607162 MIMAT0000090 hsa-miR-32-5p 3.79 0.00019 0.19 0.23 Menarche (age at onset); chr9:109031439 chr9:109046272~109046293:- COAD cis rs11792861 0.962 rs11789624 MIMAT0000090 hsa-miR-32-5p 3.79 0.00019 0.19 0.23 Menarche (age at onset); chr9:109033951 chr9:109046272~109046293:- COAD cis rs6681460 1 rs9662943 MIMAT0014979 hsa-miR-3117-3p 3.79 0.000191 0.3 0.23 Presence of antiphospholipid antibodies; chr1:66655449 chr1:66628485~66628505:+ COAD cis rs4713675 0.584 rs9394163 MIMAT0022975 hsa-miR-3934-3p -3.79 0.000191 -0.24 -0.23 Plateletcrit; chr6:33714637 chr6:33698191~33698212:+ COAD cis rs11792861 0.816 rs17792434 MIMAT0000090 hsa-miR-32-5p 3.78 0.000193 0.2 0.23 Menarche (age at onset); chr9:108905039 chr9:109046272~109046293:- COAD cis rs4865762 0.901 rs153618 MIMAT0003246 hsa-miR-581 3.78 0.000194 0.25 0.23 Intraocular pressure; chr5:53254409 chr5:53951564~53951584:- COAD cis rs113401313 0.512 rs75396397 MIMAT0000090 hsa-miR-32-5p 3.78 0.000196 0.22 0.23 CTACK levels; chr9:109348663 chr9:109046272~109046293:- COAD cis rs113401313 0.512 rs12685074 MIMAT0000090 hsa-miR-32-5p 3.78 0.000196 0.22 0.23 CTACK levels; chr9:109353407 chr9:109046272~109046293:- COAD cis rs12612435 0.869 rs16833899 MIMAT0000424 hsa-miR-128-3p 3.78 0.000196 0.19 0.23 Takotsubo syndrome; chr2:136362752 chr2:135665446~135665466:+ COAD cis rs12612435 0.869 rs16833899 MIMAT0000424_1 hsa-miR-128-3p 3.78 0.000196 0.19 0.23 Takotsubo syndrome; chr2:136362752 chr3:35744527~35744547:+ COAD cis rs6681460 1 rs6696927 MIMAT0014979 hsa-miR-3117-3p -3.78 0.000197 -0.29 -0.23 Presence of antiphospholipid antibodies; chr1:66604698 chr1:66628485~66628505:+ COAD cis rs7819412 0.595 rs10503416 MIMAT0003266 hsa-miR-598-3p 3.78 0.000197 0.27 0.23 Triglycerides; chr8:11130043 chr8:11035221~11035242:- COAD cis rs12290811 0.515 rs7127580 MIMAT0004927 hsa-miR-708-3p 3.78 0.000198 0.24 0.23 Bipolar disorder; chr11:79433812 chr11:79402032~79402053:- COAD cis rs6681460 0.966 rs10789215 MIMAT0014979 hsa-miR-3117-3p 3.78 0.000198 0.28 0.23 Presence of antiphospholipid antibodies; chr1:66685502 chr1:66628485~66628505:+ COAD cis rs10021731 0.725 rs1460770 MIMAT0003242 hsa-miR-577 -3.77 0.000199 -0.19 -0.23 Optic disc area; chr4:114484189 chr4:114656774~114656794:+ COAD cis rs7072216 0.666 rs11598689 MIMAT0026738 hsa-miR-1287-3p 3.77 0.000199 0.21 0.23 Metabolite levels; chr10:98396270 chr10:98395232~98395253:- COAD cis rs1712517 0.844 rs1163087 MIMAT0022727 hsa-miR-1307-5p -3.77 0.000202 -0.16 -0.23 Migraine; chr10:103283532 chr10:103394341~103394361:- COAD cis rs950880 0.56 rs10178436 MIMAT0019927 hsa-miR-4772-3p 3.77 0.000204 0.19 0.23 Serum protein levels (sST2); chr2:102310051 chr2:102432336~102432357:+ COAD cis rs1712517 0.524 rs1712509 MIMAT0022727 hsa-miR-1307-5p -3.77 0.000205 -0.17 -0.23 Migraine; chr10:103254113 chr10:103394341~103394361:- COAD cis rs6981523 0.553 rs11783045 MIMAT0003266 hsa-miR-598-3p -3.77 0.000206 -0.29 -0.23 Neuroticism; chr8:11198666 chr8:11035221~11035242:- COAD cis rs2303282 0.933 rs34793257 MIMAT0000430 hsa-miR-138-5p -3.76 0.000207 -0.26 -0.23 Breast cancer; chr16:56460159 chr16:56858527~56858549:+ COAD cis rs2303282 0.933 rs34793257 MIMAT0000430_1 hsa-miR-138-5p -3.76 0.000207 -0.26 -0.23 Breast cancer; chr16:56460159 chr3:44114234~44114256:+ COAD cis rs4713675 0.565 rs9368773 MIMAT0022975 hsa-miR-3934-3p -3.76 0.000208 -0.24 -0.23 Plateletcrit; chr6:33714764 chr6:33698191~33698212:+ COAD cis rs1712517 0.771 rs2008530 MIMAT0022727 hsa-miR-1307-5p -3.76 0.000209 -0.15 -0.23 Migraine; chr10:103299082 chr10:103394341~103394361:- COAD cis rs7527798 0.577 rs10127904 MIMAT0004673 hsa-miR-29c-5p 3.76 0.000209 0.19 0.23 Erythrocyte sedimentation rate; chr1:207574762 chr1:207801903~207801924:- COAD cis rs6681460 1 rs6697088 MIMAT0014979 hsa-miR-3117-3p 3.76 0.000209 0.3 0.23 Presence of antiphospholipid antibodies; chr1:66579041 chr1:66628485~66628505:+ COAD cis rs79387448 0.638 rs11465670 MIMAT0019926 hsa-miR-4772-5p -3.76 0.00021 -0.34 -0.23 Gut microbiota (bacterial taxa); chr2:102417980 chr2:102432300~102432321:+ COAD cis rs216303 0.554 rs216320 MIMAT0000432 hsa-miR-141-3p -3.76 0.00021 -0.2 -0.23 Low vWF levels; chr12:6034190 chr12:6964155~6964176:+ COAD cis rs216303 0.57 rs216321 MIMAT0000432 hsa-miR-141-3p -3.76 0.00021 -0.2 -0.23 Low vWF levels; chr12:6034818 chr12:6964155~6964176:+ COAD cis rs216303 0.642 rs216324 MIMAT0000432 hsa-miR-141-3p -3.76 0.00021 -0.2 -0.23 Low vWF levels; chr12:6036059 chr12:6964155~6964176:+ COAD cis rs7072216 0.77 rs7896828 MIMAT0005878 hsa-miR-1287-5p 3.76 0.000212 0.27 0.23 Metabolite levels; chr10:98410750 chr10:98395271~98395292:- COAD cis rs4713675 0.565 rs4713668 MIMAT0022975 hsa-miR-3934-3p -3.76 0.000212 -0.24 -0.23 Plateletcrit; chr6:33723019 chr6:33698191~33698212:+ COAD cis rs4713675 0.546 rs10947434 MIMAT0022975 hsa-miR-3934-3p -3.76 0.000212 -0.24 -0.23 Plateletcrit; chr6:33723724 chr6:33698191~33698212:+ COAD cis rs6543140 0.964 rs6748390 MIMAT0019927 hsa-miR-4772-3p -3.76 0.000214 -0.22 -0.23 Blood protein levels; chr2:102445715 chr2:102432336~102432357:+ COAD cis rs4865762 0.514 rs30093 MIMAT0003246 hsa-miR-581 3.76 0.000214 0.24 0.23 Intraocular pressure; chr5:53127408 chr5:53951564~53951584:- COAD cis rs4713675 0.584 rs9380375 MIMAT0022975 hsa-miR-3934-3p -3.76 0.000214 -0.24 -0.23 Plateletcrit; chr6:33714614 chr6:33698191~33698212:+ COAD cis rs11792861 0.926 rs58795279 MIMAT0000090 hsa-miR-32-5p 3.75 0.000217 0.19 0.23 Menarche (age at onset); chr9:109089622 chr9:109046272~109046293:- COAD cis rs11657269 0.518 rs8070021 MIMAT0000761 hsa-miR-324-5p 3.75 0.000217 0.18 0.23 TRAIL levels; chr17:6422894 chr17:7223343~7223364:- COAD cis rs1712517 0.771 rs7921655 MIMAT0022727 hsa-miR-1307-5p -3.75 0.000221 -0.15 -0.23 Migraine; chr10:103353944 chr10:103394341~103394361:- COAD cis rs7819412 0.521 rs10100660 MIMAT0003266 hsa-miR-598-3p -3.75 0.000222 -0.28 -0.23 Triglycerides; chr8:11181376 chr8:11035221~11035242:- COAD cis rs11792861 0.816 rs3763643 MIMAT0000090 hsa-miR-32-5p 3.74 0.000223 0.2 0.23 Menarche (age at onset); chr9:108933327 chr9:109046272~109046293:- COAD cis rs11792861 0.816 rs2275637 MIMAT0000090 hsa-miR-32-5p 3.74 0.000223 0.2 0.23 Menarche (age at onset); chr9:108933763 chr9:109046272~109046293:- COAD cis rs4713675 0.565 rs9348924 MIMAT0022975 hsa-miR-3934-3p -3.74 0.000224 -0.23 -0.23 Plateletcrit; chr6:33737659 chr6:33698191~33698212:+ COAD cis rs950880 1 rs950880 MIMAT0019927 hsa-miR-4772-3p 3.74 0.000227 0.21 0.23 Serum protein levels (sST2); chr2:102316102 chr2:102432336~102432357:+ COAD cis rs11792861 0.926 rs72607170 MIMAT0000090 hsa-miR-32-5p 3.74 0.000228 0.19 0.23 Menarche (age at onset); chr9:109074661 chr9:109046272~109046293:- COAD cis rs1712517 0.566 rs1163073 MIMAT0022727 hsa-miR-1307-5p 3.74 0.000228 0.17 0.23 Migraine; chr10:103263177 chr10:103394341~103394361:- COAD cis rs6681460 0.932 rs602513 MIMAT0014979 hsa-miR-3117-3p -3.74 0.00023 -0.27 -0.23 Presence of antiphospholipid antibodies; chr1:66711587 chr1:66628485~66628505:+ COAD cis rs10021731 0.725 rs72676244 MIMAT0003242 hsa-miR-577 3.74 0.00023 0.18 0.23 Optic disc area; chr4:114479168 chr4:114656774~114656794:+ COAD cis rs950880 0.56 rs6721346 MIMAT0019927 hsa-miR-4772-3p 3.73 0.000232 0.19 0.23 Serum protein levels (sST2); chr2:102309860 chr2:102432336~102432357:+ COAD cis rs730570 1 rs10141733 MIMAT0000453 hsa-miR-154-3p -3.73 0.000233 -0.27 -0.23 Type 2 diabetes; chr14:100676314 chr14:101059805~101059826:+ COAD cis rs1712517 0.771 rs11191676 MIMAT0022727 hsa-miR-1307-5p -3.73 0.000234 -0.15 -0.23 Migraine; chr10:103395309 chr10:103394341~103394361:- COAD cis rs953387 0.58 rs1519527 MIMAT0026477 hsa-miR-128-1-5p 3.73 0.000234 0.21 0.23 Arthritis (juvenile idiopathic); chr2:136210847 chr2:135665411~135665433:+ COAD cis rs7105056 1 rs4936054 MIMAT0000686 hsa-miR-34c-5p 3.73 0.000235 0.45 0.23 Immune reponse to smallpox (secreted IL-12p40); chr11:112386156 chr11:111513451~111513473:+ COAD cis rs11792861 0.855 rs72607165 MIMAT0000090 hsa-miR-32-5p 3.73 0.000237 0.19 0.23 Menarche (age at onset); chr9:109052218 chr9:109046272~109046293:- COAD cis rs6703335 0.687 rs4658560 MIMAT0019761 hsa-miR-4677-3p 3.72 0.000241 0.2 0.23 Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder; chr1:243355389 chr1:243346225~243346246:+ COAD cis rs2456930 0.714 rs2456932 MIMAT0000458 hsa-miR-190a-5p 3.72 0.000242 0.25 0.23 Brain structure (temporal lobe volume); chr15:62390947 chr15:62823971~62823992:+ COAD cis rs2456930 0.714 rs1850573 MIMAT0000458 hsa-miR-190a-5p 3.72 0.000242 0.25 0.23 Brain structure (temporal lobe volume); chr15:62391976 chr15:62823971~62823992:+ COAD cis rs12758548 0.624 rs12760161 MIMAT0004564 hsa-miR-214-5p 3.72 0.000242 0.14 0.23 Erythrocyte cadmium concentration in never smokers; chr1:172528734 chr1:172138857~172138878:- COAD cis rs10021731 0.725 rs6850121 MIMAT0003242 hsa-miR-577 -3.72 0.000242 -0.18 -0.23 Optic disc area; chr4:114484294 chr4:114656774~114656794:+ COAD cis rs75358501 0.901 rs76270461 MIMAT0014994 hsa-miR-3130-3p 3.72 0.000243 0.49 0.23 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206788929 chr2:206783245~206783265:- COAD cis rs75358501 0.901 rs76270461 MIMAT0014994_1 hsa-miR-3130-3p 3.72 0.000243 0.49 0.23 3-hydroxy-1-methylpropylmercapturic acid levels in smokers; chr2:206788929 chr2:206783277~206783297:+ COAD cis rs11792861 0.89 rs57387569 MIMAT0000090 hsa-miR-32-5p 3.72 0.000245 0.19 0.23 Menarche (age at onset); chr9:109158112 chr9:109046272~109046293:- COAD cis rs7829975 0.774 rs11775523 MIMAT0019728 hsa-miR-4660 3.72 0.000245 0.26 0.23 Mood instability; chr8:8821666 chr8:9048453~9048475:+ COAD cis rs6543140 0.964 rs6543138 MIMAT0019927 hsa-miR-4772-3p -3.72 0.000246 -0.21 -0.23 Blood protein levels; chr2:102449672 chr2:102432336~102432357:+ COAD cis rs7072216 0.77 rs942810 MIMAT0005878 hsa-miR-1287-5p 3.72 0.000246 0.27 0.23 Metabolite levels; chr10:98408103 chr10:98395271~98395292:- COAD cis rs6681460 0.932 rs603750 MIMAT0014979 hsa-miR-3117-3p -3.72 0.000246 -0.27 -0.23 Presence of antiphospholipid antibodies; chr1:66711805 chr1:66628485~66628505:+ COAD cis rs7072216 0.621 rs11189595 MIMAT0026738 hsa-miR-1287-3p 3.72 0.000249 0.22 0.23 Metabolite levels; chr10:98407565 chr10:98395232~98395253:- COAD cis rs79387448 0.638 rs7600961 MIMAT0019926 hsa-miR-4772-5p -3.71 0.00025 -0.34 -0.23 Gut microbiota (bacterial taxa); chr2:102418995 chr2:102432300~102432321:+ COAD cis rs10021731 0.691 rs6849064 MIMAT0003242 hsa-miR-577 -3.71 0.00025 -0.18 -0.23 Optic disc area; chr4:114483807 chr4:114656774~114656794:+ COAD cis rs216303 0.642 rs216335 MIMAT0000432 hsa-miR-141-3p -3.71 0.000251 -0.19 -0.23 Low vWF levels; chr12:6038839 chr12:6964155~6964176:+ COAD cis rs11792861 0.926 rs11788904 MIMAT0000090 hsa-miR-32-5p 3.71 0.000252 0.19 0.23 Menarche (age at onset); chr9:109102772 chr9:109046272~109046293:- COAD cis rs11792861 0.926 rs11787878 MIMAT0000090 hsa-miR-32-5p 3.71 0.000252 0.19 0.23 Menarche (age at onset); chr9:109104469 chr9:109046272~109046293:- COAD cis rs11792861 0.926 rs56899598 MIMAT0000090 hsa-miR-32-5p 3.71 0.000252 0.19 0.23 Menarche (age at onset); chr9:109104991 chr9:109046272~109046293:- COAD cis rs11792861 0.926 rs12683988 MIMAT0000090 hsa-miR-32-5p 3.71 0.000252 0.19 0.23 Menarche (age at onset); chr9:109105010 chr9:109046272~109046293:- COAD cis rs11792861 0.855 rs116127510 MIMAT0000090 hsa-miR-32-5p 3.71 0.000252 0.19 0.23 Menarche (age at onset); chr9:109106064 chr9:109046272~109046293:- COAD cis rs11792861 0.926 rs2271878 MIMAT0000090 hsa-miR-32-5p 3.71 0.000252 0.19 0.23 Menarche (age at onset); chr9:109106605 chr9:109046272~109046293:- COAD cis rs11792861 0.926 rs7870597 MIMAT0000090 hsa-miR-32-5p 3.71 0.000252 0.19 0.23 Menarche (age at onset); chr9:109109584 chr9:109046272~109046293:- COAD cis rs216303 0.57 rs216339 MIMAT0000432 hsa-miR-141-3p -3.71 0.000253 -0.22 -0.23 Low vWF levels; chr12:6040118 chr12:6964155~6964176:+ COAD cis rs950880 0.767 rs2287037 MIMAT0019927 hsa-miR-4772-3p 3.71 0.000253 0.2 0.23 Serum protein levels (sST2); chr2:102362568 chr2:102432336~102432357:+ COAD cis rs12758548 0.601 rs2227189 MIMAT0004564 hsa-miR-214-5p -3.71 0.000253 -0.15 -0.23 Erythrocyte cadmium concentration in never smokers; chr1:172614412 chr1:172138857~172138878:- COAD cis rs11792861 0.816 rs11790105 MIMAT0000090 hsa-miR-32-5p 3.71 0.000253 0.19 0.23 Menarche (age at onset); chr9:108969505 chr9:109046272~109046293:- COAD cis rs1712517 0.787 rs1163089 MIMAT0022727 hsa-miR-1307-5p -3.71 0.000254 -0.16 -0.23 Migraine; chr10:103284207 chr10:103394341~103394361:- COAD cis rs7072216 0.881 rs7082192 MIMAT0005878 hsa-miR-1287-5p 3.71 0.000254 0.26 0.23 Metabolite levels; chr10:98392087 chr10:98395271~98395292:- COAD cis rs7527798 0.535 rs34070762 MIMAT0004515 hsa-miR-29b-2-5p 3.71 0.000255 0.22 0.23 Erythrocyte sedimentation rate; chr1:207599263 chr1:207802492~207802513:- COAD cis rs7527798 0.535 rs17259038 MIMAT0004515 hsa-miR-29b-2-5p 3.71 0.000255 0.22 0.23 Erythrocyte sedimentation rate; chr1:207600557 chr1:207802492~207802513:- COAD cis rs7072216 0.77 rs1739 MIMAT0026738 hsa-miR-1287-3p 3.71 0.000255 0.2 0.23 Metabolite levels; chr10:98416582 chr10:98395232~98395253:- COAD cis rs950880 0.767 rs4851569 MIMAT0019927 hsa-miR-4772-3p 3.71 0.000255 0.2 0.23 Serum protein levels (sST2); chr2:102366787 chr2:102432336~102432357:+ COAD cis rs950880 0.767 rs1420098 MIMAT0019927 hsa-miR-4772-3p 3.71 0.000255 0.2 0.23 Serum protein levels (sST2); chr2:102367819 chr2:102432336~102432357:+ COAD cis rs950880 0.699 rs1882348 MIMAT0019927 hsa-miR-4772-3p 3.71 0.000255 0.2 0.23 Serum protein levels (sST2); chr2:102368211 chr2:102432336~102432357:+ COAD cis rs11792861 0.926 rs12686736 MIMAT0000090 hsa-miR-32-5p 3.71 0.000256 0.19 0.23 Menarche (age at onset); chr9:109126459 chr9:109046272~109046293:- COAD cis rs4865762 0.904 rs254198 MIMAT0003246 hsa-miR-581 3.71 0.000257 0.23 0.23 Intraocular pressure; chr5:53204982 chr5:53951564~53951584:- COAD cis rs4713675 0.565 rs942640 MIMAT0022975 hsa-miR-3934-3p -3.71 0.000258 -0.24 -0.23 Plateletcrit; chr6:33718665 chr6:33698191~33698212:+ COAD cis rs4713675 0.584 rs2966 MIMAT0022975 hsa-miR-3934-3p -3.71 0.000258 -0.24 -0.23 Plateletcrit; chr6:33721743 chr6:33698191~33698212:+ COAD cis rs4713675 0.565 rs4711341 MIMAT0022975 hsa-miR-3934-3p -3.71 0.000258 -0.24 -0.23 Plateletcrit; chr6:33723020 chr6:33698191~33698212:+ COAD cis rs6681460 0.932 rs618093 MIMAT0014979 hsa-miR-3117-3p -3.71 0.000258 -0.27 -0.23 Presence of antiphospholipid antibodies; chr1:66712745 chr1:66628485~66628505:+ COAD cis rs9646944 0.501 rs10202813 MIMAT0019927 hsa-miR-4772-3p -3.71 0.000259 -0.23 -0.23 Blood protein levels; chr2:102403280 chr2:102432336~102432357:+ COAD cis rs7527798 0.577 rs34883952 MIMAT0004673 hsa-miR-29c-5p 3.7 0.000259 0.18 0.23 Erythrocyte sedimentation rate; chr1:207567523 chr1:207801903~207801924:- COAD cis rs2456930 0.714 rs2459893 MIMAT0000458 hsa-miR-190a-5p 3.7 0.000262 0.24 0.23 Brain structure (temporal lobe volume); chr15:62393915 chr15:62823971~62823992:+ COAD cis rs4713675 0.565 rs4711343 MIMAT0022975 hsa-miR-3934-3p -3.7 0.000262 -0.23 -0.22 Plateletcrit; chr6:33746771 chr6:33698191~33698212:+ COAD cis rs11792861 0.888 rs75543406 MIMAT0000090 hsa-miR-32-5p 3.7 0.000263 0.19 0.22 Menarche (age at onset); chr9:109054623 chr9:109046272~109046293:- COAD cis rs11792861 0.926 rs3750451 MIMAT0000090 hsa-miR-32-5p 3.7 0.000263 0.19 0.22 Menarche (age at onset); chr9:109060586 chr9:109046272~109046293:- COAD cis rs35847492 1 rs17730481 MIMAT0019728 hsa-miR-4660 -3.7 0.000263 -0.27 -0.22 Neuroticism; chr8:9418653 chr8:9048453~9048475:+ COAD cis rs1712517 0.771 rs10883858 MIMAT0022727 hsa-miR-1307-5p -3.7 0.000267 -0.15 -0.22 Migraine; chr10:103367951 chr10:103394341~103394361:- COAD cis rs11792861 0.926 rs75128146 MIMAT0000090 hsa-miR-32-5p 3.7 0.000267 0.19 0.22 Menarche (age at onset); chr9:109071511 chr9:109046272~109046293:- COAD cis rs11792861 0.926 rs76689835 MIMAT0000090 hsa-miR-32-5p 3.7 0.000267 0.19 0.22 Menarche (age at onset); chr9:109071512 chr9:109046272~109046293:- COAD cis rs950880 0.961 rs13020553 MIMAT0019927 hsa-miR-4772-3p 3.69 0.000269 0.21 0.22 Serum protein levels (sST2); chr2:102315366 chr2:102432336~102432357:+ COAD cis rs7941030 1 rs1945390 MIMAT0010195 hsa-let-7a-2-3p 3.69 0.000269 0.17 0.22 HDL cholesterol;Cholesterol, total; chr11:122649545 chr11:122146523~122146544:- COAD cis rs4713675 0.565 rs4713670 MIMAT0022975 hsa-miR-3934-3p 3.69 0.000269 0.23 0.22 Plateletcrit; chr6:33732105 chr6:33698191~33698212:+ COAD cis rs4072705 0.967 rs10818984 MIMAT0004558 hsa-miR-181a-2-3p -3.69 0.000269 -0.24 -0.22 Menarche (age at onset); chr9:124651272 chr9:124692518~124692539:+ COAD cis rs11792861 0.781 rs28361152 MIMAT0000090 hsa-miR-32-5p 3.69 0.00027 0.19 0.22 Menarche (age at onset); chr9:108965249 chr9:109046272~109046293:- COAD cis rs2456930 0.714 rs2471028 MIMAT0000458 hsa-miR-190a-5p 3.69 0.00027 0.25 0.22 Brain structure (temporal lobe volume); chr15:62393995 chr15:62823971~62823992:+ COAD cis rs11792861 0.926 rs59904140 MIMAT0000090 hsa-miR-32-5p 3.69 0.000271 0.18 0.22 Menarche (age at onset); chr9:109147771 chr9:109046272~109046293:- COAD cis rs2871473 1 rs2871473 MIMAT0019926 hsa-miR-4772-5p -3.69 0.000272 -0.26 -0.22 Blood protein levels; chr2:102490821 chr2:102432300~102432321:+ COAD cis rs4713675 0.546 rs2296739 MIMAT0022975 hsa-miR-3934-3p -3.69 0.000273 -0.25 -0.22 Plateletcrit; chr6:33689192 chr6:33698191~33698212:+ COAD cis rs7527798 0.535 rs10158414 MIMAT0004515 hsa-miR-29b-2-5p 3.69 0.000274 0.22 0.22 Erythrocyte sedimentation rate; chr1:207597507 chr1:207802492~207802513:- COAD cis rs950880 1 rs13001325 MIMAT0019927 hsa-miR-4772-3p 3.69 0.000276 0.21 0.22 Serum protein levels (sST2); chr2:102322576 chr2:102432336~102432357:+ COAD cis rs7819412 0.521 rs10110684 MIMAT0003266 hsa-miR-598-3p -3.69 0.000277 -0.28 -0.22 Triglycerides; chr8:11181650 chr8:11035221~11035242:- COAD cis rs4072705 1 rs2067791 MIMAT0004558 hsa-miR-181a-2-3p -3.69 0.000277 -0.24 -0.22 Menarche (age at onset); chr9:124676015 chr9:124692518~124692539:+ COAD cis rs6981523 0.553 rs11783890 MIMAT0003266 hsa-miR-598-3p -3.68 0.000281 -0.3 -0.22 Neuroticism; chr8:11198879 chr8:11035221~11035242:- COAD trans rs1120787 0.793 rs625661 MIMAT0002817 hsa-miR-495-3p -6.29 1.35e-09 -0.4 -0.37 HIV-1 control; chr18:57347192 chr14:101033804~101033825:+ COAD trans rs6546537 0.91 rs10779953 MIMAT0003339 hsa-miR-421 -6.09 4.05e-09 -0.32 -0.36 Serum thyroid-stimulating hormone levels; chr2:69659625 chrX:74218392~74218414:- COAD trans rs1875517 0.518 rs1501869 MIMAT0003257 hsa-miR-550a-3p -6.09 4.13e-09 -0.31 -0.36 Waist circumference; chr3:117583190 chr7:29680748~29680769:- COAD trans rs1875517 0.518 rs1501869 MIMAT0003257_1 hsa-miR-550a-3p -6.09 4.13e-09 -0.31 -0.36 Waist circumference; chr3:117583190 chr7:30289854~30289875:+ COAD trans rs1875517 0.518 rs1501869 MIMAT0003257_2 hsa-miR-550a-3p -6.09 4.13e-09 -0.31 -0.36 Waist circumference; chr3:117583190 chr7:32733041~32733062:+ COAD trans rs488628 0.518 rs705265 MIMAT0004784 hsa-miR-455-3p 6.07 4.63e-09 0.41 0.35 White matter integrity (bipolar disorder risk interaction); chr3:118343939 chr9:114209487~114209507:+ COAD trans rs1875517 0.518 rs2036397 MIMAT0003257 hsa-miR-550a-3p 6.03 5.66e-09 0.31 0.35 Waist circumference; chr3:117581616 chr7:29680748~29680769:- COAD trans rs1875517 0.518 rs2036397 MIMAT0003257_1 hsa-miR-550a-3p 6.03 5.66e-09 0.31 0.35 Waist circumference; chr3:117581616 chr7:30289854~30289875:+ COAD trans rs1875517 0.518 rs2036397 MIMAT0003257_2 hsa-miR-550a-3p 6.03 5.66e-09 0.31 0.35 Waist circumference; chr3:117581616 chr7:32733041~32733062:+ COAD trans rs6546537 0.955 rs1396798 MIMAT0003339 hsa-miR-421 -6 6.78e-09 -0.33 -0.35 Serum thyroid-stimulating hormone levels; chr2:69660705 chrX:74218392~74218414:- COAD trans rs1155750 0.564 rs980823 MIMAT0000687 hsa-miR-299-3p 5.84 1.54e-08 0.58 0.34 Colorectal cancer; chr6:54989873 chr14:101023832~101023853:+ COAD trans rs10502386 0.716 rs12956492 MIMAT0019208 hsa-miR-3074-5p 5.83 1.7e-08 0.37 0.34 Obesity-related traits; chr18:8950562 chr9:95086063~95086083:- COAD trans rs2790232 1 rs78532356 MIMAT0004774 hsa-miR-501-3p -5.82 1.74e-08 -0.5 -0.34 Obesity-related traits; chr10:58333016 chrX:50009772~50009793:+ COAD trans rs2882834 0.597 rs1549862 MIMAT0003233 hsa-miR-551b-3p 5.81 1.81e-08 0.4 0.34 Capecitabine sensitivity; chr7:10350685 chr3:168551914~168551934:+ COAD trans rs2882834 0.597 rs2352102 MIMAT0003233 hsa-miR-551b-3p 5.81 1.81e-08 0.4 0.34 Capecitabine sensitivity; chr7:10350882 chr3:168551914~168551934:+ COAD trans rs2882834 0.607 rs35011145 MIMAT0003233 hsa-miR-551b-3p 5.81 1.81e-08 0.4 0.34 Capecitabine sensitivity; chr7:10351052 chr3:168551914~168551934:+ COAD trans rs2882834 0.597 rs13247104 MIMAT0003233 hsa-miR-551b-3p 5.81 1.81e-08 0.4 0.34 Capecitabine sensitivity; chr7:10351805 chr3:168551914~168551934:+ COAD trans rs2882834 0.633 rs6967157 MIMAT0003233 hsa-miR-551b-3p -5.8 1.91e-08 -0.41 -0.34 Capecitabine sensitivity; chr7:10396073 chr3:168551914~168551934:+ COAD trans rs11743006 0.626 rs1072158 MIMAT0018191 hsa-miR-3917 -5.75 2.46e-08 -0.45 -0.34 Mathematical ability; chr5:137168977 chr1:25906384~25906403:- COAD trans rs6922269 0.847 rs4869959 MIMAT0005924 hsa-miR-1270 5.75 2.57e-08 0.47 0.34 Coronary heart disease; chr6:150940403 chr19:20399320~20399342:- COAD trans rs2882834 0.597 rs10263548 MIMAT0003233 hsa-miR-551b-3p -5.74 2.63e-08 -0.39 -0.34 Capecitabine sensitivity; chr7:10366934 chr3:168551914~168551934:+